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The 2017 edition of the EU Industrial R&D Investment 
Scoreboard (the Scoreboard) comprises the 2500 
companies investing the largest sums in R&D in the 
world in 2016/17. These companies, based in 43 
countries, each invested over €24 million in R&D for a 
total of €741.6bn which is approximately 90% of the 
world’s business-funded R&D. They include 567 EU 
companies accounting for 26% of the total, 822 US 
companies for 39%, 365 Japanese companies for 14%, 
376 Chinese for 8% and 370 from the rest-of-the-world 
(RoW) for 13%. 
This report analyses the main changes in companies’ 
R&D and economic indicators over the past year and 
their performance over the past ten years. It also includes 
results from additional complementary studies on com-
panies’ productivity, their development of ICT-related 
technologies and scientific publication activity.
Summary
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Highlights
1 The 2500 companies raised their total R&D by a substantial 5.8% over the previous year, the sixth consecutive year of significant increases. The increase was driven by the ICT services sec-
tor (up 11.7%). The EU group raised its R&D by 7.0% - more than the global average, just less 
than the US (7.2%) but much more than Japan (-3.0%). China increased its R&D by 18.8% but 
its total R&D is still small compared to the size of its economy.
2 Turning to other performance measures, the 2500 companies increased sales by only 0.1% over the previous year, operating profits by 8.7% and employee numbers by 1.7% but capex 
was down by 6.2%. Overall R&D intensity (R&D as % sales) was 4.1%, capex intensity 6.7% and 
profitability (profit as % sales) 9.5%. 
3 Companies’ R&D and financial performance varies greatly across industries and, since the sector mix of different world regions is very different, so is regional performance. All major regions have 
two-thirds to three-quarters of their R&D in three major industries but with very different mixes. 
The EU has 29.7% of its R&D in automotive, 19.5% in ICT and 23.2% in Health with Japan fairly 
similar (30% automotive, ICT 24.3% and health 12%). The US, on the other hand, has only 8.1% 
in automotive but 49.2% in ICT and 26.5% in Health. China has some similarities to the US with 
12.5% in automotive and 44.1% in ICT but has only 3% in Health.
4 EU companies’ R&D growth is led by automotive together with ICT and health whereas in non-EU companies it is led by the ICT and health industries.
5 Global R&D is concentrated in the largest companies with 40% of total R&D accounted for by the top 50 companies and 53% by the top 100. A substantial number of the world’s top 
R&D investors are based in the EU with the top investor for the fourth consecutive year being 
Volkswagen. There are 16 EU companies in the world top 50 and 30 in the world top 100. The 
top 50 also contains 22 companies from the US, 10 from Asia and 2 from Switzerland. 
6 An analysis of the Scoreboard’s history database over the 10 year period 2007-16 shows that the EU’s share of world R&D has remained constant at 26% with the US’s rising a little to 40%, 
Japan’s falling from 24% to 16% but both China and the rest of the world rising.
9The 2017 EU Industrial R&D Investment Scoreboard
 7 An analysis of the six largest R&D sectors over this 10-year period shows interesting sec-toral and regional differences. The EU outperforms or performs comparably in size (of R&D 
and sales) and R&D intensity for Aerospace & Defence, Automobiles and Pharmaceuticals. 
But in Biotechnology, Software and IT hardware the EU shows persistent weakness in most 
indicators such as size and R&D/firm or sales/firm (in particular compared to the US). The EU/
non-EU gap in these latter three sectors has widened over the last ten years.
 8 The Scoreboard also contains extensive data on the 1000 top R&D investors in the EU drawn from 20 member states (the 567 in the global list plus another 433 with R&D be-
tween €7m and €24m). Nearly two-thirds of these companies are based in the three largest 
member states (Germany 224, UK 290 and France 108). The German companies show the 
largest sales growth with the UK showing the highest growth in R&D (and the highest prof-
itability).
 9 An analysis of firm performance shows that labour productivity (in terms of sales/employee) is 3 to 7 times higher for the most productive firms in a sector compared to the least pro-
ductive. The EU has the most productive firms in Chemicals, Industrials and low tech sector 
groups with US firms most productive in health and ICT.
10 The Scoreboard also contains a study of patent data for the ICT sector and an analysis of scientific publications by company authors for a range of different sectors.
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The top 2500 Scoreboard companies invested in R&D 
€741.6bn in 2016/17, an increase of 5.8% with respect to 
2015/16, following an increase of 6.8% in the year before. 
Companies also raised significantly operating profits 
(8.7%) and more modestly the number of employees 
(1.7%). In contrast, net sales showed only 0.1% growth 
while capital expenditures fell substantially by 6.2% (a 
Capex reduction of €77bn compared with the R&D 
increase of €64bn). Profitability has remained close to 
10% over the last five years. See evolution of key figures 
over the past 10 years in Figure S1.
The main contribution to the global R&D growth was 
made by the ICT and Health industries that also increased 
significantly their net sales. The overall fall in net 
sales was mostly due to low tech sectors, in particular 
due to oil-related companies, but was also caused by 
the Industrials and Chemicals sectors. The increase in 
operating profits was mostly due to high tech sectors 
(excepting ICT producers) whereas the decline in capital 
expenditures was mainly caused by the low tech and 
Automobiles sectors.
 In 2016/17, companies increased significantly their R&D investments and profits 
while showing an important decline in fixed capital investments, stagnation in 
revenue growth and a modest increase in number of employees
 Companies’ R&D and economic results varied greatly across industries
 EU companies raised R&D above the world’s average growth rate
Key findings
-15 
-10 
-5 
0 
5 
10 
15 
20 
2016 2015 2014 2013 2012 2011 2010 2009 2008 
(%
) 
R&D investment Net sales Profitability 
FIGURE S1: GLOBAL GROWTH RATE OF R&D AND NET SALES AND PROFITABILITY FOR THE PERIOD 2007-2016.
Note: growth rates for the three variables have been computed on 1697 out of the 2500 EU companies for which data are available for the entire period 2007-2016.
Source: The 2017 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
The 567 companies based in the EU invested €192.5bn in 
R&D, a substantial increase in this period (7.0%) although 
at a lower pace than in the previous year (8.1%). The 822 
companies based in the US and 376 in China showed a 
high R&D growth (7.2% and 18.8% respectively) while the 
365 Japanese companies reduced their R&D investment 
by 3.0%. See comparison of EU and global companies’ 
R&D growth in Figure S2.
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 Other indicators of EU companies showed mixed performance
 R&D growth in the EU driven by Automobiles, ICT producers and Health industries
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FIGURE S2: NOMINAL CHANGE OF R&D OVER THE PAST YEAR FOR THE EU AND WORLD SAMPLES OF COMPANIES.
Note: growth rates have been computed for 566 EU and 2493 World companies for which R&D data are available for both years 2015 and 2016.
Source: The 2017 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
The EU companies decreased significantly capital expendi-
tures, by 5.1% (a reduction of €18.5bn compared with 
the R&D increase of €12.6bn). The best performance of 
EU companies was in terms of profits (+16.7%) which led 
to a significant increase of their profitability level (from 
6.8% to 7.6%). The 567 companies employed 18.8million, 
2.2% more than the year before.
For the EU sample, the largest contribution1 to R&D growth 
was made by Automobiles, ICT producers and Health 
industries but with negative contributions by Aerospace 
& Defence and Chemicals. Among the largest member 
1 The company or sector contribution to the R&D growth of the sample is the nominal growth rate of the company or sector weighed by the R&D share of the company or sector.
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states, German and UK companies showed the highest 
R&D growth (7% and 9% respectively) while companies 
based in France and the Netherlands increased R&D at 
a lower than average rate (3.3%). In the EU sample, R&D 
growth was led by increases in R&D of companies such as 
NOKIA(96%), NXP(90%), SAP(13%), SHIRE(56%), ZF(40%), 
RENAULT(20%), DAIMLER(15%), CONTINENTAL(15%), 
GLAXOSMITHKLINE(12.9%) and ROBERT BOSCH(7.4%). 
R&D for some of these companies was increased by 
acquisitions, e.g. NOKIA’s acquisition of Alcatel-Lucent.
The largest contribution to the R&D growth of non-EU 
companies was made by ICT services, ICT producers and 
Health industries but with negative contributions by the 
Chemicals and Automobiles sectors. In the non-EU group, 
top R&D companies showing high R&D growth were 
HUAWEI (29%), APPLE (25%), GILEAD (55%), BROADCOM 
(155%), ALPHABET (13%), DELL (116%), BOEING (42%), 
FACEBOOK (23%), MICROSOFT (9%), and WESTERN 
DIGITAL (50%). R&D for some of these companies was 
increased by acquisitions, e.g. DELL’s $67bn acquisition 
of EMC.
For the 4th consecutive year the top R&D investor is the 
German company Volkswagen (€13.7bn). The 2nd and 
3rd positions are taken by the US companies Alphabet 
(€12.9bn) and Microsoft (€12.4bn). The other companies 
in the top-ten are Samsung from South Korea, Intel, Apple 
and Johnson & Johnson from the US, Novartis and Roche 
from Switzerland and Huawei from China.
Among the top 50 R&D investors there are 16 EU 
companies, one more than last year, and 30 companies 
among the top 100, same number as in last ranking (see 
ranking of top 50 in Chapter 4).
The world top 50 companies ordered by R&D intensity are 
naturally almost all from the high tech sectors of ICT and 
biotech. This top 50 includes 12 from the EU, 26 from the 
US, 10 from Asia and 2 from Switzerland.
 Non-EU companies’ R&D growth also led by ICT and Health industries
 An important number of top industrial R&D players are based in the EU
 The share of global R&D for EU companies remained stable over 2007-2016 …
Over the past 10 years, EU companies’ share of the total 
R&D remained practically unchanged, at about 26.0%. The 
main change in this indicator is observed for the Japa-
nese companies whose R&D share fell by ca. 8 percent-
age points. The loss of R&D share by Japanese companies 
corresponds to increases in R&D shares for other Asian 
countries, especially for companies based in China (see 
Figure S3).
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 … however, the sector composition of the EU sample underwent significant changes
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FIGURE S3: EVOLUTION OF R&D SHARES OF MAIN REGIONS OVER 2007-2016.
Note: Calculated for a sample of 1697 companies for which data are available for the entire period 2007-2016.
Source: The 2017 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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FIGURE S4: EVOLUTION OF GLOBAL R&D SHARES FOR THE EU COMPANIES BY INDUSTRIAL SECTOR. 
Note: Calculated for a sample of 402 companies for which data on R&D, Net Sales and Operating Profits are available for the entire period 2007-2016.
Source: The 2017 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
EU companies increased significaltly their share of 
global R&D in the Automobiles & other transport sector 
(from 36% to 44%) and reduced their contribution to 
the total R&D of Aerospace & Defence (from 48% to 
42%). In contrast, US companies strongly increased their 
global R&D share in ICT services (from 66% to 75%) 
while decreasing their contribution to the world R&D of 
Automobiles (from 25% to 19%). On the other hand, the 
R&D share of Chinese companies increased for all sectors 
whereas that of companies based in Japan fell across the 
bord. See evolution of global R&D shares for EU companies 
in Figure S4 and companies’ R&D specialisation (sector’s 
share within the region) for the EU and World samples in 
Figure S5.
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In relative terms, Chinese companies showed the largest 
increases in all the three indicators, however, in absoute 
terms, the largest increase in R&D was made by the US 
companies and that of employment by companies based 
in the EU. 
A closer look to the EU and US data show that their 
companies increased both net sales and employment at 
a similar rate (ca. 14%, i.e. labour poductivity unchanged). 
However, they show contrasting differences in the net 
sales/employees ratio at sector level (see Table S1 and 
Figure S6). For example:
- In Automobiles, EU 17.2% vs. US -14.6%; 
- in ICT sectorss, EU -1.1% vs. US 31.1% and
- in Others (mainly low tech sectors), both with negative 
performance, EU -10.1% vs. US -33%.
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FIGURE S5: R&D SPECIALISATION (SECTORS’ SHARES WITHIN EACH REGION) FOR EU AND WORLD COMPANIES IN 2007 AND 2016.
Note: shares computed for 456 EU and 1836 World companies for with R&D data are available for the all period 2007-2016.
Source: The 2017 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
 An analysis of 10-year changes in R&D, net sales and employment across regions 
and sectors show characteristic structural differences2
2 For a set of 1476 companies that reported R&D, net sales and number of employees over the whole period 2007-2016, EU-400, US-503, Japan-343, China-96 and 
RoW group-134 (see sectors definition in Chapter 1).
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The 10-year trajectory of EU companies is compared 
against their non-EU counterparts for six sectors where 
R&D is a critical competitiveness factor.
For the first three sectors (Aerospace & Defence, 
Automobiles and Pharmaceuticals), EU companies 
outperform or show comparable performance to their 
global counterparts in terms of the main performance 
ratios (R&D/firm, net sales/firm, R&D/net sales) and show 
a very large size of both R&D and sales compared to the 
weight of the EU economy in the world (see Table S2). 
But in three other high tech sectors (Biotechnology, 
Software and IT-hardware), EU companies show persistent 
weaknesses compared to their non-EU counterparts in 
most of the indicators (in particular due to the strong 
34.7% 
17.2% 
-0.3% 
13.0% 
-1.1% -2.8% 
-10.1% 
31.6% 
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FIGURE S6: CHANGE OF THE NET SALES/EMPLOYEES RATIO OVER 2007-2016 FOR THE EU AND US COMPANIES BY SECTOR.
Note: For a set of 400 EU and 503 US companies for which all variables are available over the 2007-2016 period.
Source: The 2017 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
 An analyisis of company dynamics for the six largest R&D sectors over the past 10 
years show strenghts, weaknesses and challenges for EU companies
Region Sector
R&D (€ bn.) Net Sales (€ bn.) Employment (million)
2007 2016 2007 2016 2007 2016
EU
Aerospace & Defence 7.7 8.8 117.0 173.8 0.5 0.5
Automobiles & other transport 28.9 53.0 628.0 967.6 2.2 2.9
Chemicals 4.0 5.0 169.0 194.0 0.4 0.5
Health industries 25.8 41.0 212.7 358.6 0.9 1.3
ICT sectors 24.6 34.3 476.8 516.5 2.2 2.4
Industrials 7.0 10.1 492.6 496.1 2.4 2.5
Others 10.9 16.4 2062.2 2015.1 5.1 5.5
US
Aerospace & Defence 7.6 9.7 224.9 271.4 0.8 0.7
Automobiles & other transport 5.9 7.8 227.0 223.4 0.7 0.8
Chemicals 4.9 6.6 171.8 178.5 0.3 0.3
Health industries 35.3 62.9 370.6 610.8 0.8 1.0
ICT sectors 69.2 119.9 850.1 1266.1 2.8 3.2
Industrials 7.7 11.0 388.8 356.5 1.2 1.2
Others 12.4 15.5 1233.9 1025.2 1.8 2.2
TABLE S1: R&D, NET SALES AND EMPLOYEES FOR THE EU AND US COMPANIES BY SECTOR IN 2007 AND 2016.
Note: For a set of companies that reported R&D, net sales and number of employees over the whole period 2007-2016, EU-400, US-503 (see sectors definition in Chapter 1).
Source: The 2017 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
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performance of US companies). In general the EU 
companies show much lower ratios3 of R&D/firm and 
Sales/firm and only in terms of R&D intensity do they have 
a similar ratio (Biotechnology) or higher ratio (Software 
and IT-hardware). The EU sample also has a much smaller 
size in terms of both R&D and net sales for all these three 
sectors, well below the weight of the EU economy in the 
world. It is also observed that the EU/non-EU gap in these 
three sectors has widened over the past 10 years.
Depending on the sector, the labour productivity is be-
tween 3 and 7 times higher for the most productive firms 
and this gap is rather stable over the 10-yer period. 
The top and bottom performers present distinctive fea-
tures such as the ratio R&D per employee that is consist-
ently higher for top performers or the capital expenditures 
that mostly differ across sectors. 
The geographic distribution of top performers is very sec-
tor specific with the EU hosting the largest shares of the 
most productive firms from the Chemicals, Industrials and 
low tech sector groups, whereas most of the top perform-
ers from the Health and ICT sectors are located in the 
US. Chinese firms have not managed to gain a significant 
share amongst the top performers.
3 Except for IT hardware where the R&D/firm is higher for the EU companies.
Sector Region
N. of 
firms
R&D/firm 
in 2016/17 
(€million)
 Net sales/firm 
in 2016/17  
(€million)
 R&D 
intensity (%)
 ratio EU/non-EU 
for R&D
 ratio EU/non-EU 
for Net sales
Aerospace & 
Defence
EU 16 554.7 11029.5 5.0
0.70 0.55
non-EU 33 383.4 9725.3 3.9
Automobiles
EU 36 1495.5 26975.1 5.5
0.89 0.60
non-EU 126 479.3 12834.3 3.7
Pharmaceuticals
EU 53 699.9 5095.6 13.7
0.49 0.47
non-EU 145 519.8 3929.4 13.2
Biotechnology
EU 30 78.9 328.5 24.0
0.09 0.10
non-EU 127 214.0 816.3 26.2
Software
EU 45 185.9 1647.8 11.3
0.10 0.10
non-EU 223 358.2 3318.5 10.8
IT hardware
EU 29 551.9 3506.1 15.7
0.15 0.08
non-EU 246 423.2 5183.7 8.2
TABLE S2: MAIN INDICATORS ON SELECTED INDUSTRIES FOR THE EU AND NON-EU SAMPLES OF COMPANIES.
Source: The 2017 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
 An analysis of the performance of firms in terms of labour productivity (net sales 
per employee) shows a significant gap between the most productive firms and the 
lagging firms for both the main industries and the major world regions
 A study based on patent data shows the development of ICT-related technologies by 
the Scoreboard companies, the positioning of the EU and the actual location of the 
innovation activity
As shown by the Scoreboard R&D figures, EU companies 
lag behind in the development of ICT technologies. Only 
one fourth of the total patent families by EU companies 
relate to digital technologies whereas 81% of those by the 
Chinese companies are ICT-related, 37% by US ones and 
33% by companies based in Japan.
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 A bibliometric study shows that the Scoreboard companies are actively engaged 
in scientific publications in a wide range of fields, very often in collaboration with 
academia  
Top target ICT subfields are High-speed network, Mobile 
communication, Security, and Large capacity information 
analysis. EU companies also specialise in Electronic 
measurement and Sensor and device network.
Sectoral specificities arise in the development of digital 
technologies. Large capacity information analysis is 
particularly relevant in the Software and Pharmaceuticals 
& Biotech industries. The Aerospace & Defence industry is 
very active in the development of a diversified portfolio of 
digital technologies.
EU and US companies rely to a great extent on inventors 
located abroad. This is particularly true for ICT-related 
technologies where respectively about one fourth and 
one third of patents by EU and US companies depend on 
international inventors.
Article publication in peer reviewed journals is a 
widespread phenomenon among top R&D investors. 
Engaging in scientific publications does not seem to be a 
choice of a few firms, but is quite common among firms 
actively engaged in R&D. There is a positive correlation 
between a firm’s R&D expenditure and the number of 
publications to which the firm has contributed just as 
there is with patents.
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The 2017 edition of the “EU Industrial R&D Investment 
Scoreboard” (the Scoreboard)4 comprises the 2500 
companies investing the largest sums in R&D in the 
world and an additional 433 companies to provide data 
on the top 1000 R&D investing companies based in 
the EU5. In total, there are 2933 companies incorporated 
in the 2017 Scoreboard. 
In order to avoid double counting, The Scoreboard considers 
only data from parent or independent companies. Normally, 
these companies integrate into their consolidated accounts 
the data of their subsidiary companies. 
Companies’ R&D rankings are based on information taken 
from the companies’ latest published accounts. For most 
companies these correspond to calendar year 2016, but 
significant proportions have financial years ending on 31 
March 2017 (Japanese companies in particular). There are 
few companies included with financial years ending as 
late as end June 2017 and a few for which only accounts 
to end 2015 were available.
It should be noted that the Scoreboard relies on the 
disclosure of R&D investment in companies’ published 
annual reports and accounts and that due to different 
national accounting and disclosure practices, companies 
of some countries are less likely than others to disclose 
R&D investment consistently. For example, it is a legal 
requirement in some countries that R&D investment is 
disclosed in company annual reports. For these reasons, 
companies from some countries such as Southern or 
Eastern European countries might be under-represented 
while others such as the companies from the UK could be 
over-represented. 
The overall coverage in terms of R&D is similar to 
previous editions. The total amount of R&D investment of 
companies included in the Scoreboard (€741.6 billion) is 
equivalent to more than 90% of the total expenditure on 
R&D financed by the business sector worldwide6.
The Scoreboard collects key information to enable the 
assessment of the R&D and economic performance of 
companies. The main indicators, namely R&D investment, 
net sales, capital expenditures, operating profits and 
number of employees are collected following the same 
methodology, definitions and assumptions applied in 
previous editions. This ensures comparability so that the 
companies’ economic and financial data can be analysed 
over a longer period of time. 
The capacity of data collection is enhanced by information 
gathered about the ownership structure of the Scoreboard 
parent companies and the main indicators for their 
subsidiaries. In 2017, we have collected available 
indicators reported by the more than 700.000 subsidiary 
companies involved in this Scoreboard edition. This allows 
a better characterisation of companies, in particular 
regarding the sectoral and geographic distribution of their 
research and production activities and the related patterns 
of growth and employment. 
As shown in last year’s Scoreboard, the analysis of key 
indicators such as patent data of parent companies and 
their subsidiaries allows the reassignment of companies 
to countries where they perform their actual economic or 
innovation activity. 
In this edition we have continued to use the patent data of 
parent companies and their subsidiaries to characterise the 
location of companies’ innovation activity and technological 
profile. 
Introduction
4 The EU Industrial R&D Investment Scoreboard is published annually by the European Commission (JRC-Seville/DG RTD) as part of the Industrial Research and Innovation 
Monitoring and Analysis project (IRIMA). 
5 In this report, the term EU company refers to companies whose ultimate parent has its registered office in a Member State of the EU. Likewise, non-EU company applies 
when the ultimate parent company is located outside the EU (see also the glossary and definitions in Annex 2 as well as the handling of parent companies and subsidiaries).
6 According to the latest figures reported by Eurostat, i.e. R&D financed by the business enterprise sector in 2015 compared with R&D figures in the 2016 Scoreboard.
Report structure
In this edition, we are using a different structure of the 
EU R&D Scoreboard report, organising differently the 
description of data and the analytical parts and giving 
more emphasis to long-term issues supported by our 
extensive history database.
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In chapter 1 we provide an overview of the main 
characteristics of the industrial R&D, including the main 
economic factors and technological drivers that have 
shaped R&D investments over the past year. The dataset 
of this Scoreboard edition is described in detail and, in 
particular, the geographic and sector distribution of R&D and 
its concentration at company, industry and country levels.
Chapter 2 presents an overview of global trends for industrial 
R&D. It outlines the main indicators for the top 2500 
companies and the main changes that took place over the 
past year. Companies are aggregated by industry and world 
region to analyse their performance in terms of R&D, net 
sales, profitability and employment over the past 10 years.
Chapter 3 presents an analysis of the main R&D and 
economic indicators of companies aggregated by industrial 
sector, with comparisons of EU companies and their main 
worldwide counterparts. This chapter also includes an 
analysis of company R&D dynamics over the past 10 
years for selected high R&D investing industries. 
The performance of individual companies among the top 
R&D investors is analysed in chapter 4. The list of the top 
50 and top 100 R&D companies is examined highlighting 
those companies showing remarkable R&D and economic 
results and improvement in their R&D ranking over the last 
13 years. It also includes an analysis of the ranking of the 
top 50 large companies by R&D intensity.
Chapter 5 discusses trends in the R&D and economic 
performance of companies included in the extended 
sample comprising the top 1000 R&D investors based in 
the EU and focused on the ten largest countries of the EU 
accounting for more than 98% of the total R&D of the 
sample of all 1000 companies based in the EU. 
Chapter 6 analyses the performance and dynamics of firms 
in terms of labour productivity (net sales per employee), 
comparing the most productive firms with the lagging 
firms for main industries and world regions.
In chapter 7, patent data are applied to investigate the 
development of ICT-related technologies by the Scoreboard 
companies. The chapter aims to identify the companies 
leading the development of relevant ICT technologies, to 
assess the positioning of EU companies and to analyse 
the actual location of companies’ innovation activity.
Finally, chapter 8 presents the results of an exercise 
aiming to assess the scientific publication activity of 
the Scoreboard companies. It is based on information 
collected and analysed regarding articles by authors 
affiliated to Scoreboard parent companies and their 
subsidiaries, published in peer reviewed journals over the 
period 2011-2015. 
The data have been collected by Bureau van Dijk Electronic 
Publishing GmbH, following the same approach and 
methodology applied since the first Scoreboard edition in 
2004. For background information please see Annex 1. 
The methodological approach of the Scoreboard, its 
scope and limitations are described in Annex 2, including a 
summary of main caveats in Box A2.1.
The sector and country composition of the EU 1000 
sample is found in Annex 3. The access to the full dataset 
is shown in Annex 4. 
The complete data set is freely accessible online at: http://
iri.jrc.ec.europa.eu/scoreboard17.html
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This section summarises the main economic factors and technological trends that affected companies’ R&D 
investment in the period 2016/17 covered by this report.
The industrial R&D landscape1
This chapter provides an overview of global industrial R&D and main economic factors 
and technological drivers that have shaped corporate R&D investments over the past 
year. It outlines the main characteristics of the 2017 Scoreboard dataset, including 
the distribution of companies and their R&D investments by country, world region and 
industrial sectors.
1.1 | Economic context and technological drivers
1.1.1 Economic environment for the Scoreboard companies in 2016/17
Three of the major external economic and governmental 
issues affecting the business environment for R&D were 
interest rates, the oil price and growth rates of the major 
world economies. On the political front, there were no 
major surprises in 2017’s elections in France, Germany 
and The Netherlands compared with those seen in 2016 
(Brexit and the US presidency). The three economic issues 
are each discussed below.
Interest rates are important for companies since they 
determine the cost of borrowing for investment. Interest 
rates have been extraordinarily low since the financial crisis 
and observers were watching the US Federal Reserve (the 
Fed) throughout 2015 to see when the first rate rise would 
occur. The Fed eventually raised rates from zero to 0.25% 
in December 2015 with another rise in December 2016 
(from 0.25% to 0.5%). The Fed predicted three more rises 
in 2017. The first of these occurred in March and the second 
in June – both by another 0.25% – while the third is likely 
to happen in December with further increases expected in 
2018. The Bank of England raised its interest rate from 
the 0.25% to 0.5% in early November and indicated that 
two more rises were likely in 2018. In addition, the Fed 
has already announced that it is to put its multi-trillion-
dollar QE programme into gradual reverse from October 
2017 although its asset-trimming programme would 
be suspended should economic conditions deteriorate 
substantially. Then in late October the ECB announced it 
was reducing its QE programme starting in January 2018. 
Monthly asset purchases are being halved from €60bn 
to €30bn although the programme of purchases is being 
extended to September 2018 (or beyond if necessary). It 
therefore looks as if the Fed, the ECB and the BoE all want 
to return to normality although they remain concerned 
about raising rates/reducing QE too fast and thereby 
slowing economic growth while inflation remains low. The 
Fed’s series of interest rate increases and the recent one 
by the BoE are likely to be followed later on by other central 
banks. The reason is that central banks all need to raise 
interest rates and wind down QE so that they regain the 
firepower needed to deal with future financial instabilities.
Average crude oil prices had been a little above $100/
barrel for the year up to mid-2014 but then began a 
steady decline to under $30/barrel in January 2016. There 
was a limited recovery to $54/barrel in January/February 
2016 but since mid-August 2016 the price has remained 
in the range of approximately $44-$54 per barrel and 
was around $50/barrel in mid-October 2017. The prices 
of other commodities such as metals have recovered in 
2017 from lows in the period Q3 2015 to Q3 2016. What 
seems to be happening for oil is that US shale producers 
have lowered their costs so that they can sell profitably in 
the $44-$54 range and this limits OPEC’s ability to raise 
prices even when its members can agree to limit output. A 
relatively low and stable oil price as we have had for over 
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a year is helpful for economic stability (the 1970s showed 
the harmful effects on economies of sudden and large oil 
price rises).
Economic growth has been modest but positive in the 
major economies and there have been no major political 
surprises. The surprises of 2016 have had less effect than 
predicted – Brexit did not have much effect on UK growth 
in 2016 and Donald Trump’s election did not spur growth 
as some expected mainly because the anticipated tax 
changes and substantial infrastructure investment have 
not happened yet. In June 2017 the OECD described the 
economic outlook as “Better but not good enough”. Real 
world GDP growth is expected by the OECD to be 3.5% 
in 2017, up from 3% in 2016. A small further increase to 
3.6% is expected for 2018. In the developed world, 2017 
growth is expected to be led by the US with 2.1% followed 
by the Eurozone (1.8%) and Japan (1.4%). 
Central banks’ progress in normalising interest rates and 
the OECD growth projections suggest that companies are 
likely to view 2017-18 fairly optimistically. Combined with 
a wealth of technological opportunities in the main R&D-
intensive sectors, that means R&D directors should be 
able to argue for higher R&D budgets in 2018 provided 
they can present their CEO’s with innovative project and 
new product proposals.
In the next section, Figure 1.5 shows that three broad 
sectors - ICT, Health and automotive – account for three-
quarters of the R&D of the top 2,500 companies. Fig 1.6 
shows that the largest of these three sectors by R&D in 
the EU and Japan is automotive while ICT is the largest in 
the US and China. This section therefore highlights areas 
of active development in these three major sectors – 
transport (particularly electric & self-driving technologies), 
ICT (robotics & artificial intelligence (AI) and their 
applications including to transport) and health (cancer 
immunotherapy, gene editing and stem cells). 
Any major technological change in a sector creates 
winners and losers – this was graphically illustrated by 
the demise of Kodak as photography transitioned from 
chemical to digital image recording. Another example is 
smartphones where leaders in mobile telephony such 
as Nokia and Motorola failed to make the transition to 
smartphones which are now dominated by new entrants 
such as Apple and Samsung. In the same way some 
current automotive manufacturers are likely to suffer like 
Kodak while others will succeed in adapting. At the same 
time new entrants such as Tesla, Waymo (Google) and 
Dyson have opportunities to grow their market shares 
with innovative new electric/self-driving car products. The 
following sections describe recent developments in the 
transport, ICT and health sectors:
Electric vehicles
Automotive is the third largest sector by amount of R&D 
in the 2017 Scoreboard and the largest single sector 
in both the EU and Japan. During 2016/17 there have 
been important political, technological and commercial 
announcements about electric vehicles. The UK and French 
governments have both said that all new vehicles sold in 
their countries from 2040 must have electric propulsion. 
And Volvo announced in July 2017 that all their new cars 
introduced from 2019 will be either electric or hybrid. 
The cost of lithium batteries is being reduced – as, for 
example, in the batteries produced by Tesla’s large new 
battery factory. This has enabled Tesla to introduce its new 
model 3 at a starting US price of $35,000. 
Several mainstream vehicle manufacturers have also 
announced plans for ranges of new electric models. 
These include Volkswagen (pledged 50 pure electric 
and 30 hybrids by 2025), Daimler (entire portfolio to 
be electrified by 2022), Renault (50% electric or hybrid 
by 2022) and Honda (two-thirds of European sales to 
be offered with a hybrid option by 2025). But there are 
also new entrants in addition to Tesla. For example, Sir 
1.1.2 Key technological trends affecting the top R&D investing companies
Transport
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ICT, Robotics and AI
James Dyson announced in September 2017 that his 
company (Dyson) is investing £2.5bn to produce “a unique 
electric car” with robotic partially driverless abilities which 
would be on the market by 2020. Other new entrants 
are Faraday Future of the US (which has just acquired 
its first factory in California) and Rimac of Croatia which 
makes electric supercars. European autocatalyst makers 
such as Johnson Matthey and Umicore are investing 
in novel battery technology and substantial investment 
is now going into the charging infrastructure needed for 
electric vehicles – for example, Shell is planning to install 
fast chargers in its worldwide petrol stations starting in 
the UK and Netherlands. Improved infrastructure together 
with lower prices and improved performance from better 
batteries will help grow the electric vehicle market.
And it is not just road vehicles; in September 2017 
EasyJet, the budget airline, announced a partnership with 
Wright Electric of the US to develop, within a decade, 
a battery-propelled aircraft for short haul flights of up to 
535km.
Batteries 
The battery is the most expensive component in an 
electric car and determines key parameters such as the 
range and recharge time (and too many rapid recharges 
can degrade current batteries). Recent developments 
include Panasonic and Tesla’s new, lower cost lithium 
battery pack used in Tesla’s latest model. But the future is 
likely to be in solid state batteries to give increased range 
with longer life and reduced charging time. Toyota, for 
example, is working on an improved lithium battery with 
a solid electrolyte and other solid state batteries are likely 
to follow. Dyson is very likely to use a solid state battery in 
its new electric car based on technology from the Sakti3 
company it acquired in 2015 for $90m. 
Self-driving vehicles
Tesla’s new model 3 comes with autopilot, a step towards 
full self- driving. But although the Tesla and certain other 
current models offer partial autonomy, full autonomy 
or self-driving in mass production cars is some years 
away – probably in the period after 2025. However, non-
automotive companies such as Alphabet (Google) are 
well advanced in testing self-driving cars. The Google 
self-driving project – now an Alphabet subsidiary called 
Waymo – demonstrated its first fully self-driving vehicle 
without a steering wheel on public roads in 2015. Waymo 
is about to launch a driverless taxi service in Phoenix, 
Arizona. Regulatory authorities are encouraging testing 
with 27 companies now having permits in California to 
test self-driving cars on public roads (but with a human in 
the car ‘just in case’). And the UK government is to allow 
wirelessly-connected truck convoys on British motorways 
by the end of 2018. Road transport is the most visible 
application for autonomous vehicles but sea and air 
transport will follow.
The increase in computer processing power and the 
reduction in memory costs are enabling the use of big 
data, AI (artificial intelligence) and of more connected 
devices. AI is the key to the new smart robotics which 
is finding a wide range of applications from self-driving 
cars to medical diagnostics, surgery and farming. These 
new applications use AI and big data and are the next 
step on from the earlier generation of industrial robots 
programmed to carry out relatively simple repetitive tasks 
on a production line. 
Smart robots are finding applications not just in replacing 
manual jobs but increasingly in skilled manual and white 
collar jobs too. Self-driving cars are one of the most visible 
smart robotic applications but currently have humans on 
board just-in-case of malfunction and also to satisfy 
regulators. However, technology will progress to enable 
higher degrees of autonomy until the passenger simply 
programmes in his destination and the car drives there 
autonomously. Machine learning will enable analogous 
advances in medical diagnostics, autonomous drones and 
speech recognition. Military robots are inevitable – military 
drones are already being used for anti-terrorist missions in 
the Middle East – and will receive substantial development 
funding. Military robots are likely to evolve to intelligent 
fighting systems that can make decisions without 
human control. Other sectors that will be transformed by 
intelligent robots are logistics and warehousing, farming, 
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law, education, elderly care (an important area of R&D 
in Japan) and many others – but each on a different 
timescale. Improved cybersecurity will become ever more 
important as these applications are developed further. The 
major companies in AI include Alphabet (which acquired 
DeepMind of the UK – the company whose AI system 
defeated the world champion at Go), Amazon, Facebook, 
IBM and Microsoft.
Medical technology is advancing rapidly with systems such 
as intuitive Surgical’s da Vinci robotic surgery system in 
widespread use for a variety of different operations (each 
system currently controlled by a surgeon). Elekta and 
Philips are in the final stages of developing a MRI-guided 
radiotherapy system which allows both a tumour and the 
surrounding soft tissue to be viewed during radiotherapy. 
And Medtronic has MRI-safe small-size pacemakers, 
small drug-eluting stents and a system for replacing aortic 
heart valves without open-heart surgery all approved and 
on the market. Jarvik artificial hearts are in use to extend 
the life of patients awaiting transplants. AI is likely to be 
increasingly used in medical diagnoses and diagnoses 
without the use of AI are likely to become rare after 2025.
Advances in cancer and other drugs
Biotech is advancing rapidly and August 2017 saw 
the first ever approval of a Car-T therapy by the FDA – 
Novartis’s Kymriah. Car-T stands for Chimeric antigen 
receptor Therapy in which a patient’s blood cells are 
extracted in a hospital, then the immune system T-cells 
are modified in a laboratory by inserting a gene so they 
are armed to recognise and attack cancer cells. Kymriah 
has shown very promising results in clinical trials on 
young blood cancer patients. Kymriah is one example 
of an immunotherapy in which the body’s own immune 
system is used to fight cancer. Other immunotherapy 
drugs approved during 2016/17 include Bristol-
Myers Squibb’s nivolumab (Opdivo) and Merck’s 
pembrolizumab (Keytruda) for several different cancers 
and AstraZeneca’s durvalumab (Imfinzi) for bladder and 
other cancers. Roche’s atezolizumab (Tecentriq) was 
approved for non-small cell lung cancer in late 2016. 
This first wave of immunotherapy drugs is providing 
hope for patients with advanced cancers and the next 
few years are likely to see further progress in this exciting 
new approach to cancer treatment.
All the drugs mentioned above with generic names ending 
in ‘mab’ are monoclonal antibodies, the basis of many 
modern drugs. MorphoSys has one of the world’s largest 
libraries of fully human antibodies and has partnerships 
with most of the major pharmaceutical companies to 
develop effective new drugs using its antibodies.
Gene therapy
The cost of genetic sequencing has fallen massively over 
the last decade. The cost of the first sequencing of the 
whole human genome in 2003 was $2.7bn but this had 
fallen to $300,000 by 2006 when Illumina, the world 
leader in genomic sequencing announced its first machine. 
By 2014 Illumina could do the same thing for $1,000 
and the company is now predicting a future cost of $100. 
Oxford Nanopore, a biotech unicorn, has developed 
low cost genomic and DNA sequencing devices. These 
advances in gene and DNA sequencing together with the 
CRISPR/Cas9 gene editing tool are enabling a new range 
of personalised treatments tailored to a patient’s genetic 
make-up. Treatment of inherited genetic diseases by gene 
therapy is just one example where the faulty or missing 
DNA that is causing the disease is replaced. Genomic 
medicine has the potential to accelerate diagnoses and 
provide routes to treat rare diseases linked to genetic 
faults. Gene editing and gene synthesis are also behind 
major developments to improve plants and farm animals.
Stem cells and drugs for neurological 
diseases
Stem cell therapy is an example of another promising area 
with bone marrow transplants for blood cancers being 
a long established and effective treatment. However, 
research suggests that stem cell therapy could also be 
effective for neurological conditions such as Parkinson’s, 
for brain and spinal cord injuries and for heart conditions. 
Recent research at the Wellcome Trust has demonstrated 
expanded potential stem cells. There are also a number of 
new drugs in clinical trials for serious neurological diseases 
such as Alzheimer’s, Parkinson’s and MS. 
Medicine and health 
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This section outlines the main characteristics of the 2017 
Scoreboard dataset and highlights, in particular, the 
industrial R&D concentration at company, industry and 
country levels. 
The 2500 companies each invested more than €24 million 
in 2016/17, accounting together for €741.6 billion. 
The amount of R&D investment by these 2500 
companies is equivalent to more than 55% of the total 
expenditure on R&D worldwide (GERD) and about 90% 
of the R&D expenditure financed by the business sector 
worldwide. 
1.2 | Portrayal of the R&D investment
This is illustrated in figure 1.1 where the latest 2015 
territorial statistics are compared with the correspond-
ing figures from the previous 2016 Scoreboard (GERD 
€1183.2bn, R&D financed by the business enterprise 
sector “BES-R&D” €769.6bn and the 2016 Scoreboard 
€696.0bn).
The dataset is complemented with additional companies 
in order to cover the top 1000 R&D investing companies 
based in the EU, all of them having invested more than 
€7 million R&D in 2016/17. Of these 1000, 567 appear in 
the world top 2,500 and another 433 are added with R&D 
between €7m and €24m. 
This additional sample of 1000 is analysed separately in 
chapter 5. 
Companies’ distribution by country
The 2017 Scoreboard comprises companies with 
headquarters in 43 countries of which 18 are member 
states of the EU. The sample includes companies based 
in the EU (567), the US (821), China (377), Japan (365), 
Taiwan (105), South Korea (70), Switzerland (52), Canada 
(27), India (25) and a further 17 countries. See Table 1.1 
and Figure 1.2.
Number of companies by country
EU non-EU
Germany 134 US 822
UK 134 China 376
France 71 Japan 365
Netherlands 39 Taiwan 105
Sweden 36 South Korea 70
Denmark 26 Switzerland 52
Italy 24 Canada 27
Ireland 23 India 25
Finland 19 Israel 22
Austria 16 Australia 15
Spain 16 Norway 12
Belgium 15 Brazil 9
Luxembourg 6 Turkey 7
Greece 3 Singapore 6
Portugal 2 Malaysia 3
Hungary 1 New Zealand 3
Malta 1 Mexico 2
Slovenia 1 Further 8 countries 12
Total 567 Total 1933
TABLE 1.1: DISTRIBUTION OF COMPANIES BY COUNTRY.
Note: the 2500 companies all have R&D investment above €24 million.
Source: The 2017 EU Industrial R&D Investment Scoreboard, European Commission, 
JRC/DG RTD.
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FIGURE 1.1: COMPARISON OF R&D FIGURES OF THE SCOREBOARD AND TERRITORIAL STATISTICS.
Note: Total R&D expenditure (GERD) and R&D financed by the business sector (BES-R&D) in 2015 (green dark overlapping bar represent the BES-R&D).
Sources: Latest figures reported by Eurostat (14 November 2017) including most countries reporting R&D.  
The 2017 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
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Companies’ aggregation by industrial 
sector
Assigning companies to industrial sectors according to 
existing classification systems is not a straightforward task. 
In fact, often sector definitions do not fit unambiguously 
with actual company activities that may also change over 
time, and in addition, many companies operate in two or 
more very different industrial sectors. However companies 
usually indicate their main sector of activity in their annual 
FIGURE 1.2: DISTRIBUTION OF THE 2500 COMPANIES IN THE 2017 SCOREBOARD BY HEADQUARTERS COUNTRY.
Note: Number of companies indicated besides the country code (the world map includes only countries with at least 10 companies). R&D is represented with a bubble which size 
is proportional to R&D in 2016 in the country.
Source: The 2017 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
29The 2017 EU Industrial R&D Investment Scoreboard
reports, for example, public companies use a taxonomy 
such as the International Classification Benchmark (ICB)7.
According to the ICB, the Scoreboard comprises companies 
operating in a wide range of manufacturing and services 
sectors, including more than 50 industries with a special 
concentration on the most innovative ones such as ICT, 
health, transport and the engineering related industries. 
In the Scoreboard we use different levels of sector 
aggregation, following the distribution of companies’ 
R&D. Tables 1.2 and 1.3 describe two typical levels of the 
industrial classification applied in the Scoreboard.
The number of companies by industry for the EU and non-
EU regions is shown in Table 1.4. The top 3 companies 
by level of R&D investment for each type of industry are 
presented in Table 1.5.
Industrial 
Sector Sector classification ICB4 digits
N. of 
firms
% of total 
R&D
Aerospace & 
Defence
Aerospace; Defence 49 2.9%
Automobiles & 
other transport
Auto Parts; Automobiles; Commercial Vehicles & Trucks; Tires 197 17.1%
Chemicals Commodity Chemicals; Specialty Chemicals 123 3.2%
Health 
industries
Biotechnology; Health Care Providers; Medical Equipment; Pharmaceuticals 491 21.5%
ICT producers
Computer Hardware; Electrical Components & Equipment; Electronic Equipment; Electronic 
Office Equipment; Semiconductors; Telecommunications Equipment
514 23.4%
ICT services
Computer Services; Fixed Line Telecommunications; Internet; Mobile Telecommunications; 
Software
299 13.1%
Industrials
Aluminium; Containers & Packaging; Diversified Industrials; Industrial Machinery; Iron & 
Steel; Nonferrous Metals; Transportation Services
303 5.8%
Others*
Alternative Energy; Banks; Beverages; Construction & Materials; Electricity; Financial Services; 
Food & Drug Retailers; Food Producers; Forestry & Paper; Gas, Water & Multiutilities; General 
Retailers; Household Goods & Home Construction; Leisure Goods; Life Insurance; Media; 
Mining; Nonlife Insurance; Oil & Gas Producers; Oil Equipment, Services & Distribution; Personal 
Goods; Real Estate Investment & Services; Support Services; Tobacco; Travel & Leisure
524 13.1%
Total  2500 100.0%
TABLE 1.2: INDUSTRIAL CLASSIFICATIONS APPLIED IN THE SCOREBOARD -8 INDUSTRIAL GROUPS-.
* Sectors in the “Others” group are presented at ICB-3 digits level. 
Source: The 2017 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
7 http://www.ftse.com/products/downloads/ICBStructure-Eng.pdf.
Sector R&D 
intensity* Sector classification ICB4 digits**
N. of 
firms
% of total 
R&D
high
Aerospace; Biotechnology; Computer Hardware; Computer Services; Defence; Electronic 
Office Equipment; Health Care Providers; Internet; Leisure Goods; Medical Equipment; 
Pharmaceuticals; Semiconductors; Software; Technology Hardware & Equipment; 
Telecommunications Equipment
1128 54.6%
medium-high
Auto Parts; Automobiles; Commercial Vehicles & Trucks; Commodity Chemicals; Containers 
& Packaging; Diversified Industrials; Electrical Components & Equipment; Electronic 
Equipment; Financial Services; Household Goods & Home Construction; Industrial 
Machinery; Personal Goods; Specialty Chemicals; Support Services; Tires; Travel & Leisure
970 35.4%
medium-low
Alternative Energy; Beverages; Fixed Line Telecommunications; Food Producers; General 
Retailers; Media; Oil Equipment, Services & Distribution; Tobacco
138 3.9%
low
Aluminium; Banks; Construction & Materials; Electricity; Food & Drug Retailers; Forestry 
& Paper; Gas, Water & Multiutilities; Iron & Steel; Life Insurance; Mining; Mobile 
Telecommunications; Nonferrous Metals; Nonlife Insurance; Oil & Gas Producers; Real 
Estate Investment & Services; Transportation Services
264 6.1%
Total  2500 100.0%
TABLE 1.3: INDUSTRIAL CLASSIFICATIONS APPLIED IN THE SCOREBOARD -4 SECTORS BY R&D INTENSITY-.
Note: This classification takes into account the R&D intensity of all companies aggregated by ICB 3-digits sectors:  High above 5%; Medium-high between 2% and 5%; Medium-low 
between 1% and 2% and Low below 1%. Some sectors are adjusted to compensate the insufficient representativeness of the Scoreboard in those sectors using the OECD definition 
of technology intensity for manufacturing sectors.
* For simplification, in this report these 4 groups are also referred to as high tech, medium-high tech, medium-low tech and low tech.
**Sectors included in the “Others” group in table 1.2 are presented at ICB3 level
Source: The 2017 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
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Industrial R&D is highly concentrated. A small subset of 
companies, industries and countries account for a large 
share of the total R&D investment of the 2500 sample. As 
observed in the Scoreboard since 2004, this characteristic 
R&D concentration remains practically unchanged from 
year to year.
Figure 1.3 presents the distribution of the 2500 companies 
ranked by their level of R&D investment. 
The R&D concentration (% of total R&D) for the top 10, 
top 50, top 100 and top 500 companies is respectively 
15%, 40%, 53% and 81%. 
There are 7 companies having an R&D investment of more 
than €10bn, 68 more than €2bn and 143 more than €1bn. 
The latter group of companies comprises 39 from the EU, 
51 from the US, 22 Japanese, 14 Chinese and 5 each from 
South Korea & Switzerland.
The group of top 100 companies mostly operate in three 
sectors: 25 in Health industries (EU 9), 19 in Automobiles 
& other transport (EU 10) and 34 in ICT industries (EU 6).
Industry EU non-EU Total
ICT producers 67 (13%) 447 (87%) 514
Health industries 109 (22%) 382 (78%) 491
Industrials 91 (30%) 212 (70%) 303
ICT services 53 (18%) 246 (82%) 299
Automobiles & other transport 45 (23%) 152 (77%) 197
Chemicals 22 (18%) 101 (82%) 123
Aerospace & Defence 16 (33%) 33 (67%) 49
Others 164 (31%) 360 (69%) 524
Total 567 (22.7%) 1933 (77.3%) 2500
TABLE 1.4: DISTRIBUTION OF COMPANIES BY INDUSTRIAL SECTOR AND REGION.
Note: The figures in brackets show each sector’s EU & non-EU percentages of the total number of companies in each sector.
Source: The 2017 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
Health industries Automobiles & other transport
ROCHE Switzerland VOLKSWAGEN Germany
JOHNSON & JOHNSON US GENERAL MOTORS US
NOVARTIS Switzerland DAIMLER Germany
ICT Services ICT producers
ALPHABET US SAMSUNG South Korea
MICROSOFT US INTEL US
ORACLE US HUAWEI China
Aerospace & Defence General Industrials
BOEING US GENERAL ELECTRIC US
AIRBUS Netherlands TOSHIBA Japan
UNITED TECHNOLOGIES US HONEYWELL US
Chemicals Others
BASF Germany PANASONIC Japan
DUPONT* US SONY Japan
DOW CHEMICAL* US LG ELECTRONICS South Korea
TABLE 1.5: TOP 3 COMPANIES BY R&D FOR THE MAIN INDUSTRIES COMPRISED IN THE 2017 SCOREBOARD.
*Dow Chemical and Dupont agreed a merger in 2017.
Source: The 2017 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
Distribution of the R&D investment by company, sector and country
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R&D is also very much concentrated by country and world 
region. This is observed in figure 1.4 which shows the R&D 
share of main countries and regions. 
The top 3, top 5 and top 10 countries account respectively 
for 63%, 75% and 90% of the total R&D investment. 
Within the EU, the R&D is even more concentrated, the 
top 3, top 5 and top 10 countries account respectively 
for 67%, 82% and 98% of the total R&D invested by the 
companies based in the EU.
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FIGURE 1.3: COMPANIES OF THE 2017 SCOREBOARD RANKED BY R&D.
Source: The 2017 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
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FIGURE 1.4: R&D INVESTMENT BY THE 2500 COMPANIES BY MAIN COUNTRY/REGION (% OF TOTAL €741.6 bn).
Source: The 2017EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
The R&D is also largely concentrated by industrial sector, 
as illustrated in figure 1.5 presenting the distribution of 
R&D by industry for the main countries/regions. The four 
largest R&D investing sectors (ICT producers, Health 
industries, Automobiles & other transport and ICT services) 
account for 75% of the total R&D of the 2500 companies. 
The main contribution to the total Scoreboard R&D:
– By EU companies is 45% to Automobiles & other 
transport, 41% to Aerospace & Defence and 28% to 
Health industries;
– By US companies is 72% to ICT services, 48% to health 
industries and 45% to Aerospace & Defence;
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– By Japanese companies is 31% to Chemicals, 24% to 
Automobiles & other transport and 23% to Industrials;
– By Chinese companies is 12% to ICT producers, 12% to 
Industrials and 20% to other sectors.
Finally, the R&D shares of industrial sectors for each main 
country/region are presented in figure 1.6. This figure 
shows that each country/region has a characteristic R&D 
specialisation. The top three sectors by level of R&D 
investment for each region account for:
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FIGURE 1.5: R&D INVESTMENT BY THE 2500 COMPANIES BY INDUSTRY AND MAIN COUNTRY/REGION (€ bn).
Source: The 2017EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
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FIGURE 1.6: R&D SHARES OF INDUSTRIAL SECTORS WITHIN MAIN COUNTRIES/REGIONS.
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– 66% within the EU (Automobiles & other transport 
29%; Health industries 23% and ICT producers 13%).
– 76% within the US (Health industries 27%; ICT 
producers 25% and ICT services 24%).
– 62% within Japan (Automobiles & other transport 
30%; ICT producers 20% and Health industries 12%).
– 57% within China (ICT producers 34%; Automobiles & 
other transport 13%; and ICT services 10%).
Whereas the top five companies in the EU and the US 
account for 19.2% of the total R&D of those regions, the 
top five in China account for 28.6% and the top five for 
23.4% in Japan. Huawei alone accounts for 16.8% of 
China’s Scoreboard R&D.
2 GLOBAL INDUSTRIALR&D TRENDS
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In 2016/17, companies in aggregate increased significantly 
their R&D investments and profits while showing an 
important decline in fixed capital investments and stagnation 
in revenues growth. These companies’ results, varying 
greatly across world regions and industries, are presented 
below. Tables 2.1 and 2.2 at the end of the section present 
the one-year change of main indicators for the whole set of 
companies and also by main region and country. 
Global industrial R&D trends2
This chapter provides an overview of the main trends in R&D and economic indicators 
for the world’s top 2500 companies that each invested more than €24 million in R&D in 
2016/17. The first part concentrates on the evolution of companies’ indicators over the 
previous year and the second section analyses the long-term performance of companies 
aggregated by main world regions. The 2500 companies are grouped into five main sets: 
the top 567 companies from the EU, 822 companies from the US, 365 from Japan, 376 
Chinese companies and 370 companies from the Rest of the World group (RoW). The 
RoW group includes companies from Taiwan (105), South Korea (70), Switzerland (52), 
Canada (27), India (25), Israel (22) and companies based in a further 16 countries.
2.1 | Changes in companies’ indicators in 2016/17
8 The company or sector contribution to the R&D growth of the sample is the nominal growth rate of the company or sector weighed by the R&D share of the company 
or sector.
Key points
R&D trends
• Overall R&D investment continued to increase 
significantly in 2016/17 for the sixth consecutive year. 
The 2500 Scoreboard companies invested €741.6 
billion in R&D, 5.8% more than in 2015/16, following 
the increase of 6.8 % in the year before. 
• The 567 companies based in the EU invested €192.5bn 
in R&D, a substantial increase in this period (+7.0%) 
although at a lower pace than in the previous year 
(+8.1%). The 822 companies based in the US and 376 
in China showed a high R&D growth (7.2% and 18.8% 
respectively) while the 365 Japanese companies 
reduced their R&D investment (-3.0%). See figure 2.1.
• Worldwide R&D growth was driven by ICT services 
sectors (+11.7%), followed by the Health and ICT 
producers sectors (7%). Automobiles and Aerospace 
& Defence grew R&D at a lower pace (respectively 
2.7% and 2.2%) and Chemicals reduced R&D 
(-1.9%).
• For the EU sample, the largest contribution8 to R&D 
growth was made by Automobiles, ICT producers and 
Health industries but with negative contributions by 
Aerospace & Defence and Chemicals. Among the largest 
member states, German and UK companies showed 
the highest R&D growth (7% and 9% respectively) 
while companies based in France and the Netherlands 
increased R&D at a lower than average rate (3.3%). In the 
EU sample, R&D growth was led by increases in R&D of 
companies such as NOKIA(96%), NXP(90%), SAP(13%), 
SHIRE(56%), ZF(40%), RENAULT(20%), DAIMLER(15%), 
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CONTINENTAL(15%), GLAXOSMITHKLINE(12.9%) and 
ROBERT BOSCH(7.4%). See figure 2.2. R&D growth for 
some of these companies (and for some of the non-EU 
ones) was increased by acquisitions.
• The largest contribution to the R&D growth of non-EU 
companies was made by ICT services, ICT producers 
and Health industries and negative contribution by 
Chemicals and Automobiles sectors. In the non-EU 
group, top R&D companies showing high R&D growth 
were HUAWEI (29%), APPLE (25%), GILEAD (55%), 
BROADCOM (155%), ALPHABET (13%), DELL (116%), 
BOEING (42%), FACEBOOK (23%), MICROSOFT (9%), 
WESTERN DIGITAL (50%).
Other indicators
• For the fifth consecutive year the net sales of the 2500 
companies underperformed with respect to R&D with 
only 0.1% growth although this was an improvement 
on the previous year’s negative growth rate (-3.8%). 
This was mostly due to negative growth of net sales 
in low tech sectors while high R&D investing industries 
grew net sales well above the world’s average. Capital 
expenditures fell substantially worldwide by 6.2% (a 
reduction of €77.2bn compared with the R&D increase 
of €64bn). Operating profits increased significantly 
(+8.7%). The number of employees by the 2500 
companies increased modestly (+1.7%).
• The net sales of the 567 companies based in the EU 
reached €5.4trillion, 1.0% less than in the previous 
year. Sectors showing the best sales performance 
were ICT services, Health industries and ICT producers 
(+7.7%, 7.2% and 6.3% respectively) and the biggest 
sales declined was shown by Chemicals (-6.0%). 
• The EU companies decreased significantly capital 
expenditures, by 5.1% (a reduction of €18.5bn compared 
with the R&D increase of €12.6bn). The best performance 
of EU companies was in terms of profits (+16.7%) which 
led to a significant increase of their profitability level 
(from 6.8% to 7.6%). The 567 companies employed 
18.8million, 2.2% more than the year before.
• The 822 companies based in the US increased 
modestly net sales (+1.9%) and profits (+1.7%) and 
reduced significantly capital expenditures by 4.3% (a 
reduction of €12.8bn compared with the R&D increase 
of €19.5bn). US companies showed a modest increase 
on profits (1.7%), below their growth rate of sales 
therefore their profitability slightly decreased (from 
12.9% to 12.7%). Finally, the US companies slightly 
decreased employee numbers by 1.1% to 11.1million.
• The 365 companies based in Japan dropped net 
sales by 4.5% and capital expenditures by 4.8%. They 
increased modestly profits (2.2%) and profitability 
increased to 7.6%. Number of employees of Japanese 
companies grew by 2.1%.
• The 376 Chinese companies showed a robust growth 
in net sales (+7.4%) and net profits (+13.4%), 
reaching a profitability level of 6.9%. Chinese 
companies increased employees’ number by 4.4%. In 
terms of capital expenditure, in line with worldwide 
companies, Chinese ones dropped it by 4.7% (a 
reduction of €7.3bn compared with the R&D increase 
of €9.8bn).
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FIGURE 2.1: R&D INVESTMENT BY MAIN WORLD REGION IN THE LATEST TWO YEARS.
Note: growth rates have been computed for 566 EU, 818 US, 364 Japanese, 375 Chinese and 370 RoW companies for which data are available for both years 2015 and 2016.
Source: The 2017 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
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FIGURE 2.2: INDUSTRIES’ NET CONTRIBUTION TO THE ONE-YEAR R&D GROWTH RATE OF MAIN REGIONS*.
* R&D growth rate of the industry weighed by its R&D (the sum of industry contributions is the Region’s R&D growth).
Note: growth rates have been computed for 566 EU, 818 US, 364 Japanese, 375 Chinese and 370 RoW companies for which data are available for both years 2015 and 2016.
Source: The 2017 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
Factor World 2500
R&D in 2016/17, € bn 741.6
 One-year change, % 5.8
Net Sales, € bn 17910.3
 One-year change, % 0.1
R&D intensity, % 4.1
Operating profits, € bn 1671.2
 One-year change , % 8.7
Profitability, % 9.3
Capex, € bn 1167.9
 One-year change , % -6.2
Capex / net sales, % 6.5
Employees, million 53.0
 One-year change, % 1.7
TABLE 2.1: OVERALL PERFORMANCE OF THE 2500 COMPANIES IN THE 2017 SCOREBOARD.
Source: The 2017 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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Factor EU USA Japan China RoW
No. of companies 567 822 365 376 370
R&D in 2016/17, € bn 192.5 290.0 103.8 61.8 93.6
World R&D share, % 26.0 39.1 14.0 8.3 12.6
 One year change, % 7.0 7.2 -3.0 18.8 2.3
Net Sales, € bn 5427.2 4665.1 2976.4 2174.1 2667.6
 One year change, % -1.0 1.9 -4.5 7.4 -0.5
R&D intensity, % 3.5 6.2 3.5 2.8 3.5
Operating Profit, € bn 414.8 592.9 225.2 150.8 287.4
 One year change, % 16.7 1.7 2.2 13.4 17.0
 Profitability (1) 7.6 12.7 7.6 6.9 10.8
Capex, € bn 344.3 285.0 178.7 148.7 211.3
 One year change, % -5.1 -4.3 -4.8 -4.7 -12.4
Capex intensity, % 6.3 6.1 6.6 6.8 8.0
Employees, million 18.8 11.1 8.8 8.8 5.5
 One year change, % 2.2 -1.1 2.1 4.4 0.5
TABLE 2.2A: OVERALL PERFORMANCE OF THE 2500 COMPANIES IN THE 2017 SCOREBOARD.
Note: The RoW group comprises companies based in Taiwan, South Korea, Switzerland, Canada and a further 18 countries.
Source: The 2017 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
Factor Germany UK France Netherlands
No. of companies 134 134 71 39
R&D in 2016/17, €bn 75.1 29.1 25.4 18.4
 World R&D share, % 10.1 3.9 3.4 2.5
 One year change, % 6.8 8.9 3.3 3.3
Net Sales, €bn 1744.1 1016.4 975.2 429.0
 One year change, % 1.4 -2.4 -3.8 3.0
 R&D intensity, % 4.3 2.9 2.6 4.3
TABLE 2.2B: PERFORMANCE OF COMPANIES BASED IN THE LARGEST R&D COUNTRIES OF THE EU.
Source: The 2017 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
Factor Switzerland South Korea Taiwan Canada
No. of companies 52 70 105 27
R&D in 2016/17, € bn 28.4 26.6 15.0 4.8
 World R&D share, % 3.8 3.6 2.0 0.6
 One year change, % 0.1 1.9 3.1 1.6
Net Sales, € bn 382.1 850.2 517.2 101.2
 One year change, % 1.5 1.1 -2.4 -0.5
 R&D intensity, % 7.4 3.1 2.9 4.8
TABLE 2.2C: PERFORMANCE OF COMPANIES BASED IN THE LARGEST COUNTRIES OF THE ROW GROUP.
Source: The 2017 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
This section presents the evolution of the majority of company indicators over the past 10 years for the main world 
regions.
2.2 | Long-term performance of companies
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2.2.1 Long-term R&D trends
The figures below illustrate 10 years evolution of R&D and 
main indicators for companies based in the EU, US, Japan 
and China. Figure 2.3 shows the world R&D share of each 
region and Figures 2.4 to 2.7 present the annual growth 
rates of R&D and net sales and profitability. These figures 
are based on our history database comprising the R&D 
and economic indicators over the whole 207-2016 period 
for 1699 companies (EU 404, US 599, Japan 345, China 
114 and RoW 287).
• Over the past 10 years, the R&D share of EU companies 
over the total R&D remained practically unchanged, 
about 26.0%. The main change in this indicator is 
observed for the Japanese companies whose R&D 
share fell by ca. 8 percentage points. The loss of 
R&D share by Japanese companies corresponds to 
increases in R&D shares for the other countries/regions, 
especially for companies based in China. 
• Companies based in the EU continued the R&D 
positive trend observed over the past years. Since 
2012 the growth rate of R&D has been significantly 
higher than that of net sales, however over the same 
period the growth rate of capital expenditures showed 
a negative trend. The same negative trend has been 
observed for net sales although for the last period they 
remained practically unchanged. On the other hand, 
the profitability the EU companies showed a stable 
behaviour (with a significant increase over the last 
year), but the level of profitability remains significantly 
lower than that of US companies.
• Companies based in the US continued to show 
significant R&D investment growth, similar to the level 
prior to the crisis. However over the past two years the 
level of capital expenditures has fallen significantly 
for the US companies. On terms of net sales, US 
companies seem to recover the negative figures of 
2015; however, net sales growth remains well below 
the level of R&D growth. The US-based companies 
continued to show a high level of profitability since 
2010, although it shows a slight decreasing trend 
over the past three years. The profitability of the US 
companies is higher than their EU counterparts and 
especially higher than the Japanese ones.
• Japanese companies, hit hard by the crisis in 2008-
2009 and by the earthquake in 2011, showed a two 
years positive trend for both R&D investment and 
net sales. However since 2015 growth rates of R&D 
and especially that of net sales decelerated again. 
The profitability of Japanese companies continued 
a slightly upward trend observed since 2013, but 
remained at low levels, especially compared with that 
of the US companies.
• The Chinese companies show a strong R&D trend over 
the whole 10 years period. However over the past 
two years the level of capital expenditures decreased 
significantly for the Chinese companies. In terms of net 
Key points
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FIGURE 2.3: EVOLUTION OF R&D SHARES OF MAIN REGIONS.
Note: figures displayed refer only to the 1697 companies (402 EU; 549 US; 345 Japan; 114 China; 287 RoW) with R&D data available for the all period 2007-2016.
Source: The 2017 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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sales, they have had high positive growth rates, except 
over 2015/16 where net sales significantly fell. The 
China-based companies have decreased profitability 
slightly over the past four years and remain lower as 
compared with their worldwide counterparts, especially 
lower than US ones.
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FIGURE 2.4: ONE-YEAR R&D INVESTMENT AND NET SALES GROWTH AND PROFITABILITY FOR THE EU COMPANIES.
Note: growth rates for the three variables have been computed on 402 out of the 567 EU companies for which data are available for the entire period 2007-2016.
Source: The 2017 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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FIGURE 2.5: ONE-YEAR R&D INVESTMENT AND NET SALES GROWTH AND PROFITABILITY FOR THE US COMPANIES.
Note: growth rates for the three variables have been computed on 549 out of the 822 US companies for which data are available for the entire period 2007-2016.
Source: The 2017 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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FIGURE 2.6: ONE-YEAR R&D INVESTMENT AND NET SALES GROWTH AND PROFITABILITY FOR THE JAPANESE COMPANIES.
Note: growth rates for the three variables have been computed on 345 out of the 365 Japanese companies for which data are available for the entire period 2007-2016.
Source: The 2017 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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The changes in R&D over the past 10 years are presented 
in figure 2.8 for groups of industrial sectors with 
characteristic R&D intensities9 (see definition in Chapter 1 – 
Table 1.3). The figures refer to a set of 1476 companies 
that reported R&D over the whole period 2007-2016 (EU-
400, US-503, Japan-343, China-96 and RoW group-134). 
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FIGURE 2.7: ONE-YEAR R&D INVESTMENT AND NET SALES GROWTH AND PROFITABILITY BY THE CHINESE COMPANIES.
Note: growth rates for the three variables have been computed on 114 out of the 376 Chinese companies for which data are available for the entire period 2007-2016.
Source: The 2017 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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FIGURE 2.8: R&D INVESTMENT IN 2007 AND 2016 BY MAIN REGION AND SECTOR GROUPS.
Note: figures displayed refer only to the 1476 companies for which data are available for all variables (R&D, Net Sales and Employment) both years (2007 and 2016).
Source: The 2017 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
2.2.2 Change in R&D over 2007-2016 for groups of sectors and main regions
Key points
9 For simplification, in this section these groups may be also referred to as high tech, medium-high tech, medium-low tech and low-tech.
• The world 1476 companies increased R&D by 50%: 
– By sector, high tech 56%, medium-high tech 42%, 
medium-low tech 34% and low tech 48%. 
– By region, EU 55%, US 63%, Japan 3% and China 
478%.
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• For the 400 EU companies, the main R&D increases 
were in medium-high tech sectors (70%) and high tech 
(44%)
• For the 503 US companies, the main R&D increases 
were in high tech (72%) and medium-low tech (53%). 
• For the 343 Japanese companies, the only R&D 
increase was in medium-high tech (9%) and main R&D 
decreases in the high tech (-7%).
• For the 96 companies based in China, the main R&D 
increases were in high R&D-intensive (632%) and 
medium-high (446%).
The net sales in 2007 and 2016 are presented in figure 
2.9 for groups of industrial sectors with characteristic R&D 
intensities (see definition in Chapter 1 – Table 1.3). The 
figures refer to a set of 1476 companies that reported 
R&D over the whole period 2007-2016 (EU-400, US-503, 
Japan-343, China-96 and RoW group-134). 
• The world 1476 companies increased net sales by 
17%: 
– By sector, high tech 43%, medium-high tech 20%, 
medium-low tech 26% and low tech -6%. 
– By region, EU 14%, US 13%, Japan 1% and China 
137%.
• For the 400 EU companies, the main net sales increas-
es were in high R&D-intensive sectors (44%) and me-
dium-high sectors (40%) and main net sales decrease 
in low sectors (-12%).
• For the 503 US companies, the main net sales in-
creases were in high sectors (52%) and medium-low 
R&D-intensive sectors (64%) and main net sales de-
crease in low sectors (-52%).
• For the 343 Japanese companies, the only net sales in-
crease was in medium-high R&D-intensive sectors (4%) 
and main net sales decreases in low sectors (-5%).
• For the 96 companies based in China, all sectors showed 
3-digits rise in net sales. Net sales went up in medi-
um-high R&D-intensive (274%) and high sectors (159%). 
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FIGURE 2.9: NET SALES IN 2007 AND 2016 BY MAIN REGION AND SECTOR GROUPS.
Note: figures displayed refer only to the 1476 companies for which data are available for all variables (R&D, Net Sales and Employment) both years (2007 and 2016).
Source: The 2017 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
2.2.3 Change in net sales over 2007-2016 for groups of sectors and main regions
Key points
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FIGURE 2.10: EMPLOYMENT IN 2007 AND 2016 BY MAIN REGION AND SECTOR GROUPS.
Note: figures displayed refer only to the 1476 companies for which data are available for all variables (R&D, Net Sales and Employment) both years (2007 and 2016).
Source: The 2017 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
2.2.4 Employment changes 2007-2016 for groups of sectors and main regions
Key points
The employment levels in 2007 and 2016 are presented 
in figure 2.10 for groups of industrial sectors with charac-
teristic R&D intensities (see definition in Chapter 1 – Table 
1.3). The figures refer to a set of 1476 companies that 
reported R&D over the whole period 2007-2016 (EU-400, 
US-503, Japan-343, China-96 and RoW group-134). 
• The world 1476 companies increased employment by 
20%: 
– By sector, high tech 28%, medium-high tech 24%, 
medium-low tech 14% and low tech 5%. 
– By region, EU 14%, US 14%, Japan 17% and China 
54%.
• For the 400 EU companies, the main employment 
increases were in high tech (36%) and medium-high 
tech (28%) and a slight employment decrease was in 
low tech (-5%).
• For the 503 US companies, the main employment 
increases were in medium-low tech (32%) and high 
tech (14%) and a significant employment decrease oc-
curred in low tech (-24%).
• For the 343 Japanese companies, the main employ-
ment increases were in medium-low tech (40%) and 
low tech (26%).
• For the 96 companies based in China, main employ-
ment increases were in medium-high tech (85%) and 
medium-low tech (48%).
It is important to remember that data reported by the 
Scoreboard companies do not inform about the actual 
geographic distribution of the number of employees. A 
detailed geographic analysis should take into account the 
location of subsidiaries of the parent Scoreboard compa-
nies (see for example in the 2015 Scoreboard report, an 
analysis of the location of companies’ economic and in-
novation activities).
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The comparison of 10-years changes in R&D, net 
sales and employment of the EU-400 sample with 
the US-503 one shows that:
• Both samples of EU and US companies increased 
employees by 14% and net sales by a similar amount 
(EU 14% vs US 13%).
• In low-tech sectors, both samples dropped net sales 
(EU -12% vs US -52%) and employees (EU -5% vs US 
-24%).
• US companies increased more their R&D (US 63% vs 
EU 55%) and, according to their specialisation, US’s 
higher increase was in high tech sectors (72%) while 
that of the EU’s in medium-high tech sectors (70%).
• In summary, altough the EU and US companies 
increased net sales and employment at a similar rate, 
they show contrasting differences in high tech and 
medium-high tech sectors:
 In high tech, the EU companies’ R&D increase of 44% is 
accompanied by 36% increase in employees while for 
the US’ ones their 72% increase in R&D corresponded 
only to 14% increase in employees. However the US 
companies showed a much higher increase of the ratio 
net sales/employee.
 In medium-high tech, the EU companies’ R&D 
increase of 70% is accompanied by 28% increase 
in employees while for the US’ ones their 36% 
increase in R&D corresponded to 11% increase in 
employees. However the EU companies showed 
a much higher increase of the ratio net sales/
employee. 
Comparison EU/US in terms of R&D, net sales and employment

3 R&D TRENDS BYINDUSTRY AND REGION
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The first section discusses the main changes that took 
place over the past year for the major industrial sectors 
and world regions. The second section analyses and 
compares the R&D 10-year trajectories of leading EU and 
non-EU companies and their counterparts for selected 
industries. 
R&D trends by industry and region3
This chapter presents the main R&D trends among the 2017 Scoreboard companies for 
the major regions and main industrial sectors. Industries are presented at various levels 
of aggregation according to the R&D volumes and R&D intensity of companies in them 
and depending on the issues to be illustrated. 
3.1 | Main changes in indicators in 2016/17
Tables 3.1 and 3.2 provide the nominal one-year change of R&D and net sales for the main industrial sectors and world 
regions.
Key points
• Worldwide, R&D growth was driven by the 
performance of the high R&D investing industries, 
which increased R&D above the world average 
rate of 5.8%. These are ICT services (11.7%), 
Health industries (5.9%) and ICT producers (6.8%). 
The worse performance was shown by Chemicals 
(-1.9%) and Aerospace & Defence (2.2%). 
• In terms of net sales, the average growth rate 
of the world sample (0.3%) was held back by 
low-tech sectors (-4.4%) and Chemicals (-2.2%) 
while most high R&D-investing sectors increased 
sales well above the world average of 0.3%, in 
particular ICT services (6.6%), Health industries 
(5.7%) and Aerospace & Defence (2.3%).
• The highest growth of profits was showed by the 
Industrials sector (+27%), followed by ICT services 
(16%) whereas decrease in profits were presented 
by ICT producers (-2.6%) and Health industries 
(-0.4%). The profitability level increased for 
sectors showing higher growth rate of profits than 
net sales. The highest levels of profitability are 
showed by high tech sectors such as ICT services 
(15.4%) and Health industries (14.5%). 
• For the EU sample, R&D growth was also driven by 
the high R&D investing industries that increased 
significantly R&D, i.e. ICT producers (14.4%), ICT services 
(12.7%), Health industries (7.9%) and Automobiles 
(6.7%). However also important R&D sectors showed 
a decrease in R&D, in particular Aerospace & Defence 
(-5.4%) and to a lesser extent Chemicals (-0.8%).
 Among the largest EU companies, the twelve showing 
the biggest increases in R&D in 2016/17 were:
 NOKIA(96%), NXP(90%), SAP(13%), SHIRE(56%), 
ZF(40%), RENAULT(20%), DAIMLER(15%), CONTINEN-
TAL(15%), GLAXOSMITHKLINE(12.9%), BAYER (7.6%), 
DEUTSCHE BANK (23.2%) and ROBERT BOSCH(7.4%). 
The high R&D growth of some of these companies was 
partly the result of mergers and acquisitions. Examples 
are Nokia (acquired both Alcatel-Lucent and Comptel 
in 2017) and Shire (acquired Baxalta in 2016).
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 And those showing the biggest R&D reductions were:
 ERICSSON (-10.0%), AIRBUS (-9.2%), RABOBANK 
(-72.4%), SAFRAN (-18.8%), ELECTRICITE DE FRANCE 
(-19.5%), ROYAL BANK OF SCOTLAND (-21.8%), 
DASSAULT AVIATION (-32.7%), EYGS (-45.6%), 
SEAGATE TECHNOLOGY (-8.6%), TELEFONICA (-10.5%), 
SANOFI (-1.7%) and BASF (-4.2%).
 These 24 companies altogether accounted for about 
40% of the total R&D change of the EU sample.
• Regarding net sales, the EU sectors showing the 
highest increase were in ICT services and Health 
industries (7.7% and 7.2% respectively) followed 
by ICT producers (6.3%). Reduction in net sales 
were in Chemicals (-6.0%) and Industrials (-1.8%) 
and Other (-4.1%, mainly from low-tech sectors).
 Among the largest EU companies, the following 
showed the highest increase in net sales: STANDARD 
LIFE (167%), AHOLD (30%), NOKIA (74%), HERAEUS 
(66%), ZF (21%), RENAULT (13%) and BT (26%). The 
large increase in Nokia’s sales was partly the result of 
the acquisitions mentioned above.
 And those that showed the biggest net sales decrease 
were (mostly oil-related companies): ENEL (-9%), ENI 
(-18%), BASF (-18%), TOTAL (-11%), CHRISTIAN DIOR 
(-44%), ROYAL DUTCH SHELL (-12%) and BP (-18%). 
The substantial decreases in sales for the four oil & 
gas companies reflect the lower oil price in 2016/17.
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FIGURE 3.1: NOMINAL CHANGE OF R&D OVER THE PAST YEAR FOR MAIN INDUSTRIES AND REGIONS.
Note: growth rates have been computed for 566 EU, 818 US, 364 Japanese, 375 Chinese and 370 RoW companies for with R&D data are available for years 2015 and 2016.
Source: The 2017 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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• For the non-EU sample of companies, R&D growth was 
driven by the high tech industries, especially by high 
R&D increases in the US and China, i.e. ICT services 
(US 11%, China 28%), Health industries (US 9%, 
China 19%) and ICT producers (US 5%, China 21%). 
Important R&D reductions are observed in Chemicals 
and low tech sectors. 
• Among the largest non-EU companies, high R&D growth 
was shown by companies such as HUAWEI (29%), 
APPLE (25%), GILEAD SCIENCES (55%), BROADCOM 
(155%), ALPHABET (13%) and DELL TECHNOLOGIES 
(116%); some of this growth was due to acquisitions 
- Broadcom acquired Brocade Communications during 
2016/17 and Dell completed its acquisition of EMC for 
$67bn in 2016.
• And those showing the lowest R&D growth rates were 
TOSHIBA (-18%), NOVARTIS (-8%), TATA MOTORS 
(-35%), BRISTOL-MYERS SQUIBB (-16%), TOYOTA 
MOTOR (-13%) and HP (-65%).
• Regarding the growth of net sales by non-EU 
companies, the best performance were observed in 
Chinese companies across most of sectors and for 
US companies in high tech sectors, e.g. in ICT services 
(China 20%, US 11%). Japanese companies decreased 
net sales for most of industrial sectors.
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FIGURE 3.2: NOMINAL CHANGE OF NET SALES OVER THE PAST YEAR FOR MAIN INDUSTRIES AND REGIONS.
Note: growth rates have been computed for 557 EU, 761 US, 364 Japanese, 375 Chinese and 368 RoW companies for with data are available for both variables (R&D and Net 
sales) for years 2015 and 2016.
Source: The 2017 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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 Among the largest non-EU companies, the following 
showed the highest increase in net sales: AMAZON.COM 
(27%) CHINA PETROLEUM & CHEMICALS (8%), AT&T 
(12%), HUAWEI (37%), ALPHABET (20%), GENERAL 
MOTORS (9%) and CHINA STATE CONSTRUCTION 
ENGINEERING (11%).
 And those that decreased significantly net sales: 
PETROLEOS DE VENEZUELA (-24%), STATOIL (-23%), 
JXTG (-20%), PETROCHINA (-6%), APPLE (-8%), 
CHEVRON (-15%) and EXXON MOBIL (-16%). The sales 
of these oil companies all decreased with the oil price.
This section examines the changes on the distribution of 
the R&D investment of the Scoreboard companies across 
regions and industrial sectors over the past 10 years. The 
analysis shows characteristic differences and changes in 
the global R&D shares, reflecting the R&D speciality of re-
gions and structural changes over 2007-2016. The Figure 
3.3 shows the evolution of the global R&D shares for main 
industries and Figures 3.4 and 3.5 show respectively the 
contribution to the global industry-R&D shares by the EU 
and US companies.
3.2 | Ten-year change in sector composition
Key points
• On the whole, only two sectors increased their R&D 
shares: ICT services (from 10.6% to 13.4%) and 
Health industries (from 20.7% to 21.6%). Main shares 
decreases were shown by low-tech sectors and also, to 
a lesser extent, Industrials and Automobiles sectors.
• EU companies reinforced its specialisation in medium-
high tech sectors, increasing significantly their R&D 
contribution to the global R&D of Automobiles (from 
35.9% to 44.4%) and Industrial (from 25.7% to 27.1%). 
On the other side, EU companies main reduction of 
global R&D share was in Aerospace & Defence (from 
47.6% to 42.1%) and in ICT producers (from 19.3% to 
16.5%). 
• US companies strengthened their position in high 
tech sectors, increasing substantially their global R&D 
weight in ICT services (from 66.2% to 74.9%) and 
Health industries (from 40.5% to 44.8%). On the other 
extreme, US companies strongly reduced their R&D 
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FIGURE 3.3: EVOLUTION OF THE GLOBAL R&D SHARE FOR INDUSTRIAL SECTORS. 
Note: Calculated for a sample of 1697 companies for which data on R&D, Net Sales and Operating Profits are available for the entire period 2007-2016.
Source: The 2017 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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3.3 | Company dynamics of selected sectors
share in Automobiles (from 25.5% to 19.4%) and, to a 
lesser extent, in low tech sectors.
• For Asian companies, contrasting changes in global 
R&D shares are observed for those based in China and 
Japan. Chinese companies increased their golbal R&D 
shares for all sectors (mostly in low tech, ICT services 
and Industrials) whereas Japanese companies’ global 
R&D shares fell across the bord (mostly in losw tech, 
ICT services and Automobiles). 
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FIGURE 3.4: EVOLUTION OF THE GLOBAL R&D SHARE OF THE EU COMPANIES FOR MAIN INDUSTRIAL SECTORS.
Note: Calculated for a sample of 402 companies for which data on R&D, Net Sales and Operating Profits are available for the entire period 2007-2016.
Source: The 2017 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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FIGURE 3.5: EVOLUTION OF THE GLOBAL R&D SHARE OF THE US COMPANIES FOR MAIN INDUSTRIAL SECTORS. 
Note: Calculated for a sample of 549 companies for which data on R&D, Net Sales and Operating Profits are available for the entire period 2007-2016.
Source: The 2017 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
This section analyses the R&D trajectories of EU companies 
and compares their performance against their non-EU 
counterparts in selected industries among the large R&D 
investing sectors. Some of the sectors defined in chapter 1 
are further broken down to explore the specific differences 
between EU and non-EU companies while keeping a 
meaningful number of companies. 
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Six sectors are analysed: three sectors where the EU 
and non-EU companies show comparable performances 
(Aerospace & Defence, Automobiles and Pharmaceuticals) 
and three sectors where EU companies show persistent 
underperformance when compared with their non-EU 
counterparts (Biotechnology, Software and IT-hardware). 
R&D is a critical factor for competitiveness of these 6 
industries and especially for the last three sectors that 
show the highest R&D intensity among the Scoreboard 
companies (see distribution of high R&D-intensity 
companies in the Scoreboard in Box 3.1).
For each sector and region, the companies are separated 
into two groups, the top group consisting of (at least) two 
or more companies that together account for more than 
25% of the total sector’s R&D and the bottom group 
where the rest of companies of the sector are grouped. 
The idea is to look for specific characteristics of the top and 
bottom groups within each region, i.e. firstly to understand 
the role of each group in shaping the R&D profile of the 
sector and secondly to compare performance between the 
two regions.
Table 3.1 summarises the main characteristics of the 
selected sectors and related leading companies and 
figures 3.6 to 3.11 show the R&D trajectories for the top 
and bottom groups of EU and non-EU companies for the 
six sectors (please be aware that for practical graphical 
reasons the figures on Biotechnology, Software and IT-
hardware have substantially different scales for the EU 
and non-EU companies).
Automobiles
• In general, EU companies outperform with respect to 
their non-EU counterparts in most indicators, i.e. larger 
ratios of R&D/firm, Sales/firm and R&D/net sales (R&D 
intensity). The ratios EU/non-EU for R&D (0.9) and 
sales (0.6) are very large as compared with the weight 
of the EU economy in the world. The profitability of the 
EU companies is slightly larger than that of the non-EU 
ones (6.4% vs 6.0%).
• Within the EU, the R&D trajectories of the top and 
bottom groups followed a similar path, recovering 
quickly from the effects of the crisis in 2008, and then 
following an uptrend that has been more pronounced 
for the bottom group for the last three years. However 
the R&D concentration of the sector has increased, 
i.e. the R&D share of the top group has increased by 
several percentage points.
• The comparison of EU/non-EU companies shows that 
non-EU companies have been more affected by the 
crisis, and then the bottom group having recuperated 
a significant R&D growth whereas the top group’s R&D 
has stagnated. Over the past three years, both top and 
bottom groups of the EU showed higher R&D growth 
than the non-EU ones. 
Aerospace & Defence
• On the whole, EU companies show higher ratios than 
their non-EU counterparts (although less so than those 
in Automobiles), i.e. larger R&D/firm, Sales/firm and 
R&D/net sales (R&D intensity). As for the Automobiles, 
the ratios EU/non-EU for R&D (0.7) and sales (0.6) 
are very large as compared with the weight of the EU 
economy in the world. The profitability of the non-EU 
companies is significantly larger than that of the EU 
sample (6.9% vs 9.6%).
• Within the EU, the top and bottom groups followed 
different but converging R&D trajectories (decreasing 
the R&D share of the top group). The top group 
recuperated quickly from the crisis but shows a 
downtrend since 2012. The R&D of the bottom 
group stagnated until 2011, grew at high rates until 
2014 and then, like the top group, followed an R&D 
decreasing trend until 2016/17.
• The comparison of EU/non-EU companies shows that 
non-EU top and bottom companies have also followed 
a converging R&D trend, showing higher R&D growth 
than their EU counterparts in the last periods (as 
mentioned above, the EU’s top and bottom companies 
reduced R&D over the most recent years). 
Key points
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Pharmaceuticals
• In general, EU companies show higher ratios than their 
non-EU counterparts (although less so than those in 
Automobiles), i.e. larger R&D/firm, Sales/firm and similar 
R&D/net sales (R&D intensity). The ratios EU/non-EU 
for R&D (0.5) and sales (0.5) are large as compared 
with the weight of the EU economy in the world, even 
though lower than those for the Automobiles and 
Aerospace. The profitability of EU companies (13.0%) 
is lower than that of the non-EU sample (16.9%)
• Within the EU, the R&D trajectories of the top and 
bottom groups followed a different path, the bottom 
group has followed an uptrend for most of the years, 
accelerating over the past three years, whereas the 
top group’s R&D remained practically unchanged 
(thus leading to a significant reduction of the R&D 
concentration of the sector). 
• The comparison of EU/non-EU companies shows that 
non-EU top and bottom companies have also followed 
a different path that led to higher relative R&D share 
of the bottom group which increased significantly R&D 
over the whole period whereas the top group increased 
it only slightly. However over the last two years the 
R&D growth of the bottom group stagnated while the 
top group continued to grow its share steadily. 
Biotechnology
• On the whole, EU companies underperform with respect 
to their non-EU counterparts in most indicators (mostly 
due to US companies), showing much lower ratios of 
R&D/firm, Sales/firm. The EU and non-EU samples 
are only comparable in terms of R&D/net sales (R&D 
intensity). The EU sample also underperforms in terms 
of relative size, i.e. the ratios EU/non-EU for R&D (0.1) 
and sales (0.1) are low with respect to the weight of 
the EU economy in the world. In terms of profitability, 
the non-EU companies largely outperform their EU 
counterparts (non-EU 29.5% vs -0.3%).
• Within the EU, the top and bottom groups followed 
a similar R&D uptrend until 2014, and then the two 
groups diverged, the top companies breaking the R&D 
growth while the bottom ones continued to grow R&D 
at a larger pace. As a result of the fast R&D growth of 
the bottom companies over the last three years, their 
overall R&D investment became higher than that of 
the top group, thus reducing the R&D concentration of 
the sector.
• The comparison of EU/non-EU companies (mind the 
different scales in figure 3.6) shows the strength of 
the non-EU companies in this sector (in particular the 
US ones). Both non-EU top and bottom companies 
increased R&D significantly over the whole period, and 
particularly, since 2011 when their R&D investment 
accelerated. The latter effect was more pronounced for 
the top group of companies over the last three years, 
leading to an important increase of their R&D share in 
the non-EU biotechnology sector (from 15% to 40% of 
the total sector R&D). 
Software
• Largely, EU companies underperform with respect to 
their non-EU counterparts in most indicators of the 
Software sector. As for the Biotechnology sector (and 
again mostly due to US companies), EU companies 
show much lower ratios of R&D/firm and Sales/firm 
and have a comparable ratio only in terms of R&D/
net sales (R&D intensity). The EU sample shows also a 
much lower size in both R&D and net sales, about 10% 
of those of the non-EU sample, well below the weight 
of the EU economy in the world. The EU companies 
show a large profitability (15.6%) but lower than that 
of the non-EU companies (17.2%).
• Within the EU, the bottom group of companies 
followed an R&D uptrend for most of the 10 year 
period, practically doubling their R&D investment. 
The top group, with R&D share comparable to that 
of the bottom one in 2007, followed a similar trend 
but at somewhat higher pace. As a result, the R&D 
concentration of the sector increased, with the two 
companies of the top group having a 55% R&D share 
of the total sector’s R&D.
• The comparison of EU/non-EU companies (mind the 
different scales in figure 3.7) shows the strength of 
the non-EU companies in this sector (in particular the 
US ones). Both non-EU top and bottom companies 
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followed a similar R&D trajectory: their R&D investment 
stagnated over 2007-2009 (crisis effects) and then 
resumed to grow R&D at high pace for the rest of the 
10 years period. The latter effect was more pronounced 
for the bottom group of companies over the last three 
years, however, the top (two US companies) still 
increased their R&D share in the non-EU Software 
sector (from 29% to 35% of the total sector R&D). 
IT-hardware
• Overall, EU companies underperform with respect to 
their non-EU counterparts in most indicators. As for the 
Software and Biotechnology sectors (and over again 
mostly due to US companies), EU companies show 
much lower ratios of R&D/firm and Sales/firm, however, 
EU companies show much higher R&D/net sales (R&D 
intensity). The EU sample shows also a much lower size 
in terms of both R&D and net sales (about 15% R&D 
and 8% net sales of the non-EU sample), well below the 
weight of the EU economy in the world. EU companies 
show also a small profitability (4.6%), one-third than 
the profitability of their non-EU counterparts (13.8%).
• Within the EU, the bottom group of companies fol-
lowed an R&D uptrend for most of the 10 year period, 
increasing it by 55%. The top group followed an erratic 
trend10, showing only a strong R&D growth over the 
past year to recover a level of R&D investment similar 
to the one in 2007. As a result, the R&D concentration 
of the sector reduced significantly, with the two top 
and bottom groups having similar R&D share of the 
total sector’s R&D.
• The comparison of EU/non-EU companies (mind the 
different scales in figure 3.8) shows the strength of 
the non-EU companies in this sector (in particular the 
US ones). Both non-EU top and bottom companies fol-
lowed a similar R&D trajectory: due to the effects of 
the crisis, their R&D investment stagnated over 2007-
2009 and then resumed to grow R&D at high pace for 
the rest of the 10 years period (except for the bottom 
group over the past year that showed a slight R&D de-
crease). However, altogether the R&D growth rate was 
steadily higher for the top group (two US companies) 
that have more than doubled their R&D share in the 
non-EU IT-hardware sector (from 12% to 26% of the 
total sector R&D).
10 This reflects Nokia’s problems with its mobile phone business and its recent focus on telecom infrastructure with the acquisition of Alcatel-Lucent.
SECTOR Region
No. 
firms
R&D in 2016/17 
(€bn)
Net sales in 
2016/17 (€bn)
R&D intensity 
(%)
Top companies*
Automobiles 
EU 36 53.8 971.1 5.5 Volkswagen, Daimler
non-EU 126 60.4 1617.1 3.7 General Motors, Toyota
Aerospace & Defence
EU 16 8.9 176.5 5.0 Airbus, Leonardo
non-EU 33 12.7 320.9 3.9 Boeing, United Technologies
Pharmaceuticals
EU 53 37.1 270.1 13.7 AstraZeneca, Sanofi Aventis
non-EU 145 75.4 569.8 13.2 Roche, Johnson & Johnson
Biotechnology
EU 30 2.4 9.9 24.0 Novozyme, Qiagen
non-EU 127 27.2 103.7 26.2 Gilead, Celgene
Software 
EU 45 8.4 74.2 11.3 SAP, Amadeus
non-EU 223 79.9 740.0 10.8 Alphabet, Microsoft
IT-hardware sector 
EU 29 16.0 101.7 15.7 Nokia, Ericsson
non-EU 246 104.1 1275.2 8.2 Intel, Apple
TABLE 3.1: MAIN INDICATORS FOR THE SELECTED SECTORS FOR THE EU AND NON-EU SAMPLES.
*Consisting of (at least) two or more companies that together account for more than 25% of the total sector’s R&D. Only companies for which data are available for the whole 
period (2007-2016) are taken into account.
Source: The 2017 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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FIGURE 3.6: R&D TRAJECTORIES FOR THE TOP AND BOTTOM GROUPS OF EU AND NON-EU COMPANIES IN THE AUTOMOBILES SECTOR.
Note: For the 26 out of 36 EU and 96 out of 126 non EU companies with data available for all the ten years.
Source: The 2017 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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FIGURE 3.7: R&D TRAJECTORIES FOR THE TOP AND BOTTOM GROUPS OF EU AND NON-EU COMPANIES IN THE AEROSPACE & DEFENCE SECTOR.
Note: For the 15 out of 16 EU and 26 out of 33 non EU companies with data available for all the ten years.
Source: The 2017 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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FIGURE 3.8: R&D TRAJECTORIES FOR THE TOP AND BOTTOM GROUPS OF EU AND NON-EU COMPANIES IN THE PHARMACEUTICALS SECTOR.
Note: For the 39 out of 54 EU and 87 out of 157 non EU companies with data on R&D available for all the ten years 
Source: The 2017 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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FIGURE 3.9: R&D TRAJECTORIES FOR THE TOP AND BOTTOM GROUPS OF EU AND NON-EU COMPANIES IN THE BIOTECHNOLOGY SECTOR. 
SCALES OF THE TWO PANELS ARE DIFFERENT.
Note: For the 11 out of 32 EU and 62 out of 156 non EU companies with data on R&D available for all the ten years.
Source: The 2017 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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FIGURE 3.10: R&D TRAJECTORIES FOR THE TOP AND BOTTOM GROUPS OF EU AND NON-EU COMPANIES IN THE SOFTWARE SECTOR. 
SCALES OF THE TWO PANELS ARE DIFFERENT.
Note: For the 34 out of 45 EU and 141 out of 224 non EU companies with data on R&D available for all the ten years. 
Source: The 2017 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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FIGURE 3.11: R&D TRAJECTORIES FOR THE TOP AND BOTTOM GROUPS OF EU AND NON-EU COMPANIES IN THE SOFTWARE SECTOR. 
SCALES OF THE TWO PANELS ARE DIFFERENT.
Note: For the 24 out of 29 EU and 209 out of 247 non EU companies with data on R&D available for all the ten years.
Source: The 2017 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
57The 2017 EU Industrial R&D Investment Scoreboard
Box 3.1 -  
Distribution of high R&D-intensity 
companies in the 2017 Scoreboard.
The four high R&D sectors described above 
(pharmaceuticals, biotechnology, hardware 
and software) provide most of the higher in-
tensity companies in the world top 2,500. It 
is therefore interesting to examine the preva-
lence of high intensity companies throughout 
the Scoreboard and for the various world re-
gions. High intensity is defined as 5% or more 
in Chapter 1 – Table 1.3. A detailed analysis 
of the prevalence of such high intensity com-
panies in the Scoreboard shows that:
• A larger proportion of EU companies 
in the Scoreboard are of high intensi-
ty (46.2% compared to the rest-of-the 
world except the US (RoWexUS) which 
has 39.3%. However, the US has 66.3% 
of its companies of high intensity reflect-
ing its strong software, hardware and bi-
otech sectors.
• All three regions have larger propor-
tions of high intensity companies in 
the Scoreboard’s top 500. Again the EU 
with 51.9% has a higher proportion than 
RoWexUS with 42.1% but the US alone 
has 77%.
• Proportions of high intensity companies 
are lower in the bottom 500 of the Score-
board compared to the top for all regions 
with the EU having 44.7%, higher than 
RoWexUS with 41.5% but much lower 
than the US with 61.3%. The bottom 
500 also has a lower proportion of all 
EU companies than the top 500 (18.8% 
vs. 25.8%) with non-EU companies hav-
ing 81.2% vs. 74.2%. It is not clear why 
smaller EU companies by R&D are much 
less prevalent in the bottom 500 but 
some countries have fewer companies 
than expected (e.g. France with only 9 in 
the bottom 500).
4 PERFORMANCE OFTOP R&D INVESTORS
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In this section, the world’s top 100 R&D companies are analysed, underlining those presenting important performance 
changes over the last reporting period.
Performance of top R&D investors4
This chapter describes the performance of individual companies, with a focus on the results 
of companies at the top of the world R&D ranking, highlighting those companies that show 
considerable changes in economic and R&D performance. Due to data availability, R&D 
figures for some companies may be under- or over-stated (see explanations in Box 4.1).
4.1 | Main changes in 2016/17
Key points
• For the 4th consecutive year the top R&D investor is 
the German company Volkswagen (€13.7bn). The 2nd 
and 3rd positions are for the US companies Alphabet 
(€12.9) and Microsoft (€12.4bn). The other companies 
in the top-ten are Samsung from South Korea, Intel, 
Apple and Johnson & Johnson from the US, Novartis 
and Roche from Switzerland and Huawei from China.
• The top 100 companies account for 53.1% of the total 
R&D by the 2500 companies, showed growth of R&D 
(5.9%) similar to the world average (5.8%) but higher 
growth of net sales (1.7% vs 0.3%).
• Sixty-one companies in the top 100 have shown 
positive R&D investment growth. Among them, 30 
companies had double-digit R&D growth, and of these, 
17 companies also showed double-digit growth in net 
sales.
• Most of the top 100 companies showing double-digit 
R&D increases are in the ICT producers (8), Health 
industries (6) and ICT services (4). The 5 companies 
showing the largest increase in R&D are BROADCOM 
(154.9%), DELL TECHNOLOGIES (115.8%), NOKIA 
(96.0%), NXP SEMICONDUCTORS (90.1%) and GILEAD 
SCIENCES (54.8%). Broadcom, Dell and Nokia all 
made large acquisitions in 2016/17. Gilead acquired 
Nimbus Therapeutics in 2016 and NXP made a large 
acquisition in 2016 (of Freescale Semiconductor) but 
NXP has now been taken over by Qualcomm.
• As mentioned above, 17 companies had double-digit 
growth in R&D and net sales, the top 5 companies 
among them are Alphabet, Huawei Facebook, Nokia 
and Celgene.
• Thirty-nine companies in the top 100 have experienced 
a decrease in R&D investment. The companies with the 
largest decrease in R&D are TOYOTA MOTOR (-35%); 
TOSHIBA (-18%); BRISTOL-MYERS SQUIBB (-16 %); 
DUPONT (-13%) and TOYOTA MOTOR (-12%).
• The R&D intensity of companies in the top 100 (7.0%) 
increased, as in the previous year, due to a higher R&D 
growth (5.9%) than net sales growth (1.7%). The EU 
companies in the top 100 have slightly higher R&D 
intensity than that of non-EU companies (7.0% vs. 
7.5%).
• Among the top 100 companies, 5 made losses (DELL, 
ALLERGAN, NOKIA, DEUTSCHE BANK and BROADCOM) 
with 23 showing profitability of only 5% or less but 
25 showed profitability over 20%. All but two of the 
25 operate in high R&D-intensive sectors (Procter & 
Gamble and Banco Santander). 
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This section analyses the behaviour of the top companies 
over the long-term based on our history database contain-
ing company data for the period 2002-2016. Results of 
companies showing outstanding R&D and economic re-
sults are underlined. 
The R&D ranking of the top 50 companies is presented 
in figure 4.1 and table 4.2 shows changes in such ranking 
since the first Scoreboard in 2004. A ranking of the top 
R&D investors by R&D intensity is shown in Table 4.3, in-
dicating the reasons for main changes observed over the 
last period. It is important to note, as stated in the previ-
ous reports, that the growth of companies is often accom-
panied by mergers and acquisitions. 
4.2 | Long-term performance of top R&D companies
• There are 16 EU companies (18 in 2004) and 34 non-
EU companies (32 in 2004) with data available for the 
whole period. 
• In the EU group, six companies left the top 50 (ALCA-
TEL, ISTITUTO FINANZIARIO INDUSTRIALE, PHILIPS, 
RENAULT, BAE SYSTEMS and PEUGEOT) and four 
companies joined the top 50 (BOEHRINGER INGEL-
HEIM, FIAT CHRYSLER, SAP and CONTINENTAL). Alca-
tel first merged with lucent and the combined entity 
was then acquired by Nokia.
• In the non-EU group, eleven companies left the 
top 50 (Fujitsu, Canon, Fujitsu, Matsushita Electric, 
NEC, Motorola, Nortel Networks (acquired), Wyeth 
(acquired), Delphi, Sun Microsystems (acquired), 
NTT and Toshiba) and thirteen companies joined 
the top 50 (AMGEN, APPLE, DENSO, GILEAD 
SCIENCES, ALPHABET, HUAWEI, LG ELECTRONICS, 
ORACLE, PANASONIC, QUALCOMM, TAKEDA 
PHARMACEUTICALS, FACEBOOK and ABBVIE-
demerged from Abbott Laboratories).
• The distribution of the top 50 companies by main in-
dustrial sector and region changed from 2004 to 2017 
as follows:
– Automobiles & Parts, from 13 (EU 7) to 12 (EU 6)
– Health industries, from 11 (EU 3) to 17 (EU 4)
– ICT industries, from 13 (EU 3) to 15 (EU 4)
• Three EU companies improved in the R&D ranking by 
at least 20 places are Bayer (now ranked 29th), SAP 
(now 47th) and CONTINENTAL (48th). 
• There are 13 non-EU companies that gained more than 
20 places. They include Samsung (now 4th), ALPHABET 
(now 2nd), HUAWEI (now 6th), APPLE (now 7th), ORA-
CLE (now 17th), QUALCOMM (now 28th), TAKEDA (now 
49th), LG ELECTRONICS (now 50th), GILEAD SCIENCES 
(now 32th), BRISTOL-MYERS SQUIBB (now 30th), CEL-
GENE (now 33st), FACEBOOK (19th) and BEING (36th).
• Two companies dropped twenty or more places but re-
mained within the top 50: SONY (now 41th) and PANA-
SONIC (now 40th).
Key points
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Companies showing the largest 10-years changes in R&D, net sales  
and employees
Box 4.1 -  
Understatement or overstatement 
of R&D figures
The Scoreboard relies on consistent disclosure 
of R&D investment in published annual re-
ports and accounts. However, due to different 
national accounting standards and disclosure 
practices, in some cases, R&D costs cannot 
be identified separately in companies’ ac-
counts, e.g. appearing integrated with other 
operational expenditures such as engineering 
costs. To avoid overstatement of R&D figures, 
the Scoreboard methodology excludes R&D 
figures that are not disclosed separately (see 
methodological notes in Annex 2). Inevitably, 
the strict application of this criterion may lead 
to understating the actual R&D effort of some 
companies. 
An example of a possible large understate-
ment of R&D figures is the US company Am-
azon. The figure of $511m used in the Score-
board for Amazon’s R&D is just the small 
capitalised element of R&D. Amazon also 
expenses ‘Technology & Content’ invest-
ment of $16.085bn but does not say how 
much of this is R&D. However, from informa-
tion given in the Amazon annual reports for 
2012-15, it is estimated that approximate-
ly $10.3bn of the $12.5bn of technology & 
content investment in 2015 was R&D. This 
2015 figure needs to be raised by a propor-
tion of the $3.55bn increase in technology 
& content investment from 2015 to 2016 
and the capitalised R&D of $0.5bn for 2016. 
Consequently, an estimate of Amazon’s R&D 
could be in the range of €12bn which would 
make Amazon #6 in the world ranking of 
companies by R&D (just below Intel at ‘#5)”. 
Companies among the top 100 R&D investors presenting 
remarkable results in terms of R&D, sales and employees 
over the past 10 years are listed in table 4.1. 
The high growth companies, at the top of the table, si-
multaneously increased R&D (by more than 500%), net 
sales (by more than 400%) and employees (by more than 
196%).
On the other extreme, the firms at the bottom of the table 
showed an important simultaneous drop of R&D, net sales 
and employees.
Firm
R&D investment 
2016 (€bn) 
Change in R&D 
2007-2016 (%) 
Change in net sales 
2007-2016 (%) 
Change in employees 
2007-2016 (%)
High growth 
firms
ALPHABET 12.9 539.6 444.0 328.8
APPLE 9.5 1184.5 777.4 389.5
GILEAD SCIENCES 4.4 689.5 618.4 202.1
CELGENE 4.2 1081.1 698.8 323.3
ALLERGAN 2.7 1848.0 483.6 196.1
TENCENT 1.6 3704.5 3876.5 792.6
Low growth 
firms
NOKIA 4.9 -7.1 -53.8 -10.0
PANASONIC 3.9 -14.5 -19.0 -15.8
SONY 3.6 -14.0 -14.3 -28.9
HITACHI 2.6 -24.3 -18.4 -12.6
TOSHIBA 2.4 -24.9 -36.5 -22.5
PROCTER & GAMBLE* 1.8 -15.8 -17.9 -28.0
TABLE 4.1: COMPANIES AMONG THE TOP 100 R&D INVESTORS SHOWING THE LARGEST CHANGES IN R&D, NET SALES AND EMPLOYEES.
*Procter and Gamble demerged several units over the 10-year period.
Source: The 2017 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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50. LG ELECTRONICS INC., South Korea 
49. TAKEDA PHARMACEUTICAL COMPANY LIMITED, Japan 
48. CONTINENTAL AG, Germany 
47. SAP SE, Germany 
46. C.H. BOEHRINGER SOHN AG & CO. KG, Germany 
45. AIRBUS SE, Netherlands 
44. TELEFONAKTIEBOLAGET LM ERICSSON, Sweden 
43. DENSO CORPORATION, Japan 
42. AMGEN INCORPORATED, US 
41. SONY CORPORATION, Japan 
40. PANASONIC CORPORATION, Japan 
39. ABBVIE INC., US 
38. GLAXOSMITHKLINE PLC, UK 
37. NISSAN MOTOR CO LTD, Japan 
36. BOEING COMPANY (THE), US 
35. ELI LILLY AND COMPANY, US 
34. FIAT CHRYSLER AUTOMOBILES N.V., Netherlands 
33. CELGENE CORP, US 
32. GILEAD SCIENCES INC, US 
31. GENERAL ELECTRIC COMPANY, US 
30. BRISTOL-MYERS SQUIBB COMPANY, US 
29. BAYER AG, Germany 
28. QUALCOMM INC, US 
27. NOKIA OYJ, Finland 
26. INTERNATIONAL BUSINESS MACHINES CORP, US 
25. SIEMENS AG, Germany 
24. SANOFI, France 
23. BAYERISCHE MOTOREN WERKE AG, Germany 
22. ASTRAZENECA PLC, UK 
21. HONDA MOTOR CO LTD, Japan 
20. ROBERT BOSCH GMBH, Germany 
19. FACEBOOK, INC., US 
18. CISCO SYSTEMS INC, US 
17. ORACLE CORP, US 
16. MERCK & CO., INC., US 
15. FORD MOTOR CO, US 
14. PFIZER INC, US 
13. TOYOTA MOTOR CORPORATION, Japan 
12. DAIMLER AG, Germany 
11. GENERAL MOTORS COMPANY, US 
10. NOVARTIS AG, Switzerland 
9. JOHNSON & JOHNSON, US 
8. ROCHE HOLDING AG, Switzerland 
7. APPLE INC., US 
6. HUAWEI INVESTMENT & HOLDING CO., LTD., China 
5. INTEL CORP, US 
4. SAMSUNG ELECTRONICS CO.,LTD., South Korea 
3. MICROSOFT CORP., US 
2. ALPHABET INC., US 
1. VOLKSWAGEN AG, Germany 
R&D investment (Euro million) 
EU
US
Japan
South Korea
Switzerland
China
FIGURE 4.1: THE WORLD’S TOP 50 COMPANIES BY THEIR TOTAL R&D INVESTMENT (€million) IN THE 2017 SCOREBOARD.
Source: The 2017 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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Rank  
in 2017
Company Country
R&D in 2016/17 
(€bn)
R&D intensity 
(%)
Rank change  
2004-2017
1 VOLKSWAGEN Germany 13,7 6,3 up 7
2 ALPHABET US 12,9 15,0 up > 200 
3 MICROSOFT US 12,4 14,5 up 10
4 SAMSUNG South Korea 12,2 7,7 up 29
5 INTEL US 12,1 21,5 up 9
6 HUAWEI China 10,4 19,2 up > 200 
7 APPLE US 9,5 4,7 up 97
8 ROCHE Switzerland 9,2 19,6 up 10
9 JOHNSON & JOHNSON US 8,6 12,7 up 3
10 NOVARTIS Switzerland 8,5 18,2 up 10
11 GENERAL MOTORS US 7,7 4,9 down 5
12 DAIMLER Germany 7,5 4,9 down 9
13 TOYOTA MOTOR Japan 7,5 3,3 down 8
14 PFIZER US 7,4 14,7 down 12
15 FORD MOTOR US 6,9 4,8 down 14
16 MERCK US US 6,5 17,2 up 13
17 ORACLE US 5,8 16,3 up 29
18 CISCO SYSTEMS US 5,7 12,6 up 12
19 FACEBOOK US 5,6 21,4 up > 200 
20 ROBERT BOSCH Germany 5,6 7,6 up 8
21 HONDA MOTOR Japan 5,4 4,7 up 10
22 ASTRAZENECA UK 5,4 24,6 up 3
23 BMW Germany 5,2 5,5 up 6
24 SANOFI France 5,2 14,1 down 8
25 SIEMENS Germany 5,1 6,3 down 20
26 IBM US 4,9 6,5 down 16
27 NOKIA Finland 4,9 20,8 down 17
28 QUALCOMM US 4,9 21,9 up 64
29 BAYER Germany 4,8 10,0 up 31
30 BRISTOL-MYERS SQUIBB US 4,6 24,9 up 12
31 GENERAL ELECTRIC US 4,5 3,9 up 6
32 GILEAD SCIENCES US 4,4 15,4 up > 200 
33 CELGENE US 4,2 39,8 up > 200 
34 FIAT CHRYSLER Netherlands 4,2 3,8 up 10
35 ELI LILLY US 4,2 20,8 up 6
36 BOEING US 4,1 4,6 up 21
37 NISSAN MOTOR Japan 4,0 4,2 down 3
38 GLAXOSMITHKLINE UK 4,0 12,1 down 27
39 ABBVIE US 3,9 16,0 new
40 PANASONIC Japan 3,9 6,5 down 33
41 SONY Japan 3,6 5,9 down 26
42 AMGEN US 3,6 16,6 down 5
43 DENSO Japan 3,3 9,0 down 8
44 ERICSSON Sweden 3,3 14,1 down 27
45 AIRBUS Netherlands 3,3 4,9 down 10
46 BOEHRINGER SOHN Germany 3,1 21,0 up 16
47 SAP Germany 3,0 13,8 up 23
48 CONTINENTAL Germany 2,9 7,2 up 69
49 TAKEDA PHARMACEUTICAL Japan 2,7 20,1 up 24
50 LG ELECTRONICS South Korea 2,7 6,3 up 60
TABLE 4.2: THE TOP 50 COMPANIES IN THE 2017 SCOREBOARD: RANK CHANGE 2004-2017
Note: companies in “blue” went up more than 20 ranks and in “red” lost more than 20 ranks.
Source: The 2017 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
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The previous section looked at the top 50 companies 
ranked by the size of their R&D investment. However, since 
some large companies have very large sales, their R&D 
intensities (R&D as % sales) may be quite modest and 
R&D may not be the key driver of growth. For example, 
in the world top 150 by amount of R&D we have NTT at 
#81 by size of R&D but with R&D intensity of 1.9%. Hon 
Hai Precision at #94 with intensity of 1.2% and Shell (oil & 
gas) at #148 with an intensity of only 0.4%. This section 
therefore examines the subset of larger companies in the 
Scoreboard having high R&D intensities, all in double digit 
percentages. The top 50 such companies all have R&D as 
a very substantial proportion of sales and profits and R&D 
is a key driver of growth. These companies are drawn from 
the top few highest R&D intensity sectors. The criteria for 
selection, the new entrants and leavers for the top 50, the 
make-up of the 2017 top 50 and the reasons for large 
rises/falls in the ranking are described below.
The two criteria for inclusion in the top 50 large companies 
with the highest R&D intensity are:
• R&D should be over €1bn which means that only the 
top 143 companies in the world by amount of R&D are 
eligible.
• R&D intensity should be a double-digit percentage so 
that R&D is a major investment and significant driver 
of growth. To enter the top 50 in 2017 R&D intensity 
needs to be 12.7% or more.
In the 2016 Scoreboard, it was possible to enter the top 
50 by R&D intensity with an intensity of 10.2% or more so 
there are more high intensity large companies in the 2017 
Scoreboard where an intensity of 12.7% or more is required.
The top 50 large companies by R&D intensity are shown 
in Table 4.3. The 50 companies are listed in order of 
R&D intensity, the highest first. The table also gives each 
company’s sector, R&D investment and rank change from 
the 2016 top 50.
New entrants, leavers and large 
movers
There are 10 new entrants in the ranking of the top 50 
by R&D intensity in the 2017 Scoreboard and therefore 
10 companies that were in the 2016 top 50 but no 
longer qualify. Seven of the leavers are from the nine 
companies with the lowest R&D intensity in the 2016 
top 50. These seven all have R&D intensities ranging 
from 10.2% to 12.6% and therefore are under the 2017 
minimum intensity for entry of 12.7%. They are EMC, 
Cisco, Finmeccanica, Monsanto, Seagate Technology, SK 
Hynix and Syngenta. Two other companies were taken 
over – Alcatel-Lucent (now part of Nokia) and Yahoo! (now 
part of Verizon). The tenth company is GlaxoSmithKline 
whose R&D intensity fell because its sales increased more 
than its R&D to give a 2017 intensity of 12.1%, just below 
the 12.7% needed for entry in 2017. GSK’s 2016 intensity 
was 12.9%. The reason for the sales increase was GSK’s 
purchase of Novartis’s consumer healthcare and vaccines 
businesses; the two companies’ consumer healthcare 
businesses are now in a joint venture controlled by GSK 
which has the majority shareholding. 
There are ten new entrants for the 2017 top 50. Six of 
these companies have increased their R&D from below 
€1bn to above €1bn from 2015/16 to 2016/17 and 
so meet the first criterion for entry mentioned above. 
These six are Broadcom, Ctrip.com International, Intuit, 
NXP Semiconductor (which has now been acquired by 
Qualcomm), Salesforce.com and Vertex Pharma. There is 
one company new to the Scoreboard – Altaba, a software/
internet company. And there are three companies whose 
R&D intensity increased – eBay, Gilead Sciences and 
Micron Technology. Seven of the new entries are from the 
US with two from Asia and one from the EU. The leavers 
include four from the EU, four from the US, one from Asia 
and one from Switzerland.
Eight companies changed their ranking by nine or more 
places between the 2016 and 2017 top 50 tables. All eight 
fell between 9 and 11 places in the ranking, six of them 
because sales increased by more than R&D so the R&D 
intensity decreased (AbbVie, Facebook, Huawei, Johnson 
& Johnson, Mediatek & Merck DE). In the other two cases 
(Novartis & Sanofi), both R&D and sales decreased but 
R&D was down more than sales.
The top 50 by sector and by world 
region
Just three broad sectors account for 49 of the 50 
companies with one company drawn from a fourth sector. 
The numbers in each sector are:
Ranking of large companies by R&D intensity
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• Biotech & Pharmaceuticals: 23 companies
• Tech Hardware/Telecoms Equipment: 14 companies 
• Software/internet: 12 companies
• Travel & Leisure: 1 company (Ctrip.com International, 
an internet company incorporated in the Cayman 
Islands but which is a major provider of travel-related 
services in China)
It is not surprising that these three broad sectors 
dominate the rankings since these are the sectors where 
R&D is crucial for growth and continued success. What is 
surprising, however, is that many of the large companies 
in the top 50 have R&D intensities well above their sector 
averages. Smaller companies frequently have R&D 
intensities above their sector average because their sales 
are modest but growing so the R&D needed to develop 
new products is spread over smaller sales volumes than 
for larger companies. The global average R&D intensity for 
the biopharma sector was 10.6% in the 2016 Scoreboard 
yet all the biopharma companies in the top 50 have R&D 
intensity well above this. The global average for tech. 
hardware was 8.4% yet again every hardware company in 
the top 50 exceeds this. For software/internet, the global 
average was 15% but just over half of the top 50 software 
companies exceed this.
The regional make-up of the top 50 as between the US, 
the EU, Asia and Switzerland is:
• The US contributes just over half the companies with 
26 in the top 50
• The EU is the next largest region with 12 companies
• Asia contributes 10 companies (Japan 4, China 4 if we 
include Ctrip.com, Singapore 1 and Taiwan 1)
• Switzerland has 2 companies (Novartis & Roche) 
The US accounts for 11 of the 23 biopharma companies 
in the top 50, 5 of the 14 tech. hardware companies 
but a massive 10 of the 12 software companies. The 
EU has 6 biopharma companies, 5 from tech. hardware 
and 1 from software. Asia has 4 biopharma companies, 4 
from Tech. hardware, 1 from software and 1 from travel 
& leisure. These numbers reflect the relative strengths 
of the different regions with the US the world leader in 
software/internet but biopharma and tech. hardware are 
spread more evenly between regions although the US is 
particularly strong in biotech.
The US is particularly successful in the software/internet 
sector with 10 of the 12 companies in the top 50. These 
include household names such as Alphabet (Google), eBay, 
Facebook, Microsoft and Oracle. 
The other area where the US excels is biotech and all five 
of the biotech companies in the top 50 are from the US. 
These are Amgen, Biogen, Celgene, Gilead and Vertex. The 
five companies labelled biopharma in the top 50 (which all 
have notable biotech drugs such as immunotherapies on 
the market) include 2 from the US (Bristol-Myers Squibb 
& Merck), 2 from Switzerland (Novartis & Roche) and 
one from the EU (AstraZeneca). Roche’s biotech expertise 
arises from its early acquisition of Genentech of the US.
In many instances above average R&D intensity is a 
driver of sales growth since innovative and improved new 
products give a company an edge over competitors in the 
market. It is therefore not surprising that a number of the 
companies in the top 50 by R&D intensity have moved well 
up the Scoreboard rankings in both R&D and sales over 
the last five years. Examples include Alphabet (ranked #2 
by R&D in 2017 but #26 in 2012), Baidu (#103 in 2017 
but #450 in 2012, Facebook (#19 in 2017 but #295 in 
2012), Gilead Sciences (#32 in 2017 but #112 in 2012), 
Huawei (#6 in 2017 but #41 in 2012), NXP Semiconductor 
(#98 in 2017 but #203 in 2012), Salesforce.com (#125 
in 2017 but #493 in 2012) and Vertex Pharma (#142 in 
2017 but #224 in 2012).
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Rank by
R&D int.
R&D (€bn)
& R&D rank
Company
Industrial
Sector
R&D int.2016 
(%)
Rank change and  
reason for change
 1* (new) 1.01bn (142) Vertex Pharma Health industries 62,5 R&D rose above €1bn
 2‡ (new) 1.05bn (136) Ctrip.com Int. Others 40,0 R&D rose above €1bn
 3* (1) 4.24bn (33) Celgene Health industries 39,8 -2
 4* (2) 4.60bn (30) Bristol-Myers Squibb Health industries 24,9 -2
 5† (8) 5.36bn (22 ) AstraZeneca Health industries 24,6 3
 6* (5) 1.11bn (131) Electronic Arts ICT services 24,2 -1
 7‡ (11) 1.74bn (79) Daiichi Sankyo Health industries 22,4 4
 8* (10) 4.89bn (28) Qualcomm ICT producers 21,9 2
 9* (new) 1.07bn (134) Intuit ICT services 21,8 R&D rose above €1bn
10* (9) 12.09bn (5) Intel ICT producers 21,5 -1
11* (3) 5.62bn (19) Facebook ICT services 21,4 -8
12* (4) 1.39bn (104) Nvidia ICT producers 21,2 -8
13† (12) 3.11bn (46) Boehringer Sohn Health industries 21,0 -1
14* (new) 1.03bn (140) Altaba ICT services 20,9 New to Scoreboard
15*= (13) 4.18bn (35) Eli Lilly Health industries 20,8 -2
15†= (19) 4.90bn (27) Nokia ICT producers 20,8 4
17*= (new) 2.54bn (55) Broadcom ICT producers 20,2 R&D rose above €1bn
17‡= (7) 1.64bn (84) Mediatek ICT producers 20,2 -10, %Sales↑>R&D ↑
19‡ (16) 2.73bn (49) Takeda Pharma Health industries 20,1 -3
20‡ (15) 9.24bn (8) Roche Health industries 19,6 -5
21† (22) 2.68bn (53) Allergan Health industries 19,4 1
22‡ (12) 10.36bn (6) Huawei ICT producers 19,2 -10, %Sales↑>R&D↑
23† (21) 1.23bn (119) ST Microelectronics ICT producers 18,6 -2
24‡ (14) 8.54bn (10) Novartis Health industries 18,2 -10, %R&D↓>Sales↓
25* (23) 6.48bn (16) Merck US Health industries 17,2 -2
26* (17) 1.83bn (74) Biogen Health industries 16,9 -9, sales ↑/ R&D ↓
27* (20) 3.61bn (42) Amgen Health industries 16,6 -7
28* (29) 5.84bn (17) Oracle ICT services 16,3 1
29*(18) 3.90bn (39) AbbVie Health industries 16,0 -11, %Sales↑>R&D↑
30† (new) 1.44bn (98) NXP Semiconductor ICT producers 16,0 R&D rose above €1bn
31‡ (26) 1.69bn (82) Astellas Pharma Health industries 15,9 -5
32* (new) 4.43bn (32) Gilead Sciences Health industries 15,4 R&D up, sales down
33† (25) 1.03bn (138) ASML ICT producers 15,1 -8
34* (27) 12.86bn (2) Alphabet ICT services 15,0 -7
35* (28) 7.38bn (14) Pfizer Health industries 14,7 -7
36*= (35) 12.37bn (3) Microsoft ICT services 14,5 -1
36*= (new) 1.15bn (125) Salesforce.com ICT services 14,5 R&D rose above €1bn
38‡ (30) 1.39bn (103) Baidu ICT services 14,4 -8
39* (32) 1.46bn (96) Applied Materials ICT producers 14,2 -7
40†= (34) 3.30bn (44) Ericsson ICT producers 14,1 -5
40‡= (36) 1.37bn (105) Otsuka Health industries 14,1 -3
40†= (31) 5.16bn (24) Sanofi Health industries 14,1 -9, %R&D↓>%Sales↓
43* (new) 1.19bn (122) eBay Others 13,9 Intensity rose 
44† (40) 3.04bn (47) SAP ICT services 13,8 -4
45‡ (37) 1.86bn (70) ZTE ICT producers 13,5 -8
46† (44) 2.00bn (67) Novo Nordisk Health industries 13,3 -2
47† (38) 1.97bn (68) Merck DE Health industries 13,1 -9, %Sales↑>R&D↑
48* (new) 1.53bn (89) Micron Technology ICT producers 13,0 Sales ↓, R&D ↑
49* (43) 2.32bn (59) Western Digital ICT producers 12,8 -6
50* (41) 8.63bn (9) Johnson & Johnson Health industries 12,7 -9, %Sales↑>R&D↑
TABLE 4.3: RANKING OF LARGE COMPANIES BY R&D INTENSITY.
Note: The colours indicate world region (red for US, blue for EU, black for Asia & green for Switzerland.
Source: The 2017 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
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As explained in chapter 1 for the world sample of companies, 
industrial R&D is very concentrated by country and sector. 
Among the EU 1000 sample, there are 906 companies 
based in the top 10 Member States accounting for 97.3 % 
of the total R&D. Moreover, the overall performance of the 
EU 1000 group is largely driven by the results of companies 
based in Germany, France and the UK, accounting for 67% 
of the total R&D and 68% of total net sales.
The first section presents the one-year changes in R&D 
and economic indicators of companies, especially those 
based in the top 10 largest Member States. The second 
section analyses long-term trends of company results, 
mainly in terms of R&D, net sales and employment.
Analysis of the top EU 1000 R&D investors5
This chapter examines the R&D and economic trends of companies based in Members 
States of the EU. This specific analysis is based on an extended sample of companies 
representing the top 1000 R&D investors in the EU, i.e. the 567 EU companies included 
in the world top 2500 sample and 433 additional companies based in the EU. The 
distribution of the EU 1000 companies across industrial sectors and countries can be 
found in Annex 3.
5.1 | Changes in the main indicators in 2016/17
• The top 1000 R&D companies in the EU invested 
€198.3bn, 6.9% more than the previous year.
• The German companies made the largest contribution 
to the results of the EU 1000 sample. They increased 
R&D by 6.7% and net sales only by 1.1%. These re-
sults reflect to a large extent the performance of the 
German companies in the Automobiles sector (7.1% 
in R&D and 3.6% in net sales). Companies from this 
sector showing the highest R&D growth were Daimler, 
ZF, Continental and Robert Bosch. German companies 
showing good performance in other sectors were SAP 
(ICT Services) and Bayer (Health industries).
• The companies based in the UK increased R&D by 9.2% 
but showed a modest increase in net sales (0.6%). The 
largest contribution to R&D growth was made by the 
Health industries (Largest contribution from Shire and 
GlaxoSmithKline), other industries (Lloyds Banking, 
Kemble Water Holdings), Aerospace & Defence (Rolls-
Royce) and ICT Services (BT, Atlassian Corporation).
• Companies based in France increased R&D by 3.4% 
and dropped sales by 3.6%. Among these companies, 
the largest contribution to the R&D growth came from 
Automobile sector (Renault, Valeo), ICT Services (Ubi-
soft Entertaiment, Dassault) and other industries (Al-
stom, Vivendi, Technicolor, L’Oreal). 
• Apart from the three top Member States, among the 
group of largest EU countries, those whose companies 
increased R&D above the EU average were:
– Finland by 63.8%, mostly due to Nokia’s acquisi-
tion of Alcatel-Lucent, 
– Denmark by 7.5%, large contributions from Health 
industries (Novo Nordisk, Symphogen, Ascendis 
Pharma, Forward Pharma, Alk Abello) and Other in-
dustries (Vestas, Carlsberg),
Key points
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– Belgium by 11.6%, large contributions from ICT 
industries (Proximus, Barco), Health industries 
(Mithra Pharma, UCB), Chemicals (Solvay) and 
Other industries (Anheuser-Busch, KBC).
• Among the large countries, only the group of Swedish 
companies decreased R&D (-1.2%). In this group, high 
R&D growth of companies such as Saab, Assa Abloy, 
Swedish Orphan Biovitrum, Lansforsakringar and Fin-
gerprint Cards has been offset by reduction of R&D by 
companies such as Ericsson, Atlas Copco and Elekta.
• In term of net sales, companies from several countries 
showed negative results, Italy (-9.4%), Sweden (-4.1%), 
France (-3.6%) and Spain (-2.7%), mostly due to oil-
related companies such as Total, Eni, Enel and Repsol. 
• In 2017, for the fourth consecutive year, the average 
R&D intensity of the EU-1000 companies increased 
because of the higher increase of R&D investments 
compared to that of net sales, 6.9% vs. -0.6%. 
It is important to remember that in many countries, the 
aggregate country indicators depend to a large extent on 
the figures of a very few firms. This is due, either to the 
country’s small number of companies in the Scoreboard 
or to the concentration of R&D in a few large firms. For 
example Ericsson and Volvo account for 57% of the 
total R&D by the Swedish companies, Nokia for 77% of 
the companies based in Finland and Telecom Italia and 
Leonardo for 52% of the companies based in Italy.
Country
No. of 
companies
R&D in 2016 
(€bn)
R&D Share within 
EU (%)
 R&D one year 
growth (%)
Net Sales one year 
growth (%)
Germany 224 76.3 38.5 6.7 1.1
UK 290 31.0 15.6 9.2 -1.5
France 108 26.0 13.1 3.4 -3.6
Netherlands 46 18.5 9.3 3.2 3.1
Ireland 27 9.9 5.0 5.4 0.8
Sweden 82 9.5 4.8 -1.2 -4.1
Finland 36 6.4 3.2 63.8 7.8
Italy 38 5.9 3.0 4.0 -9.6
Spain 21 4.8 2.4 3.5 -2.7
Denmark 32 4.7 2.4 7.5 4.7
Top 10 countries 904 192.9 97.3 6.9 -0.9
Other EU 96 5.4 2.7 9.4 -3.2
Total EU 1000 198.3 100 6.9 -1.0
TABLE 5.1: R&D TRENDS FOR COMPANIES BASED IN THE TOP 10 EU MEMBER STATES.
Note: For the sample of 1000 EU companies.
Source: The 2017 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
Sector
R&D in 2016 
(€bn)
Germany 1-year 
change (%)
France 1-year change 
(%)
UK 1-year 
change (%)
 R&D Net Sales  R&D Net Sales  R&D Net Sales 
Aerospace & Defence 9.0 15.2 11.3 -13.1 2.3 11.2 7.9
Automobiles & other transport 57.4 7.1 3.6 11.0 5.2 3.0 10.1
Chemicals 5.7 -2.1 -10.9 4.3 8.9 6.1 29.0
Health industries 45.7 6.9 5.1 1.4 2.1 12.2 14.8
ICT producers 26.0 5.8 5.7 0.1 -4.7 8.4 17.8
ICT services 13.1 12.3 5.1 15.3 4.8 19.6 19.1
Industrials 12.3 5.4 1.6 11.9 -9.3 3.7 8.0
Others 29.1 7.7 -1.7 0.7 -6.2 3.9 -5.9
Total 198.3 6.7 1.1 3.4 -3.6 9.2 -1.5
TABLE 5.2: GROWTH OF R&D AND NET SALES FOR THE GERMAN, FRENCH AND UK COMPANIES - BREAK DOWN FOR 7 MAJOR INDUSTRIAL SECTORS.
Note: For the sample of 1000 EU companies.
Source: The 2017 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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This section presents the evolution of the main company 
indicators over the past 10 years for the companies in the 
EU 1000 group.
5.2 | Long-term trends for companies based in the large 
Member States
Key points
5.2.1 Long-term trends
The annual growth rates of R&D and net sales and 
profitability for companies based in Germany, France and 
the UK over the past 10 years is provided respectively in 
figures 5.1, 5.2 and 5.3. These figures are based on our 
history database comprising these indicators over the 
whole 2007-2016 period for EU companies based in 
Germany (156), France (77) and the UK (290).
• Companies based in Germany continued the strong per-
formance in terms of R&D shown since 2010, recovering 
to and then improving on levels of R&D growth prior to 
the crisis. However, the growth of net sales has not fol-
lowed the same path, a slowdown from 2010 to 2013 
has been followed by a hesitant recovery in 2014/15 but 
then again sales decreased from 2015 to 2016. On the 
other hand, German companies have maintained a stable 
level of profitability over the past 10 years although one 
that was lower than their French and UK counterparts. 
• Companies based in France showed a low but positive 
trend in R&D growth after the decrease from 2011 to 
2013, but at much lower levels than their EU or non-
EU counterparts although growth increased from 2015 
to 2016. However, the growth of net sales continued 
to be negative to 2013 but improved somewhat from 
2015 to 2016. The average profitability of the French 
companies broke the decreasing trend showed since 
2011 and has increased from 2015 to 2016.
• Companies based in the UK showed a strong recovery 
of R&D and net sales in 2010-2011 that then 
reversed in 2012. In 2012-2013 their R&D investment 
resumed to grow at significant pace but with a level 
of net sales practically unchanged. In 2014-15 the 
R&D level remained practically unchanged although 
with a significant decrease of net sales but both R&D 
and sales increased strongly from 2015-2016. The 
average profitability of the UK companies was the 
highest of the three countries throughout the period 
although, like their French counterparts, showed 
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FIGURE 5.1: ONE-YEAR R&D INVESTMENT AND NET SALES GROWTH AND PROFITABILITY BY THE GERMAN COMPANIES.
Note: Note: growth rates for the three variables have been computed on 156 out of the 244 German companies for which data are available for the entire period 2007-2016.
Source: The 2017 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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FIGURE 5.2: ONE-YEAR R&D INVESTMENT AND NET SALES GROWTH AND PROFITABILITY BY THE FRENCH COMPANIES.
Note: growth rates for the three variables have been computed on 77 out of the 108 French companies for which data are available for the entire period 2007-2016.
Source: The 2017 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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FIGURE 5.3: ONE-YEAR R&D INVESTMENT AND NET SALES GROWTH AND PROFITABILITY BY THE UK COMPANIES.
Note: growth rates for the three variables have been computed on 142 out of the 290 UK companies for which data are available for the entire period 2007-2016.
Source: The 2017 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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FIGURE 5.4: ONE-YEAR R&D INVESTMENT AND NET SALES GROWTH AND PROFITABILITY BY THE DUTCH COMPANIES.
Note: growth rates for the three variables have been computed on 28 out of the 46 Dutch companies for which data are available for the entire period 2007-2016.
Source: The 2017 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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a decreasing trend from 2011-2015 but a strong 
increase in 2016/17.
• Companies based in the Netherlands registered an 
increase in R&D, Net Sales and profitability. The growth 
was less strong than last years but still positive, giving 
continuity to the recovery after the slowdown of 2013 
and 2014.
Key points
5.2.2 Change in R&D over 2007-2016 for groups of sectors and main  
EU company aggregates
The levels of R&D, net sales and employment in 2007 and 
2016 are presented in figures 5.5, 5.6 and 5.7 for groups 
of industrial sectors with characteristic R&D intensities11 
(see definition in Chapter 1 – Table 1.3). The figures refer 
to a set of 689 companies that reported R&D, net sales 
and number of employees over the whole period 2007-
2016 (DE-166, FR-85, UK-158, NL-26 and Other-254). 
11 For simplification, in this section these groups are referred to as high tech, medium-high tech, medium-low tech and low-tech.
• Over the past 10 years, the R&D, net sales and em-
ployment changes for the whole sample of 689 EU 
companies for which data are available are very simi-
lar to those of the EU 400 sample within the world set 
(concentration effect).
 The overall changes for each indicator are:
– R&D 53%(high tech 44%, medium-high tech 69%, 
medium-low tech 37% and low tech 26%)
– Net sales 14%(high tech 45%, medium-high tech 
38%, medium-low tech 20% and low tech -12%)
– Employment 14 (high tech 36%, medium-high tech 
27%, medium-low tech -3% and low tech -5%).
• These three indicators changed in very different pro-
portions across member states and sector groups. By 
sector groups the highest increases were:
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Note: figures displayed refer only to the 689 companies for which data are available for all variables (R&D, Net Sales and Employment) in both years (2016 and 2007).
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– In high tech (for R&D, DE 74%; for Net sales, DE 
69% and for Employment, FR 58%)
– In medium-high tech (for R&D, DE 86%; for Net 
sales, UK 57% and for Employment, Other 40%)
– In medium-low tech (for R&D, NL 203%; for Net 
sales, NL 79% and for Employment, NL 113%)
– In low tech sectors (for R&D, Other 43%; for Net 
sales, FR -3%% and for Employment, FR 5%)
• The above results analysed by member state show 
distinct characteristics of the R&D investing companies 
in each country. For example, 
– German companies increased their R&D by 74% 
and employment by 52% in high tech whereas 
French companies grew R&D only by 20% but 
employment by 58% in high tech. This is due to 
the fact that the ratio R&D/employees in the high 
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tech sector increased for German companies but 
decreased for French ones. On the other hand, 
German companies increased the ratio sales/
employee more than the French companies for 
high tech and for the whole sample.
– UK companies showed overall stagnation in sales 
(-1%) although showing large net sales growth in 
3 groups (high, medium-high and medium- tech 
groups). This is due to 21% sales decrease in the 
low tech sector which has companies with very 
large sales, e.g. oil & gas, mining and banks).
– Companies based in the Netherlands showed 
significant increases for the 3 indicators in all 
sectors.
6 DYNAMICS OF THE WORLD’S MOST PRODUCTIVE 
COMPANIES
77The 2017 EU Industrial R&D Investment Scoreboard
Top performing firms are those firms that are amongst the 
top 10% of firms with the highest labour productivity in 
each of the sector groups. Here, labour productivity is de-
fined as net sales per employee. The main objective is to 
characterise the top firms and compare these to the bot-
tom 90% of companies.
In a subsequent step, the dynamics of the top performers 
will be checked: to what degree do the most productive 
firms manage to maintain their lead over time? What is 
the regional (EU vs. US vs. others) composition of the top 
performers for each of the sector groups and how has this 
changed over the 10-year period of our dataset? What are 
the characteristics of the most productive firms compared 
to the rest of the firms?
Dynamics of the world’s most productive 
companies
6
This chapter focuses on the performance and dynamics of the most productive firms 
as compared to lagging firms. We use a panel dataset that covers 10 years of R&D 
Scoreboard data (from 2007 to 2016) with the main variables: R&D investments, Net 
Sales, Employment, Capital Expenditures.
Key points
• The productivity gap between the most productive 
and rest of the firms is significant, even in a dataset 
as used in this analysis where only the largest global 
firms are considered. Depending on the sector, the net 
sales per employee is between 3 and 7 times higher 
for the most productive firms. 
• In some cases, like in Health industries, this is due to 
the existence of many small (biotech) companies that 
have considerable amounts of R&D funding (which is 
why these firms enter in the R&D Scoreboard) but do not 
report any or very little sales while researching a break-
through medicine or component. In other cases, mainly 
for Industrials, no direct explanation can be given. 
• Over the 10-year period of our sample, the top 
performers in the Aerospace & Defence and Health 
Industries seem to further increase the productivity 
gap with respect to the bottom 90% of the firms, while 
in the Other sector group the gap is declining. The 
other sector groups do not show a clear pattern. 
• The top performers are not per se also the largest 
firms in terms of employees: only top performers in 
both ICT sector groups, Aerospace and Defence and 
Automobiles and Other Transport are larger than the 
lagging firms. 
• Capital Expenditures the factor that differs most between 
top and bottom performers, although the magnitude of 
this difference varies between sector groups. For sector 
groups where firms rely on superior machinery, such as 
Automobiles and Other Transport and ICT Services, this 
embodies the importance of acquisition of state of the 
art technologies that are incorporated in the high-end 
production process of the top performers. 
• The region of origin of the top performers over time is 
very sector specific. The EU hosts the largest shares of 
the most productive firms from the Chemicals, Indus-
trials and Others sector groups. 
• Most of the top performers from the Health Industries 
and ICT sector groups are located in the US. The loca-
tion of the group of top performers from the Automo-
biles and Other Transport sector group has shown the 
most dynamic changes during the 10-year period. 
• Chinese firms have not managed to gain a significant 
share amongst the top performers.
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Firms are classified in 8 sector groups (see table 1.2 in 
chapter 1 for details). The number of firms is shown in 
Table 6.1, also displaying the number of firms per sector 
group for the year 2016:
Sector group Number of firms
Aerospace & Defence 60
Automobile and other transport 219
Chemicals 155
Health 616
ICT Producers 589
ICT Services 401
Industrials 391
Other 693
Total 3124
TABLE 6.1: NUMBER OF FIRMS PER SECTOR GROUP.
Source: The 2017 EU Industrial R&D Investment Scoreboard. European Commission, 
JRC/DG RTD.
The data used in this analysis consists of a (unbalanced) 
panel data set with more than 3000 companies with 
at least 1 year of observation. The average number 
of available years for R&D investment, Net Sales and 
Employees is between 8 and 9 years, which indicate that 
it is a very richly filled panel data set. 
The following Figure 6.1 reports the summary statistics 
of net sales, number of employees, R&D investments and 
intensity, capital expenditures, market capitalisation and 
operating profits for the top 10%, the bottom 90% and for 
all firms together.
On average, the top performing companies from Others 
sector group in our dataset are the largest based on net 
sales. This is mainly due to the presence of oil and other 
energy companies and banks that traditionally show a high 
turnover. Net Sales are also much higher for top performing 
companies in Aerospace and Defence and Automobiles 
and Other Transport. Top performing companies are on 
average more profitable, have higher capital expenditures 
and a higher market capitalisation than lagging firms, but 
are not always larger in terms of employees. 
6.1 | Data
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FIGURE 6.1: AVERAGES OF SELECTED VARIABLES OVER THE PERIOD 2007-2016 BY SECTOR GROUP: ALL FIRMS, TOP 10% AND BOTTOM 90%
Source: The 2017 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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Here we look at how labour productivity of the top vs 
bottom firms has been changing over the duration of the 
10-year period, from 2007 to 2016. For our analysis, the 
top 10% and bottom 90% are calculated in each year so 
that the dynamics can be studied.
The comparison of labour productivity for the bottom 90% 
vs the top 10% per sector group over the last 10 years 
shows some interesting insights. The productivity gap 
seems to remain stable over this period in each of the 
sectors. For the bottom 90%, labour productivity is very 
similar amongst all sector groups (apart from Chemicals), 
around €200k per employee. The top performers display 
a broader range of productivity levels that are at least a 
multiple of 3 higher than the bottom 90%.
Especially for the Chemicals, Health Industries and Others, 
the productivity gap is very large and has increased since 
2013. The large gap in the Health Industries can be (partly) 
explained by the presence of many smaller companies 
with very low sales – and subsequently low labour 
productivity – high losses and high R&D investments for a 
few years before either bringing a new drug to the market, 
being acquired by a large firm or disappearing completely. 
6.2 | Changes of labour productivity over time
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FIGURE 6.2: COMPARISON OF LABOUR PRODUCTIVITY PER SECTOR GROUP (2007-2016).
Source: The 2017 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
82 The 2017 EU Industrial R&D Investment Scoreboard
For our analysis, it is also interesting to look at how 
other characteristics like Net Sales, R&D investment 
and intensity, Capital Expenditures, profitability and 
number of Employees differ between top performers 
and lagging firms and how it developed over the period 
2007-2016. 
For this, the ratio between the top and bottom firms’ 
levels of Capital Expenditures, Employees, Net Sales, 
R&D investments and R&D intensity has been calculated. 
Results are shown in Figure 6.3. A logarithmic scale has 
been used for the graphs so that values between 0 and 
1 (the bottom 90% has a higher average for the selected 
variable than the top 10%) are magnified and values 
above 1 (the top 10% has a higher average for the selected 
variable than the bottom 90%) are also displayed. 
The greatest differences between top performers 
and lagging firms are in Capital Expenditures, Market 
Capitalisation and Operating Profit levels, where top 
performing firms have on average higher levels than the 
lagging firms in all sector groups. 
For Capital Expenditures, especially top performing firms 
from the sector groups of Automobiles and ICT Services 
have significantly higher levels of capital expenditures 
than the rest. As earlier research showed (with R&D 
Scoreboard companies), technological change embodied 
in capital expenditures (such as superior machinery for 
production) is of importance for firm’s productivity growth 
in low R&D intensive sectors.12
The high ratios for Market Capitalisation of ICT Producers 
and ICT Services firms show that firms from these sector 
groups are very highly valued on the stock market. 
Some companies that are in the top 10% performers of 
these sectors are APPLE, ALPHABET, CISCO, FACEBOOK, 
MICROSOFT and SAMSUNG.
If we look at firm size, in terms of the number of employees, 
we see that only in Automobiles and Other Transport 
firms and Aerospace and Defence the top performers are 
on average much larger than the lagging firms. These 
differences are much less pronounced for the other sector 
groups, and in some sector groups the lagging firms are 
larger (Industrials, Others and Health Industries).
For R&D intensity, the differences are much smaller and 
in many sectors the average R&D intensity for the lagging 
firms is higher than for the top performing firms. Here, 
several reasons can be thought of having an impact on 
this. First, more productive firms are more effective in 
turning R&D investments into productivity gains. Second, 
there is a size effect: the top 10% are on average larger 
than the rest of the firms and can perform similar research 
and development with a smaller share of the firm’s sales. 
Third, less productive firms will need to invest more in R&D 
in order to improve productivity.
6.3 | Other characteristics of top performers vs. bottom 
performers
12 See Ortega-Argilés, R., Potters, L. & Vivarelli, M. Empirical Economics (2011) 41: 817.
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FIGURE 6.3: RATIOS OF TOP 10% OVER BOTTOM 90% FOR SELECTED VARIABLES.
Source: The 2017 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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In this section we look at the regional composition of the 
most productive firms and how this has changed over 
time. We group the home base countries into five regions, 
EU, the US, China, US and the Rest of the World (RoW). 
The Scoreboard data provides data on the location of the 
headquarters of the firms. Although these multinational 
enterprises are globally active, research does show that 
most firms have the principal R&D location in their home 
country.13
The graphs in Figure 6.4 below show that the regional 
composition of top performers differs both over time and 
per sector group. The top performers from the Aerospace 
& Defence sector group are basically shared between the 
EU and the US, where AIRBUS, BOEING and LOCKHEED are 
the main players.
The EU hosts a large share of the top performers from the 
sector groups Chemicals, Industrials and Others. The latter 
sector group includes many large EU oil firms like ROYAL 
DUTCH SHELL, TOTAL, REPSOL and BP. 
We see that some US top performers from the Automobiles 
and Other Transport sector group disappeared after the 
US automotive industry crisis (2008-2010): the US share 
of top performers in this sector group has been declining 
since 2011. The top performing firms are mainly located in 
Japan, with large car manufacturers like NISSAN, TOYOTA, 
HONDA, MAZDA and SUBARU. 
The strength of the US can be mainly seen in the Health 
sector group and the ICT sector groups (both Producers and 
Services), with around 60-70% of the top performing firms 
located there. For The US hosts many large pharmaceutical 
companies like MERCK, AMGEN and BRISTOL-MEYERS 
SQUIBB. For ICT Producers and Services we saw earlier 
that big firms like APPLE, ALPHABET, CISCO, FACEBOOK 
and MICROSOFT are located in the US.
Remarkably, although China has shown a remarkable 
economic growth during the last 10 years, Chinese 
companies continue to have only a small share of top 
performing firms and this share has not increased during 
the 10-year period either.
13 See EU R&D Survey 2017.
6.4 | Regional composition
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FIGURE 6.4: REGIONAL COMPOSITION OF TOP PERFORMERS.
Source: The 2017 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
7 COMPANIES’ DEVELOPMENT OF PATENTED ICT-RELATED 
TECHNOLOGIES
87The 2017 EU Industrial R&D Investment Scoreboard
Digital technologies are transforming our manufacturing 
and industrial systems. Understanding the capacity of EU 
companies to master ICT-related technologies is critical 
in the context of initiatives that aimed at improving the 
competitiveness of industry such as the so-called “Industry 
4.0”. This fourth industrial revolution, that brings together 
ICTs and traditional industries, yields major opportunities 
and challenges for the reindustrialisation of the EU, for 
instance in terms of automation, flexible production 
processes, manufacturing speed or the integration of 
users’ needs. Hence, mapping the scale and features of 
corporate technological developments in the digital era is 
essential to inform policies aiming at a more digitized and 
stronger industry. 
Companies’ development of patented  
ICT-related technologies
7
Key points
• With only one fourth of total patent families related to 
digital technologies, EU based companies lag behind in 
ICT technological development. US (37%) and Japan 
(33%) based companies show higher, but comparable, 
shares of digital related patents. 
• The vast majority of patents from Chinese companies are 
related to digital technologies (81%), this holds true for 
about half of patents from the rest of the world. The par-
ticular high digital share for Chinese companies is coupled 
with a very small number of international patents. 
• EU-, US- and China-based top R&D investors show 
close specialisation profiles within ICT technologies. 
They are specialised in High-speed network, Mobile 
communication, Security, and Large capacity 
information analysis. EU based top R&D investors also 
present specialisation in Electronic measurement and 
Sensor and device network.
• Sectoral specificities arise in the development of 
digital technologies. Large capacity information 
analysis is particularly relevant in the Software & 
computer services and Pharma & Biotech industries. 
The Aerospace and defence industry, very intensive in 
the development of digital technologies, shows a more 
distributed portfolio of digital technologies.
• US- and EU-based top R&D performers rely to the 
greatest extent to inventors located abroad. This is 
particularly true for ICT-related technologies where 
about one third and one fourth of patents rely on 
international inventors On the contrary, companies 
located in the rest of the world seems to rely more on 
international inventors for the development of non-ICT 
technologies. 
This chapter examines the development of ICT-related 
technologies by top corporate R&D investors and 
addresses the following issues:
• Where does the EU stand in the development of ICT 
technologies? Which are EU’s relative strengths in the 
development of specific ICT technologies? 
• Which corporate R&D investors lead the development 
of ICTs? Which specific technologies do they target 
across different sectors?
• Where are most of the digital related patents owned 
and where are they actually developed? Which 
differences can be observed between the location 
of inventive activities related to ICT and non-ICT 
technologies?
To answer these questions, this chapter exploits the recent 
JRC/OECD COR&DIP© database, v.1. 2017 built in the 
framework of our collaboration with the OECD to investigate 
the development of digital technologies carried out by 
Scoreboard companies.14 The patent statistics reported 
14 For further information, please see the report “World Corporate Top R&D Investors: Industrial Property Strategies in the Digital Economy” http://iri.jrc.ec.europa.eu/docu-
ments/10180/12268/JRC-OECD-WorldCorporateTopRDInvestors.pdf.
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here are based on families of patent applications15 filed 
between 2012 and 2014 at the five largest IP offices 
(IP5), namely the European Patent Office (EPO), the Japan 
Patent Office (JPO), the Korean Intellectual Property Office 
(KIPO), the State Intellectual Property Office of the People’s 
Republic of China (SIPO) and the United States Patent 
and Trademark Office (USPTO). Moreover, we use a recent 
classification for ICT-related patents16 in order to analyse 
the importance of specific ICT-related technologies.
15 Patent families refer here to IP5 families of patent applications with members filed in at least one of the five largest IP offices, provided that another family member 
has been filed in any other office worldwide (see Dernis et al., 2015 for further discussion of IP5 families).
16 See Inaba, T. and Squicciarini, M. (2017). ICT: A new taxonomy based on the international patent classification”, OECD Science, Technology and Industry Working Papers, 
2017/01, http://dx.doi.org/10.1787/ab16c396-en.
17 The claims define what the patent legally protects.
This section looks at the patenting activity and 
specialisation profiles of top corporate R&D investors 
across selected world’s regions of headquarters location. In 
particular, it looks at the absolute and relative performance 
of top corporate R&D investors in ICTs development.
Figure 7.1 shows the total number of patents families (left 
axis) and the share of ICT-related patents (right axis). 
Japan-located corporate investors record an almost twice 
higher number of IP5 patents families than other major 
world regions as the EU and US. As for the levels of R&D 
investments, such differences in patenting volumes are 
often associated with specific structural and industrial 
features of the economies (major industries, industrial 
specialisation) as well as targeted patents regulation and 
support (for instance, R&D tax credit including patents 
and other IPRs). It should also be considered that average 
number of claims per family for Japanese firms is much 
smaller (2.5) than for firms based in the other areas (5.3 
for US, 4.9 for EU, 4.2 for China and 4 for the RoW). This 
difference may be still the effect of the one patent one 
claim rule in place at JPO in the past.17 This might be 
causing, at least partially, inflation in the number of JP 
owned patent families. 
Chinese-based R&D performers display an overall low 
patenting activity compared to the other main world 
areas considered. Moreover, China-headquartered 
companies, with about 80% of their patenting activity 
relates to digital technologies, show a particularly high 
specialisation in ICT-related technologies. Companies 
7.1 | Corporate patenting and specialisation in ICTs
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FIGURE 7.1: TOTAL PATENTS AND ICT-PATENTING SHARES BY SELECTED WORLD’S REGIONS.
Note: Patents counts refer to the number of fractionally counted patent families. 
Source: JRC/OECD COR&DIP© database, v.1. 2017.
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located in the rest of the world file more than 50% 
percent of their patents in ICT-related technologies. This 
high share is partly due to the specialisation of Korean 
companies, and Samsung in particular, which is by far 
the company with the highest number of patent families 
during the period considered (see Daiko et al., 2017 and 
Table 7.2 later in this chapter). Companies headquartered 
in the US, Japan and EU present lower shares of ICT-
related technologies in their patent portfolio (37, 33 and 
24 percent respectively).
Once assessed the overall importance of ICT-related 
technologies in different areas, we shift to the specialisation 
profiles of each geographical area across specific digital 
technologies. Table 7.1 shows ICT-related technological 
advantages in different digital subfields for the EU and the 
other major world areas. For this purpose, we compute an 
ICT-based technological specialisation index or ICT-RTAij:
The numerator represents the share of ICT patents in 
subfield j over the total ICT patents of the region i, whereas 
the denominator represents the share of subfield j among 
the whole ICT patents. Values of ICT-RTA above 1 indicate 
a relative specialisation of the geographical area in the 
given ICT subfield, while for values lower than one reflect a 
relatively de-specialisation in that ICT sub-field.
Table 7.1 shows distinct patterns of ICT specialisation 
across world’s regions. US- and EU-headquartered 
Scoreboard companies have the broadest profile in 
terms of relative specialisation within ICTs technologies. 
On the other side of the spectrum, Japanese companies 
show a very much focused specialisation profile. Indeed, 
they are relatively specialised in Cognition and meaning 
understanding (as US and EU companies), and Imaging 
and sound technology and Information communication 
device (as companies located in the Rest of the world).
Technology EU US JP RoW CN
High speed network 1.42 1.36 0.72 0.72 1.58
Mobile communication 1.60 1.22 0.62 0.84 1.64
Security 1.63 1.42 0.74 0.64 1.29
Sensor and device network 2.07 0.99 0.78 0.92 0.50
High speed computing 0.77 1.76 0.82 0.77 0.82
Large-capacity and high speed storage 0.60 1.06 0.97 1.32 0.33
Large-capacity information analysis 1.34 1.69 0.78 0.54 1.17
Cognition and meaning understanding 1.08 1.08 1.19 0.75 0.79
Human-interface 0.51 0.65 0.82 1.59 1.34
Imaging and sound technology 0.71 0.63 1.40 1.02 0.76
Information communication device 0.80 0.63 1.20 1.20 0.75
Electronic measurement 2.75 1.38 0.78 0.44 0.18
Others 0.37 0.82 1.31 1.20 0.44
TABLE 7.1: TECHNOLOGICAL SPECIALISATION IN ICT SUB-FIELDS BY SELECTED WORLD’S REGIONS.
Note: Patents counts refer to the number of fractionally counted patent families.
Source: JRC/OECD COR&DIP© database, v.1. 2017.
ITC – RTAij = 
subictij / Σj subictij
Σi subictij / Σij subictij
EU-, US- and China-based top R&D investors show 
close specialisation profiles within ICT technologies. As 
illustrated in Table 7.1, the three economies are specialised 
in ICT subfields such as High-speed network, Mobile 
communication, Security, and Large capacity information 
analysis. In addition, EU- and US-headquartered R&D 
performers also present above-one ICT-RTAij values in 
Electronic measurement, while this holds true for China 
in Human interface. EU-based companies shows, overall, 
the only specialisation in the development of technologies 
related to Sensor and device network.
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Do companies operating in different sectors target the 
development of specific technologies? In this section, 
statistics are broken down at the industry level in order 
to see in which ICT subfields top patenting companies are 
focusing their innovative efforts. 
For these purposes, Table 7.2 reports the top 10 ICT 
patenting companies in a number of key sectors. For each 
company we report the total number of patents families 
filed over the period considered, the share of patents in ICT 
related technologies and the 3 ICT subfields where they 
file the highest number of patents.
Clearly, companies operating in ICT sectors (Software and 
Computer Services, Technology Hardware and Equipment 
and Electronic and Electrical Equipment) show very high 
concentration of patents in digital technologies; this share 
is close to 100% for companies such as SAP, Facebook, 
Autonavi and Ericsson. Among the non-ICT sectors 
considered, the Aerospace and Defence stands out in 
terms of digital patenting compared to Automobile & 
Parts and Pharmaceuticals & Biotechnology. 
Overall, Large-capacity and information analysis and High 
speed networks are the ICT subfields that are the most 
frequently target by top corporate R&D investors. This 
highlights the importance of developing competences in 
big data analytics and data handling and transmission in 
the digital era. In particular, Large-capacity and information 
analysis appears often as the first subfield designated in 
industries such as Pharmaceuticals and Biotechnology and 
Software and computers services. 
Besides these two ICT subfields, the companies considered 
in the present chapter often focus their digital patenting 
activities on Information and communication device; 
this is quite straightforward for companies operating in 
Electronic and Electrical equipment that mainly develop 
physical devices. These latter companies also dedicate 
much effort in the development of Image and sound 
technology subfield and to Human-interface technologies 
subfields. These technologies are key for the interactions 
between the digital and physical worlds. 
Other important ICT subfields include High speed 
network, Mobile communication, Electronic measurement, 
Cognition and meaning understanding and Security. For 
instance, High speed network often feature among the top 
ICT subfields in industries such as Technology hardware 
and equipment and Software and computer services, 
as well as Automobiles and Parts. High speed network 
coupled with Large-capacity and information analysis are 
essential for real time data transmission and processing, 
like the ones needed for example in autonomous and 
connected cars. These two technologies, together with 
Electronic measurement appear to be very important also 
for companies in the Aerospace and Defence industries.
7.2 | Top 10 ICT-patenting companies in selected ICT-oriented 
sectors
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This section focuses on the geographical location patterns 
of inventive activities. It overviews the location patterns 
of top R&D investors and looks at the broad differences 
that emerge in the geography of ICT and non-ICT inventive 
activities. 
Tables 7.3 show the applicant headquarters location (in 
row) and the distribution across inventor locations (in 
column) of the ICT and non-ICT patents (top and bottom 
panels respectively). The diagonal shows the extent to 
which top corporate R&D investors prefer the headquarters 
to locate their inventive activities. Commonly known as the 
home-bias, this tendency seems to be more pronounced 
for companies based in Japan, China and RoW, while it 
appears to be less frequent for EU- and US-based R&D 
performers. In relative proportions, for ICT this concerns 
around one forth of EU-made inventions and one third of 
US-made inventions. In non-ICT fields, the phenomenon 
is slightly less pronounced, with at least 20% of EU and 
25% of US-made inventions relying on inventors located 
abroad.
7.3 | Geographical location of ICT versus non-ICT technological 
development
ICT
Inventor Region
EU US JP CN RoW
Region
EU 76.51% 13.11% 0.74% 3.58% 6.06%
US 12.14% 66.69% 2.72% 8.29% 10.16%
JP 2.24% 2.79% 93.19% 0.94% 0.84%
CN 1.20% 4.31% 0.73% 90.58% 3.17%
RoW 1.88% 3.85% 1.07% 6.38% 86.81%
non-ICT
Inventor Region
EU US JP CN RoW
Region
EU 79.08% 13.95% 1.00% 1.41% 4.57%
US 15.09% 73.21% 1.32% 2.13% 8.24%
JP 1.55% 1.97% 95.64% 0.25% 0.59%
CN 3.52% 3.00% 1.43% 90.27% 1.79%
RoW 8.22% 4.73% 1.63% 7.73% 77.69%
TABLE 7.3: MATRIX OF PATENT APPLICANT-INVENTOR LOCATION, SELECTED WORLD’S REGIONS.
Note: Patents counts refer to the number of fractionally counted patent families. 
Source: JRC/OECD COR&DIP© database, v.1. 2017.
Looking at the most frequent foreign locations, US often 
come up as the top location for ICT and non-ICT patents. 
Nevertheless, in non-ICT fields, EU seems to be preferred 
to the US for the location of inventive activities of China- 
and RoW-headquartered R&D investors. Noteworthy, more 
than 20% of US patenting in ICT (above 16% in non-ICT) 
rely on inventors located in RoW. Their second preferred 
foreign location is EU for more than one tenth of their 
patent portfolio. This later economy also relies importantly 
on inventors located in RoW; that concerns about 10% of 
EU-owned patents in ICT and also non-ICT.
Focusing on differences in ICT versus non ICT, EU 
companies seem to behave in a similar fashion, as 
shown by the distributions of shares across inventors’ 
locations in ICT or non-ICT (EU in row). Differently from 
EU and Japanese firms, US, and to a much lesser extent, 
China shows a few differences across ICT and non-ICT. 
For instance, US-based companies rely in much lower 
proportions to China-located inventors for their non-ICT 
inventions. The related difference comes from a greater 
reliance to home- and EU-located inventors for non-ICT 
patents.
Figure 7.2 further details the geographical distribution 
of ICT patents’ applicants and inventors. The top panel 
displays a network graph connecting the HQ locations of 
inventors to that of the applicants at the world level. The 
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bottom panel focuses on the digital patenting of the EU28 
both in terms of applicants and of inventors.
The size of the circles relates to the number of patents 
when only inventor-located countries are considered: the 
bigger is the circle of an area, the greater is the number 
of patents with inventors located in the given area. The 
colour of the circle reflects the number of patents from 
applicants that are located in the selected area (owned 
here versus invented here): the darker is the circle, the 
higher is the number of patents with applicants located in 
the area of interest. Only countries (regions in the case of 
World
EU 28
FIGURE 7.2: APPLICANT-INVENTOR LOCATIONS FOR THE DEVELOPMENT OF DIGITAL TECHNOLOGIES.
Source: JRC/OECD COR&DIP© database, v.1. 2017.
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the EU) “owning” at least 3500 ICT related paten families 
were considered in the world network of ICTs. In addition 
self- edges were omitted.
Overall, US, Japan-, Korea-, and to a lesser extent, China-, 
EU- and Taiwan-based top corporate R&D investors 
clearly lead the development of ICT-related inventions at 
the world level. Looking at the two extreme cases, China 
stands out as an “inventor location” (lighter circle) rather 
than an applicant one, whilst US owns a great part of new 
digital technologies and, at the same time, plays a key 
role in their development or invention (inventors’ location, 
circle size). For economies like the EU28 or Korea, the 
differences are less salient, as illustrated by the lighter 
colour of the related circles (Figure 7.2, top panel). 
As illustrated in the bottom panel, all EU28 countries 
appear to be active in the development of ICT technologies, 
to different extent depending on HQ locations and on the 
applicants’ vs. inventors’ locations. This EU28-centered 
graph shows that Germany, France and the UK lead the 
inventive activities in digital technologies in the continent 
(the biggest circles); while Germany, France, the Netherland 
and Austria are countries with larger applicant-inventor 
patent flows (the thickest lines). These represent a cluster 
with high connectivity within the EU.
Looking again at the extremes of the spectrum, the UK 
seems to stand rather as an inventor location (the lightest 
circle), while the Netherlands exhibits important differences 
with a relatively higher proportion of applicants (the 
darkest circle) within the EU, as compared to the number 
of inventors that are based in the country. Other European 
economies such as France, Sweden, Finland, and to a 
lesser extent, Germany, Belgium, Austria and Italy feature 
relatively fewer differences when their role as applicants’ 
location and inventors’ location are compared.
8 SCIENTIFIC PUBLICATIONS BY COMPANIES’ 
AFFILIATE AUTHORS
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• Article publication in peer reviewed journals is a 
widespread phenomenon among top R&D investors. 
Engaging in scientific publications does not seem to be 
a choice of a few firms, but quite common among firms 
actively engaged in R&D.
• It seems than corporate publishing is not only 
a prerogative of science-based sectors such as 
Pharmaceutical, Biotechnology and Chemistry, but it is 
widespread across sectors.
• If we consider the quality of publications (proxy by the 
number of citations), about 12% of these articles are 
within the top 10% cited articles in the corresponding 
research areas.
• Overall, collaboration with academia is extremely 
frequent. In the whole sample, 58% of publications 
are co-authored with one or more university based 
authors. Many of the sectors that collaborate the most 
with academia are low R&D intensity sectors. This may 
suggest some sort of knowledge seeking activity of firms 
in these sectors, reaching out to universities to source 
knowledge they don’t have inside their boundaries.
• There is a positive correlation between a firm’s R&D 
expenditure and the number of publications to which 
the firm contributed.
Scientific publications by companies’  
affiliate authors
8
This chapter presents results of an exercise16 aiming to explore the publication activity 
carried out by authors affiliated to the Scoreboard companies and their subsidiaries. 
We collected and analysed data on articles authored by affiliated to Scoreboard 
companies (and their subsidiaries) published in in peer reviewed journals in the period 
2011-2015.
16 Full report available at (last access 30 Oct 2017): http://iri.jrc.ec.europa.eu/documents/10180/948317/Scientific%20Publication%20Activity%20of%20Scoreboard%20
Companies.
Key points
8.1 | Introduction
The number of publications in peer-reviewed journals 
is an increasingly used output indicator to evaluate the 
research activity of both individuals and organisations. 
While it’s quite common to have studies on the publica-
tion output of academics and universities, publications at 
firm level have been rarely investigated. Having access to 
the data on the papers published by authors affiliated to 
the Scoreboard companies (through their headquarters or 
their subsidiaries) can help us to:
• have an additional output indicator to measure the 
results of the R&D investments done by Scoreboard 
companies;
• understand sectoral differences in terms of publication 
behaviour of top R&D investors companies;
• better understand the spillovers of the R&D invest-
ment analysing the firm-university collaborations;
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• better characterise the location of the firm knowledge 
production activity by looking at the authors’ affilia-
tions address.
The data presented in the chapter represents the results 
of a joint study JRC- UNIT B.3 – SPRU (Science Policy Re-
search Unit - University of Sussex). We collect data on the 
publication activity of the top 2,500 worldwide compa-
nies in terms of R&D investments (as listed in the “2014 
EU Industrial R&D Investment Scoreboard”), including also 
around 570,000 subsidiaries of these companies, for the 
period 2011-2015. In order to identify publications au-
thored by firms (including their subsidiaries) in our sample, 
we searched for firms’ names in authors’ affiliation address-
es listed in publication data. Individual queries were built 
for all the 2,500 groups and downloaded the data from the 
Web of Science (WoS) by Thomson Reuters. After several 
round of data cleaning and queries redefinition, we end up 
with a final dataset of publications included 342,862 publi-
cations, including full bibliographic details and citations. We 
managed to retrieved data for 2,088 out of the top 2,500 
worldwide companies R&D investing companies.
Figure 8.1 shows the number of scientific publications pro-
duced in the top 15 sectors (in terms of number of pub-
lications). While the top publishing sectors comprise the 
‘usual suspects’ (e.g. Pharmaceuticals & Biotechnology, 
and Chemicals), these also include some less expected 
sectors such as Electronic & Electrical Equipment and Soft-
ware and Computer Services. 
8.2 | Overall publication activities
0 20000 40000 60000 80000 100000 120000 
Pharmaceuticals & Biotechnology (294)
Technology Hardware & Equipment (334)
Electronic & Electrical Equipment (242)
So ware & Computer Services (268)
Chemicals (139)
Health Care Equipment & Services (97)
General Industrials (95)
Automobiles & Parts (148)
Industrial Engineering (212)
Aerospace & Defence (51)
Oil & Gas Producers (27)
Food Producers (60)
Fixed Line Telecommunications (20)
Industrial Metals & Mining (41)
Electricity (29)
(number of firms per sector beetwen brackets)
FIGURE 8.1: NUMBER OF PUBLICATIONS (2011-2015) - TOP 15 SECTORS.
Source: “Scientific Publication Activity of Scoreboard Companies” – IRITEC technical report.
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Pharmaceuticals & Biotechnology  (290)
Technology Hardware & Equipment  (274)
Electronic & Electrical Equipment  (203)
So­ware & Computer Services  (157)
Chemicals  (134)
Health Care Equipment & Services  (94)
General Industrials  (79)
Automobiles & Parts  (132)
Industrial Engineering  (173)
Aerospace & Defence  (49)
Oil & Gas Producers  (27)
Food Producers  (55)
Fixed Line Telecommunications  (19)
Industrial Metals & Mining  (38)
Electricity  (29)
(number of publishing firms per sector beetwen brackets)
FIGURE 8.2: PERCENTAGE OF PUBLISHING FIRMS (2011-2015) - TOP 15 SECTORS FOR OVERALL NUMBER OF PUBLICATIONS.
Source: “Scientific Publication Activity of Scoreboard Companies” – IRITEC technical report.
The publication activity does not seem to be a prerogative 
of a few firms, but quite common among firms actively 
engaged in R&D. If we consider all the 40 ICB3 sectors in our 
sample, each of them features some publication activity.
Focussing on the top 15 sectors, no less than 80% of the 
firms in each of them produced at least one publication 
in the observation period (Figure 8.2). The only notable 
exception is the Software and Computer Services Sector, 
where the percentage of publishing firm is in fact lower 
(58.6%). It seems than corporate publishing is not 
only a prerogative of science-based sectors such as 
Pharmaceutical, Biotechnology and Chemistry, but it is 
widespread across sectors.
Moreover, the diffuse nature of the publication activity in 
the sample is confirmed looking at concentration indexes 
at sector level. 
Apart from five sectors17, the value of the C418 index in 
the 15 top publishing sectors is below 50%. Finally, the 
average number of publications per corporate (headquarter 
+ all its subsidiaries) varies greatly across sectors, ranging 
from just few publications to more than 400 (Figure 8.3). 
However, also inside each sector there is a huge difference 
among firms (as suggested by the standard deviation 
values between brackets).
17 Namely “Software & Computer Services”; “General Industrials”; “Food Producers”; “Fixed Line Telecommunications”; and “Electricity”.
18 C4 is a concentration index and its equals to the share of total publications for which the top 4 publishing firms in each sector are responsible.
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In addition to looking at the data from a sectoral per-
spective, we can aggregate them according to where the 
Scoreboard headquarters of the publishing company are 
located. 
Figure 8.4 reports the shares of the total number of publi-
cations per sector in five distinct geographical areas: EU, US, 
Japan, China and Rest of the World (RoW).
EU and US based companies are responsible for the bulk 
of the publications (69.8 combined share), which does 
not come as a surprise, consider they account jointly for 
66.1% of the R&D in 2013. 
Figure 8.5 disaggregates the data by sector and by region 
(for the top 5 publishing sector). In the Pharmaceuticals & 
Biotechnology sector, US and EU based companies jointly 
account for about 75% of the publications, while in the 
Electronic and Electrical Equipment and Chemicals the 
shares are more evenly distributed.
0 50 100 150 200 250 300 350 400 450 
Pharmaceuticals & Biotechnology (1346)
Technology Hardware & Equipment (292.3)
Electronic & Electrical Equipment (412.1)
So­ware & Computer Services (582.3)
Chemicals (333.7)
Health Care Equipment & Services (369.6)
General Industrials (601.9)
Automobiles & Parts (272.5)
Industrial Engineering (169.4)
Aerospace & Defence (383.6)
Oil & Gas Producers (410.4)
Food Producers (259.2)
Fixed Line Telecommunications (799.1)
Industrial Metals & Mining (207.1)
Electricity (273)
 (standard deviation beetwen brackets)  
FIGURE 8.3: AVERAGE NUMBER OF PUBLICATIONS PER FIRM BY SECTOR (2011-2015) - TOP 15 SECTORS FOR OVERALL NUMBER OF PUBLICATIONS.
Source: “Scientific Publication Activity of Scoreboard Companies” – IRITEC technical report.
EU, 31.4% 
US, 38.4% 
Japan, 13.8% 
China, 2.1% 
RoW, 14.3% 
FIGURE 8.4: SHARE OF TOTAL NUMBER OF PUBLICATIONS BY REGION (2011-
2015).
Source: “Scientific Publication Activity of Scoreboard Companies” – IRITEC technical 
report.
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Not surprisingly, US based companies have the lion’s 
share in terms of publication in ICT related sectors, 
also given the high number of US companies in these 
sectors. The distribution is particularly skewed in the 
case of the “Software and Computer Services” sector, 
where US based companies account for almost 80% 
of all the publications.
0.0% 
10.0% 
20.0% 
30.0% 
40.0% 
50.0% 
60.0% 
70.0% 
80.0% 
90.0% 
Pharmaceuticals & 
Biotechnology 
Technology Hardware & 
Equipment 
Electronic & Electrical 
Equipment 
Soware & Computer Services Chemicals 
EU US Japan China RoW 
FIGURE 8.5: SHARE OF TOTAL NUMBER OF PUBLICATIONS BY SECTOR BY REGION (2011-2015) – TOP 5 SECTORS FOR OVERALL NUMBER OF PUBLICATIONS.
Source: “Scientific Publication Activity of Scoreboard Companies” – IRITEC technical report.
8.3 | Quality of the research and collaboration with academia
The overall number of publication does not tell us 
much about the quality of the scientific output pro-
duced. To have a better understanding of it, we 
isolated in the sample the most cited publications, 
assuming number of citations as a proxy of the rele-
vance/quality of a scientific output. More specifically, 
we first isolated the sample of articles published on 
peer reviewed journal. Of the 314,411 distinct pub-
lication records to which firms in our sample contrib-
uted, about 62% (i.e. 194,679 records) are articles. 
About 12% of these articles are within the top 10% 
cited articles in the corresponding research areas 
(defined on the basis of the WoS categories) and year 
of publication. Figure 8.6 reports the percentage of 
highly cited articles in the top 15 sectors in terms of 
overall publication activity.
The rank is not exactly the same as in Figure 8.1. 
“Pharmaceuticals & Biotechnology” still ranks first, 
but now is followed by “Health Care Equipment & 
Services”, “Software & Computer Services” and “Food 
producers”, all sector s with more than 10% of their 
articles that are highly cited, i.e. relevant.
Figure 8.7 gives us some insides on the collaboration ac-
tivity (though publications) of firms in our sample by show-
ing the average number of authors per publication by sec-
tor plus the number of distinct countries in which authors 
are located (between brackets). Collaborations and co-au-
thoring seems to be extremely common, with the average 
number of authors ranging from 5 to 8.4.
These co-authorships, however, vary significantly within 
sectors.
In the top 15 publishing sectors, “Pharmaceuticals & Bi-
otechnology”, “Health Care Equipment & Services” and 
“Food producers” are those with the highest number of au-
thors per publication. Not surprisingly, the first two sectors 
are also those with the highest number of countries the 
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Pharmaceuticals & Biotechnology (62234) 
Technology Hardware & Equipment (16893) 
Electronic & Electrical Equipment (16015) 
So­ware & Computer Services (13860) 
Chemicals (14614) 
Health Care Equipment & Services (10020) 
General Industrials (9784) 
Automobiles & Parts (8529) 
Industrial Engineering (6990) 
Aerospace & Defence (6295) 
Oil & Gas Producers (8096) 
Food Producers (4934) 
Fixed Line Telecommunications (3564) 
Industrial Metals & Mining (4589) 
Electricity (3018) 
(total number of articles between brackets)  
FIGURE 8.6: ARTICLES IN TOP 10% CITED (%) BY SECTOR (2011-2015) - TOP 15 SECTORS FOR OVERALL NUMBER OF PUBLICATIONS.
Source: “Scientific Publication Activity of Scoreboard Companies” – IRITEC technical report.
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Pharmaceuticals & Biotechnology (183) 
Technology Hardware & Equipment (103) 
Electronic & Electrical Equipment (103) 
Soware & Computer Services (121) 
Chemicals (125) 
Health Care Equipment & Services (134) 
General Industrials (97) 
Automobiles & Parts (84) 
Industrial Engineering (99) 
Aerospace & Defence (86) 
Oil & Gas Producers (118) 
Food Producers (97) 
Fixed Line Telecommunications (76) 
Industrial Metals & Mining (68) 
Electricity (85) 
(number of distinct countries in which authors are located between brackets)
FIGURE 8.7: AVERAGE NUMBER OF AUTHORS PER PUBLICATION BY SECTOR (2011-2015) - TOP 15 SECTORS FOR OVERALL NUMBER OF PUBLICATIONS.
Source: “Scientific Publication Activity of Scoreboard Companies” – IRITEC technical report
103The 2017 EU Industrial R&D Investment Scoreboard
number of distinct countries in which the affiliations list-
ed in Scoreboard firms’ publications are located (181 and 
134 respectively).
Once established that these firms do collaborate with oth-
er organisations to produce their knowledge, next ques-
tion would be with whom they collaborate with. Figure 
8.8 gives an initial reply by showing the percentage of 
co-authored publications with academia. Of the 342,862 
publication-firm records in our sample, about 9% of these 
are co-authored by two or more firms (or subsidiaries of 
distinct firms) in our sample. 
About 58% of the publications in our sample involved at 
least one academic institution. For the most prolific 15 
sectors, this percentage ranges between 43.6% (fixed Line 
Telecommunications) and 70.5% (Food producers). Among 
the 40 ICB3 sectors considered in the analysis, for only 5 
there the percentage of their publications involving one or 
more universities is below 50%.
Interesting to notice, many of the sectors collaborating 
the most with academia are low R&D intensity sectors. 
This may suggest some sort of knowledge seeking 
activity of firms in these sectors, reaching out to 
universities to source knowledge they don’t have inside 
their boundaries. It also true these sectors occupy the 
bottom part of the publication chart, meaning they 
don’t publish a lot, and if they do it, it’s in collaboration 
with other organisations.
0 10 20 30 40 50 60 70 80 
Pharmaceuticals & Biotechnology 
Technology Hardware & Equipment 
Electronic & Electrical Equipment 
Soware & Computer Services 
Chemicals 
Health Care Equipment & Services 
General Industrials 
Automobiles & Parts 
Industrial Engineering 
Aerospace & Defence 
Oil & Gas Producers 
Food Producers 
Fixed Line Telecommunications 
Industrial Metals & Mining 
Electricity 
FIGURE 8.8: PUBLICATIONS WITH ACADEMIA (%) BY SECTOR - TOP 15 SECTORS FOR OVERALL NUMBER OF PUBLICATIONS.
Source: “Scientific Publication Activity of Scoreboard Companies” – IRITEC technical report.
8.4 | Correlation with R&D investment
Given we are dealing with a sample of world top R&D 
investors; it’s interesting to explore if there is some cor-
relation between the R&D invested and the amount of 
publications produced. Figure 8.9 depicts the scatter plot 
between a firm’s R&D expenditure and their number of 
publications for the top 15 most active sectors in terms of 
total number of publications. 
This analysis focuses on the 2011-2013 period (the 
2014 Scoreboard provides information about Scoreboard 
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FIGURE 8.9: CORRELATION BETWEEN R&D AND PUBLICATIONS BY SECTOR (2011-2013) - TOP 15 SECTORS FOR OVERALL NUMBER OF PUBLICATIONS.
Source: “Scientific Publication Activity of Scoreboard Companies” – IRITEC technical report.
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firms’ R&D expenditure up to the end of the year 2013). 
Firm observations in Figure 8.9 are represented with 
different symbols and colours. While symbols represent 
firm-year observations (circles depict data for the year 
2011, triangles data for the year 2012, and squares data 
for the year 2013), colours represent a firm’s size. More 
specifically, we used firms’ net sales in each year to define 
two groups of firms: “relatively large” firms (red colour) as 
those with net sales above the 3rd quartile of the net sales 
distribution of all firms in the same sector an year and 
“relatively small firms” (green colour) as those with net 
sales below the 3rd quartile of the net sales distribution of 
all firms in the same sector and year19.
19 We coloured symbols in blue when net sales data were missing.
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Investment in research and innovation is at the core of 
the EU policy agenda. The Europe 2020 growth strategy 
includes the Innovation Union flagship initiative20 with a 
3 % headline target for intensity of research and devel-
opment (R&D)21. R&D investment from the private sector 
plays also a key role for other relevant Europe 2020 initi-
atives such as the Industrial Policy22, Digital Agenda and 
New Skills for New Jobs flagship initiatives. 
The Industrial Research and Innovation Monitoring and 
Analysis (IRIMA) project23 supports policymakers in these 
initiatives and monitors progress towards the 3 % head-
line target. The Scoreboard, as part of the IRIMA project, 
aims to improve the understanding of trends in R&D in-
vestment by the private sector and the factors affecting it. 
The annual publication of the Scoreboard is intended to 
raise awareness of the importance of R&D for businesses 
and to encourage firms to disclose information about their 
R&D investments and other intangible assets.
The data for the Scoreboard are taken from companies’ 
publicly available audited accounts. As in more than 99% 
of cases these accounts do not include information on 
the place where R&D is actually performed, the compa-
ny’s whole R&D investment in the Scoreboard is attrib-
uted to the country in which it has its registered office24. 
This should be borne in mind when interpreting the Score-
board’s country classifications and analyses. 
The Scoreboard’s approach is, therefore, fundamental-
ly different from that of statistical offices or the OECD 
when preparing Business Enterprise Expenditure on R&D 
(BES-R&D) data, which are specific to a given territory25 
and include R&D carried out in that territory by compa-
nies headquartered and with their major operations in 
another territory. The Scoreboard data are primarily of 
interest to those concerned with benchmarking company 
commitments and performance (e.g. companies, investors 
and policymakers), while BES-R&D data are primarily used 
by economists, governments and international organisa-
tions interested in the R&D performance of territorial units 
defined by political boundaries. The two approaches are 
therefore complementary. The methodological approach 
of the Scoreboard, its scope and limitations are further 
detailed in Annex 2 below. 
Background informationA .1
Scope and target audience
20 The Innovation Union flagship initiative aims to strengthen knowledge and innovation as drivers of future growth by refocusing R&D and innovation policies for the main 
challenges society faces.
21 This target refers to the EU’s overall (public and private) R&D investment approaching 3 % of gross domestic product (see: http://ec.europa.eu/europe2020/pdf/tar-
gets_en.pdf),
22 The Industrial Policy for the Globalisation Era flagship initiative aims to improve the business environment, notably for small and medium-sized enterprises, and support 
the development of a strong and sustainable industrial foundation for global competition.
23 See: http://iri.jrc.ec.europa.eu/home /. The activity is undertaken jointly by the Directorate General for Research (DG RTD A; see: http://ec.europa.eu/research/index.cf-
m?lg=en) and the Joint Research Centre, Directorate Growth and Innovation (JRC-Seville; see: https://ec.europa.eu/jrc/en/science-area/innovation-and-growth).
24 The registered office is the company address notified to the official company registry. It is normally the place where a company’s books are kept.
25 The Scoreboard refers to all R&D financed by a company from its own funds, regardless of where the R&D is performed. BES-R&D refers to all R&D activities performed 
by businesses within a particular sector and territory, regardless of the location of the business’s headquarters, and regardless of the sources of finance. The sources of data 
also differ: the Scoreboard collects data from audited financial accounts and reports whereas BES-R&D typically takes a stratified sample, covering all large companies 
and a representative sample of smaller companies. Additional differences concern the definition of R&D intensity (BES-R&D uses the percentage of R&D in value added, 
while the Scoreboard considers the R&D/Sales ratio).
26 According to latest Eurostat statistics.
The Scoreboard is a benchmarking tool which provides 
reliable up-to-date information on R&D investment and 
other economic and financial data, with a unique EU-focus. 
The 2500 companies listed in this year’s Scoreboard 
account for more than 90%26 of worldwide R&D funded 
by the business enterprise sector and the Scoreboard data 
refer to a more recent period than the latest available 
official statistics. Furthermore, the dataset is extended to 
cover the top 1000 R&D investing companies in the EU. 
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The data in the Scoreboard, published since 2004, allow 
long-term trend analyses, for instance, to examine links 
between R&D and business performance.
The Scoreboard is aimed at three main audiences. 
• Companies can use the Scoreboard to benchmark 
their R&D investments and so find where they stand 
in the EU and in the global industrial R&D landscape. 
This information could be of value in shaping business 
or R&D strategy and in considering potential mergers 
and acquisitions. 
• Investors and financial analysts can use the 
Scoreboard to assess investment opportunities and 
risks.
• Policy-makers, government and business 
organisations can use R&D investment information 
as an input to policy formulation or other R&D-related 
actions such as R&D tax incentives. 
Furthermore, the Scoreboard dataset has been made 
freely accessible so as to encourage further economic and 
financial analyses and research by any interested parties.
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Methodological notesA .2
The data for the 2017 EU Industrial R&D Scoreboard (the 
Scoreboard) have been collected from companies’ annual 
reports and accounts by Bureau van Dijk Electronic 
Publishing GmbH (BvD). The source documents, annual 
reports & accounts, are public domain documents and so 
the Scoreboard is capable of independent replication. In 
order to ensure consistency with our previous Scoreboards, 
BvD data for the years prior to 2012 have been checked 
with the corresponding data of the previous Scoreboards 
adjusted for the corresponding exchange rates of the 
annual reports. 
Main characteristics of the data
Limitations
The data correspond to companies’ latest published 
accounts, intended to be their 2016 fiscal year accounts, 
although due to different accounting practices throughout 
the world, they also include accounts ending on a range of 
dates between late 2015 and mid-2017. Furthermore, the 
accounts of some companies are publicly available more 
promptly than others. Therefore, the current set represents 
a heterogeneous set of timed data.
In order to maximise completeness and avoid double 
counting, the consolidated group accounts of the 
ultimate parent company are used. Companies which 
are subsidiaries of any other company are not listed 
separately. Where consolidated group accounts of the 
ultimate parent company are not available, subsidiaries 
are included.
In the case of a demerger, the full history of the continuing 
entity is included. The history of the demerged company 
can only go back as far as the date of the demerger to 
avoid double counting of figures.
In case of an acquisition or merger, pro forma figures for 
the year of acquisition are used along with pro-forma 
comparative figures if available. 
The R&D investment included in the Scoreboard is the 
cash investment which is funded by the companies 
themselves. It excludes R&D undertaken under contract 
for customers such as governments or other companies. 
It also excludes the companies’ share of any associated 
company or joint venture R&D investment when 
disclosed. Where part or all of R&D costs have been 
capitalised, the additions to the appropriate intangible 
assets are included to calculate the cash investment and 
any amortisation eliminated.
Companies are allocated to the country of their registered 
office. In some cases this is different from the operational 
or R&D headquarters. This means that the results are 
independent of the actual location of the R&D activity. 
Companies are assigned to industry sectors according 
to the NACE Rev. 227 and the ICB (Industry Classification 
Benchmark). In the Scoreboard report we use different 
levels of sector aggregation, according to the distribution 
of companies’ R&D and depending on the issues to be 
illustrated. In chapter 1, Tables 1.2 and 1.3 describe two 
typical levels of the industrial classification applied in the 
Scoreboard.
27 NACE is the acronyme for “Nomenclature statistique des activités économiques dans la Communauté européenne”.
Users of the Scoreboard data should take into account the 
methodological limitations, especially when performing 
comparative analyses (see summary of main limitation in 
Box A2.1 below).
The Scoreboard relies on disclosure of R&D investment 
in published annual reports and accounts. Therefore, 
companies which do not disclose figures for R&D 
investment or which disclose only figures which are not 
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material enough are not included in the Scoreboard. Due 
to different national accounting standards and disclosure 
practice, companies of some countries are less likely than 
others to disclose R&D investment consistently. There is 
a legal requirement to disclose R&D in company annual 
reports in some countries.
In some countries, R&D costs are very often integrated with 
other operational costs and can therefore not be identified 
separately. For example, companies from many Southern 
European countries or the new Member States are un-
der-represented in the Scoreboard. On the other side, UK 
companies could be over-represented in the Scoreboard. 
For listed companies, country representation will improve 
with IFRS adoption.
The R&D investment disclosed in some companies’ ac-
counts follows the US practice of including engineer-
ing costs relating to product improvement. Where these 
engineering costs have been disclosed separately, they 
have been excluded from the Scoreboard. However, the 
incidence of non-disclosure is uncertain and the impact of 
this practice is a possible overstatement of some overseas 
R&D investment figures in comparison with the EU. 
Where R&D income can be clearly identified as a result of 
customer contracts it is deducted from the R&D expense 
stated in the annual report, so that the R&D investment 
included in the Scoreboard excludes R&D undertaken un-
der contract for customers such as governments or other 
companies. However, the disclosure practise differs and 
R&D income from customer contracts cannot always be 
clearly identified. This means a possible overstatement of 
some R&D investment figures in the Scoreboard for com-
panies with directly R&D related income where this is not 
disclosed in the annual report.
In implementing the definition of R&D, companies exhibit 
variability arising from a number of sources: i) different in-
terpretations of the R&D definition. Some companies view 
a process as an R&D process while other companies may 
view the same process as an engineering or other process; 
ii) different companies’ information systems for measur-
ing the costs associated with R&D processes; iii) different 
countries’ fiscal treatment of costs.
Interpretation
There are some fundamental aspects of the Scoreboard 
which affect their interpretation.
The focus of the Scoreboard on R&D investment as 
reported in group accounts means that the results can 
be independent of the location of the R&D activity. 
The Scoreboard indicates the level of R&D funded by 
companies, not all of which is carried out in the country in 
which the company is registered. This enables inputs such 
as R&D and Capex investment to be related to outputs 
such as Sales, Profits, productivity ratios and market 
capitalisation. 
The data used for the Scoreboard are different from data 
provided by statistical offices, e.g. the R&D expenditures 
funded by the business enterprise sector (BES-R&D). The 
Scoreboard refers to all R&D financed by a particular 
company from its own funds, regardless of where that 
R&D activity is performed. BES-R&D refers to all R&D 
activities performed by businesses within a particular 
sector and territory, regardless of the location of the 
business’s headquarters, and regardless of the sources of 
finance. 
Further, the Scoreboard collects data from audited 
financial accounts and reports. BES-R&D typically takes 
a stratified sample, covering all large companies and a 
representative sample of smaller companies. Additional 
differences concern the definition of R&D intensity (BES-
R&D uses the percentage of value added, while the 
Scoreboard measures it as the R&D/Sales ratio) and the 
sectoral classification they use (BES-R&D follows NACE, 
the European statistical classification of economic sectors, 
while the Scoreboard classifies companies’ economic 
activities according to the ICB classification).
Sudden changes in R&D figures may arise because a 
change in company accounting standards. For example, 
the first time adoption of IFRS28, may lead to information 
discontinuities due to the different treatment of R&D, 
28 Since 2005, the European Union requires all listed companies in the EU to prepare their consolidated financial statements according to IFRS (International Financial 
Reporting Standards, see: http://www.iasb.org/).
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i.e. R&D capitalisation criteria are stricter and, where the 
criteria are met, the amounts must be capitalised. 
For many highly diversified companies, the R&D invest-
ment disclosed in their accounts relates only to part of 
their activities, whereas sales and profits are in respect of 
all their activities. Unless such groups disclose their R&D 
investment additional to the other information in seg-
mental analyses, it is not possible to relate the R&D more 
closely to the results of the individual activities which 
give rise to it. The impact of this is that some statistics 
for these groups, e.g. R&D as a percentage of sales, are 
possibly underestimated and so comparisons with non-di-
versified groups are limited.
At the aggregate level, the growth statistics reflect the 
growth of the set of companies in the current year set. 
Companies which may have existed in the base year but 
which are not represented in the current year set are not 
part of the Scoreboard (a company may continue to be 
represented in the current year set if it has been acquired 
by or merged with another but will be removed for the 
following year’s Scoreboard). 
For companies outside the Euro area, all currency amounts 
have been translated at the Euro exchange rates ruling at 31 
December 2016 as shown in Table A2.1. The exchange rate 
conversion also applies to the historical data. The result is 
that over time the Scoreboard reflects the domestic curren-
cy results of the companies rather than economic estimates 
of current purchasing parity results. The original domestic 
currency data can be derived simply by reversing the trans-
lations at the rates above. Users can then apply their own 
preferred current purchasing parity transformation models.
Table A2.1. Euro exchange rates applied to Scoreboard data for companies based in different  
currency areas (as of 31 Dec 2016).
Country As of 31 Dec 2015 As of 31 Dec 2016
Australia $ 1.49 $ 1.46
Brazil 4.25 Brazilian real 3.43 Brazilian real
Canada $ 1.51 $ 1.42
China 7.07 Renminbi 7.33 Renminbi
Czech Republic 27.03 Koruna 27.03 Koruna
Denmark 7.44 Danish Kronor 7.43 Danish Kronor
Hungary 312.50 Forint 309.6 Forint
India 72.20 Indian Rupee 71.63 Indian Rupee
Israel 4.25 Shekel 4.05 Shekel
Japan 131.23 Yen 123.15 Yen
Mexico 18.73 Mexican Peso 21.85 Mexican Peso
Norway 9.59 Norwegian Kronor 9.09 Norwegian Kronor
Poland 4.25 Zloty 4.41 Zloty
Russia 79.37 Rouble 63.94 Rouble
South Korea 1282.05 Won 1265.82 Won
Sweden 9.19 Swedish Kronor 9.55 Swedish Kronor
Switzerland 1.08 Swiss Franc 1.07 Swiss Franc
Turkey 3.17 Turkish lira 3.71 Turkish lira
UK £ 0.73 £ 0.86
USA $ 1.09 $ 1.05
Taiwan $ 35.88 $ 34.05
South Africa 16.95 ZAR 14.42 ZAR
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Box A2.1 - 
Methodological caveats
Users of Scoreboard data should take into ac-
count the methodological limitations summa-
rised here, especially when performing com-
parative analyses: 
A typical problem arises when compar-
ing data from different currency areas. The 
Scoreboard data are nominal and expressed 
in Euros with all foreign currencies converted 
at the exchange rate of the year-end closing 
date (31.12.2016). The variation in the ex-
change rates from the previous year directly 
affects the ranking of companies, favouring 
those based in countries whose currency has 
appreciated with respect to the other curren-
cies. In this reporting period, the exchange 
rate of the Euro depreciated by 3.3% and 
6.2% against the US dollar and the Japa-
nese Yen respectively, and appreciated by 
17.4% against the pound sterling. However, 
ratios such as R&D intensity or profitability 
(profit as % sales) are based on the ratio of 
two quantities taken from a company report 
where they are both expressed in the same 
currency and are therefore less affected by 
currency changes.
The growth rate of the different indicators for 
companies operating in markets with different 
currencies is affected in a different manner. In 
fact, companies’ consolidated accounts have 
to include the benefits and/or losses due to 
the appreciation and/or depreciation of their 
investments abroad. The result is an ‘appar-
ent’ rate of growth of the given indicator that 
understates or overstates the actual rate 
of change. For example, this year the R&D 
growth rate of companies based in the Euro 
area with R&D investments in the US is part-
ly overstated because the ‘benefits’ of their 
overseas investments due to the depreciation 
of the Euro against the US dollar (from $1.09 
to $1.05). Conversely, the R&D growth rate of 
US companies is partly understated due to the 
‘losses’ of their investments in the Euro area. 
Similar effects of understating or overstating 
figures would happen for the growth rates of 
other indicators, such as net sales. 
When analysing data aggregated by country 
or sector, be aware that in many cases, the 
aggregate indicator depends on the figures of 
a few firms. This is due, either to the country’s 
or sector’s small number of firms in the Score-
board or to the indicator dominated by a few 
large firms.
The different editions of the Scoreboard are 
not directly comparable because of the year-
on-year change in the composition of the 
sample of companies, i.e. due to newcom-
ers and leavers. Every Scoreboard comprises 
data of several financial years (8 years since 
2012 and 10 years since this edition) allow-
ing analysis of trends for the same sample of 
companies.
In most cases companies’ accounts do not 
include information on the place where R&D 
is actually performed; consequently the ap-
proach taken in the Scoreboard is to attribute 
each company’s total R&D investment to the 
country in which the company has its regis-
tered office or shows its main economic activ-
ity. This should be borne in mind when inter-
preting the Scoreboard’s country classification 
and analyses.
Growth in R&D can either be organic, the out-
come of acquisitions or a combination of the 
two. Consequently, mergers and acquisitions 
(or de-mergers) may sometimes underlie 
sudden changes in specific companies’ R&D 
and sales growth rates and/or positions in the 
rankings. 
Other important factors to take into account 
include the difference in the various countries’ 
(or sectors’) business cycles which may have a 
significant impact on companies’ investment 
decisions, and the initial adoption or stricter 
application of the International Financial Re-
porting Standards (IFRS)29. 
29 Since 2005, the European Union requires all listed companies in the EU to prepare their consolidated financial statements according to IFRS (see: EC Regulation No 
1606/2002 of the European Parliament and of the Council of 19 July 2002 on the application of international accounting standards at http://eur-lex.europa.eu/LexUriServ/
LexUriServ.do?uri=CELEX:32002R1606:EN:HTML).
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1. Research and Development (R&D) investment in
the Scoreboard is the cash investment funded by the
companies themselves. It excludes R&D undertaken
under contract for customers such as governments
or other companies. It also excludes the companies’
share of any associated company or joint venture
R&D investment. Being that disclosed in the annual
report and accounts, it is subject to the accounting
definitions of R&D. For example, a definition is set
out in International Accounting Standard (IAS)
38 “Intangible assets” and is based on the OECD
“Frascati” manual. Research is defined as original and
planned investigation undertaken with the prospect
of gaining new scientific or technical knowledge and
understanding. Expenditure on research is recognised
as an expense when it is incurred. Development
is the application of research findings or other
knowledge to a plan or design for the production of
new or substantially improved materials, devices,
products, processes, systems or services before the
start of commercial production or use. Development
costs are capitalised when they meet certain criteria
and when it can be demonstrated that the asset will
generate probable future economic benefits. Where
part or all of R&D costs have been capitalised, the
additions to the appropriate intangible assets are
included to calculate the cash investment and any
amortisation eliminated.
2. R&D expenditures funded by the business enterprise
sector (BES-R&D), provided by official statistics, refer
to the total R&D expenditures within a territorial unit
that have been funded by private or public companies
(business enterprise sector).
3. Net sales follow the usual accounting definition of
sales, excluding sales taxes and shares of sales of joint 
ventures & associates. For banks, sales are defined
as the “Total (operating) income” plus any insurance
income. For insurance companies, sales are defined as 
“Gross premiums written” plus any banking income.
4. R&D intensity is the ratio between R&D investment
and net sales of a given company or group of
companies. At the aggregate level, R&D intensity is
calculated only by those companies for which data
exist for both R&D and net sales in the specified year.
The calculation of R&D intensity in the Scoreboard is
different from than in official statistics, e.g. BES-R&D,
where R&D intensity is based on value added instead
of net sales.
5. Operating profit is calculated as profit (or loss) before
taxation, plus net interest cost (or minus net interest
income) minus government grants, less gains (or plus
losses) arising from the sale/disposal of businesses or
fixed assets.
6. One-year growth is simple growth over the previous
year, expressed as a percentage: 1 yr growth =
100*((C/B)-1); where C = current year amount, and B
= previous year amount. 1yr growth is calculated only
if data exist for both the current and previous year. At
the aggregate level, 1yr growth is calculated only by
aggregating those companies for which data exist for
both the current and previous year.
7. Capital expenditure (Capex) is expenditure used by
a company to acquire or upgrade physical assets such
as equipment, property, industrial buildings. In accounts 
capital expenditure is added to an asset account (i.e.
capitalised), thus increasing the asset’s base. It is
disclosed in accounts as additions to tangible fixed
assets.
8. Number of employees is the total consolidated
average employees or year-end employees if average
not stated.
Glossary of definitions
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The analysis of chapter 5 applies an extended sample 
of 1000 companies based in the EU. It consists of 567 
companies included in the world R&D ranking of top 2500 
companies and additional 433 companies also ranked by 
level of R&D investment. The composition by country and 
industry of the EU 1000 sample is presented in the table 
A3.1 below.
Composition of the EU 1000 sampleA .3
Industry
EU country codes
AT BE CZ DE DK ES FI FR GR HU IE IT LU MT NL PL PT SE SI UK Tot
Aerospace & Defence 1 1 3 1 5 1 2 1 9 24
Alternative Energy 4 1 1 6
Automobiles & Parts 3 1 21 1 6 5 2 2 9 50
Banks 2 6 2 2 1 2 2 1 2 2 3 25
Beverages 1 1 2 4
Chemicals 2 3 14 1 3 2 3 3 11 42
Construction & Materials 2 4 7 1 4 2 4 2 1 1 1 2 4 35
Electricity 1 1 1 2 2 2 2 1 1 3 16
Electronic & Electrical Equip. 3 3 15 2 2 7 1 4 1 5 4 19 66
Equity Investment Instr. 1 1
Financial Services 6 1 3 3 13
Fixed Line Telecom. 1 1 1 1 1 1 6
Food & Drug Retailers 1 2 3
Food Producers 1 2 1 2 3 2 2 3 10 26
Forestry & Paper 3 1 2 1 7
Gas, Water & Multiutilities 1 2 3 1 3 10
General Industrials 2 1 15 1 1 1 1 1 2 5 9 39
General Retailers 3 1 5 9
Health Care Equip. & Services 1 11 3 3 2 2 5 13 40
Household Goods & Home Constr. 5 1 2 2 1 2 1 4 18
Industrial Engineering 5 1 35 3 3 7 7 2 7 2 4 12 12 100
Industrial Metals & Mining 2 3 4 1 1 1 3 1 2 1 19
Industrial Transportation 1 1 1 3 2 1 1 10
Leisure Goods 2 1 4 7
Life Insurance 1 1 2 4
Media 5 2 7 14
Mining 1 2 2 5
Mobile Telecom. 1 2 1 1 1 3 9
Nonlife Insurance 1 1 2 4
Oil & Gas Producers 1 1 1 1 1 2 7
Oil Equip., Services & Distribution 1 1 1 1 4
Personal Goods 7 3 3 1 14
Pharmaceuticals & Biotechnology 1 9 16 10 4 2 21 1 1 10 5 9 1 1 9 1 50 151
Real Estate Investment & Services 3 3 6
Software & Computer Services 2 1 19 2 2 5 16 1 2 1 7 56 114
Support Services 11 1 1 1 1 3 18 36
Technology Hardware & Equip. 2 2 6 1 1 5 1 1 6 8 11 44
Tobacco 1 1 2
Travel & Leisure 1 2 1 1 1 1 3 10
Total 28 35 3 224 32 21 36 108 5 1 27 38 15 1 46 2 4 82 2 290 1000
TABLE A3.1: DISTRIBUTION OF THE SAMPLE OF 1000 COMPANIES BASED IN THE EU BY COUNTRY AND INDUSTRY.
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The 2017 Scoreboard comprises two data samples:
• The world’s top 2500 companies that invested more
than €24 million in R&D in 2016/17.
• The top 1000 R&D investing companies based in the
EU with R&D investment exceeding €7 million.
For each company the following information is available: 
• Company identification (name, country of registration
and sector of declared activity according to the Score-
board sector classification).
• R&D investment
• Net Sales
• Capital expenditure
• Operating profit or loss
• Total number of employees
• Market capitalisation (for listed companies)
• Main company indicators (R&D intensity, Capex inten-
sity, Profitability)
• Growth rates of main indicators over one year and
three years.
The following links provide access to the two Scoreboard 
data samples containing the main economic and financial 
indicators and main statistics over the past four years.
R&D ranking of world top 2500 companies.
http://iri.jrc.ec.europa.eu/documents/10180/edefa311-
3325-46fc-aca8-8bbac469afe6
R&D ranking of EU top 1000 companies.
http://iri.jrc.ec.europa.eu/documents/10180/bb866d5b-
8722-4c65-96dc-31cc525949ab
Access to the full datasetA .4
European Commission
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Abstract
The 2017 edition of the EU R&D Scoreboard (the Scoreboard) comprises the 2500 companies investing 
the largest sums in R&D in the world in 2016/17. These companies, based in 43 countries, each invested 
over €24m in R&D for a total of €741.6bn which is approximately 90% of the world’s business-funded 
R&D. They include 567 EU companies accounting for 26% of the total, 822 US companies for 39%, 365 
Japanese companies for 14%, 376 Chinese for 8% and the rest-of-the-world (RoW) for 13%. 
Worldwide, companies’ R&D investment increased by 5.8% over the previous year, the sixth consecutive 
year of significant increases. The companies headquartered in the EU increased their R&D investments 
more than the global average up to 7.0%. This increase is similar to the US (7.2%) and substantially above 
Japan (-3.0%). Chinese companies increased their R&D investment by 18.8%.
R&D growth was driven by ICT services (+11.7%), followed by Health and ICT producers (6.9% and 6.8% 
respectively). These three sectors, together with Automobiles, account for 75% of the total R&D of the 
2500 companies in the Scoreboard. R&D investment of companies in the Automobiles and Aerospace & 
Defence sectors grew at a lower pace (2.7% and 2.2%, respectively), whereas that of Chemicals companies 
decreased (-1.9%).
In the EU, R&D growth was driven by the same sectors as worldwide, i.e. ICT producers (+14.4%), ICT 
services (+12.7%), Health industries (+7.9%) and Automobiles (+6.7%). However, companies from a few 
important sectors for the EU economy decreased their R&D, in particular Aerospace & Defence (-5.4%) and 
to a lesser extent Chemicals (-0.8%).
The 2017 Scoreboard includes an analysis of the 10-year economic and R&D performance of the top R&D 
investors showing that:
• The EU share of world R&D remained constant at 26%, whereas at sector level, significant changes in
EU’s R&D shares are observed, namely an increase in the Automobiles sector (from 36% to 44%) and a
decrease in Aerospace & Defence (from 48% to 42%).
• Compared to their non-EU counterparts, EU companies outperform or perform comparably in size (of
R&D and sales) and R&D intensity for Aerospace & Defence, Automobiles and Pharmaceuticals. But in
Biotechnology, Software and IT hardware the EU shows persistent weaknesses in most indicators such
as size and R&D/firm or sales/firm (in particular compared to US companies). The EU/non-EU gap in
these latter three sectors has widened over the last ten years.
• In terms of productivity (net sales/employee ratio), EU and US companies showed similar overall
performance (ca. 14% increase in both net sales and employment). However, at sector level, contrasting 
productivity changes are observed, e.g. in Automobiles, EU 17% vs. US -15%; in ICT sectors, EU -1% vs.
US 31% and in low tech sectors, EU -10% vs. US -33%.
All over the European Union there are hundreds of Europe Direct information centres. You can find the address of the centre nearest
you at: http://europea.eu/contact 
Europe Direct is a service that answers your questions about the European Union. You can contact this service:
– by freephone: 00 800 6 7 8 9 10 11 (certain operators may charge for these calls), 
– at the following standard number: +32 22999696, or 
– by electronic mail via: http://europea.eu/contact
Information about the European Union in all the official languages of the EU is available on the Europa website at: http://europa.eu  
You can download or order free and priced EU publications from EU Bookshop at: http://bookshop.europa.eu. Multiple copies of free 
publications may be obtained by contacting Europe Direct or your local information centre (see http://europa.eu/contact).
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